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ABSTRACT 
Daniel A. Riccio: S-Nitrosothiol-Derived Nitric Oxide Delivery Vehicles: Synthesis and 
Detection 
(Under the direction of Professor Mark H. Schoenfisch) 
 
 The bioactivity of nitric oxide (NO) is endogenously transduced by S-nitrosothiols 
(RSNOs), a class of NO donor that may decompose via thermal, photolytic, or reductive 
pathways. Recent research has focused on employing RSNOs as NO delivery agents for 
biomedical applications. As part of my doctoral work, I have designed NO-releasing sol-
gel-derived materials using RSNOs. Thiol functionalities are readily incorporated 
throughout silica scaffolds via the hydrolysis and co-condensation of 
mercaptopropyltrimethoxysilane and alkoxysilanes. After nitrosation, NO storage levels 
up to 4.40 µmol mg
-1
 may be achieved. As anticipated, the NO release is dependent on 
heat, light, and/or copper concentration. For particle synthesis, a high degree of control 
over monodispersity and size may be obtained using controlled silane addition rates. 
Additionally, greater water concentrations during synthesis decrease particle size without 
altering NO storage. 
 To prolong NO release, tertiary RSNO functionalities were incorporated within 
xerogel films by hydrolysis and co-condensation of a novel tertiary thiol-bearing silane 
with alkoxy- and alkylalkoxysilanes. Nitrosation resulted in NO storage up to 1.78 μmol 
cm
-2
 dependent on the concentration of silane precursors and coating thicknesses. These 
materials exhibited enhanced stability due to steric hindrance surrounding the nitroso 
group, as evidenced by release of only ~11% of the stored NO after 24 h at 37 °C. 
  
iii 
Photolysis may be used to trigger NO release from the films at physiological temperature 
irrespective of soak time. Indeed, NO fluxes were greater under irradiation than in the 
dark (e.g., ~23 vs. 3 pmol cm
-2
 s
-1
, respectively). A benefit of such NO release was 
demonstrated whereby ~90% less bacteria adhered to RSNO-modified xerogels when 
irradiated.  
 In the last phase of my dissertation research, RSNO decomposition to NO by 
visible photolysis was coupled with a NO-permselective electrode to develop a RSNO 
electrochemical sensor. Increasing the irradiation time enhanced sensitivity up to 1.56 nA 
μM-1 and lowered the theoretical detection limit to 30 nM for low molecular weight 
RSNOs. Detection of a nitrosated protein was also possible, but at decreased sensitivity 
(0.11 nA μM-1). This methodology was demonstrated by measuring RSNOs in plasma, 
illustrating the potential to elucidate the basal levels of RSNOs in circulation.
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Chapter 1:  
Nitric Oxide Delivery and Measurement of S-Nitrosothiol Transport Vehicles 
 
1.1  Nitric oxide and low molecular weight NO donors 
Ignarro, Furchgott, and Murad’s Nobel Prize-winning discovery that the endothelial 
derived relaxation factor (EDRF) was in fact nitric oxide (NO) inaugurated an extensive swell 
of research into the pivotal role of NO in numerous other physiological systems.
1
 The diverse 
list of biological processes that NO is associated with includes vasodilation
2
, platelet 
aggregation and adhesion,
2
 the immune response to infection,
3
 wound repair,
4
 as well as 
cancer biology and pathology.
5
   
Nitric oxide is produced endogenously from L-arginine via the enzyme nitric oxide 
synthase (NOS).
2
 Due to its integral role in human physiology, deficiencies in NO 
biosynthesis have been linked to a number of disease states.
6
 Strategies for delivering 
exogenous NO thus hold promise for a number of biomedical applications ranging from 
cardiovascular regulation to antimicrobial and tumoricidal therapies. However, the reactivity 
of NO gas has hindered the development of effective NO-based therapies.
7
  
In response to the need for controlled NO delivery, much work has focused on the 
synthesis of NO donors.
8
 Many classes of NO donors exist, including organic nitrates, 
nitrites, metal–NO complexes, nitrosamines, N-diazeniumdiolates (NONOates), and S-
nitrosothiols (RSNOs). Based on their ability to spontaneously release NO in physiological 
media, NONOates and RSNOs represent the most widely used NO donor systems. 
 2 
N-Diazeniumdiolates are arguably the most extensively studied and used class of NO 
donors. Stable NONOates are formed via the reaction of secondary amines with high 
pressures (i.e., 5 atm) of NO (Figure 1.1).
9
 Efficient diazeniumdiolate formation requires the 
presence of a second basic residue, either an unreacted amine substrate or an added metal 
alkoxide base, to deprotonate the backbone amine and promote its nucelophilic attack on NO. 
The cation (e.g., protonated additional amine or metal from alkoxide base) stabilizes the 
charge of the resulting anionic NONOate. N-Diazeniumdiolates are attractive as NO donors 
because they decompose to NO upon protonation of the amine bearing the NONOate moiety. 
Indeed, NONOates regenerate the parent amine compound and two moles of NO per mole of 
donor in physiological solution (i.e., 37 C, pH 7.4).9 The structure of the amine precursor 
directly affects the NO release kinetics. Certain N-diazeniumdiolate polyamines exhibit 
lengthy durations of NO release due to hydrogen bonding stabilization from additional 
amines. For example, diethylenetriamine (DETA/NO) features an NO release half-life (t1/2) of 
20 h.
9
 In contrast, the NO release from metal cation-stabilized N-diazeniumdiolate adduct of 
the amino acid proline (PROLI/NO) is rapid with a t1/2 of only 1.8 s.
9
 
In contrast to the strictly exogenous NONOates, RSNOs are an endogenous class of 
NO donor touted as the physiological transporters of NO in vivo.
10
 In the lab, RSNOs are 
prepared upon reaction of a thiol with a nitrosating agent (e.g., alkyl nitrite, dinitrogen 
trioxide, or nitrous acid) (Figure 1.2).
8
 Confirmation of RSNO formation is easily made by 
their color as they absorb light in both the UV (225–261 and 330–350 nm) and the visible 
(550–600 nm) regions.8  
Whereas NONOates decompose and release NO as a function of pH, RSNOs may 
decompose via multiple triggers (Figure 1.2).
8
 For example, thermal and photoinitiated 
decomposition of RSNOs results in homolytic cleavage of the S–N bond to generate a thiyl  
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Figure 1.1 N-Diazeniumdiolate formation and decomposition of representative secondary amine-
bearing compounds, illustrating the difference between metal cation and protonated amine 
formation and stabilization. 
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Figure 1.2 S-Nitrosothiol formation and decomposition. 
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radical and NO.
10
 The thiyl radical further reacts with another RSNO to yield a disulfide and 
additional NO. Trace copper ions also affect RSNO decomposition.
10
 Reduction of Cu(II), 
usually by trace thiolate, forms Cu(I) that subsequently reacts with RSNOs to produce NO, 
the thiolate and Cu(II). The thiolate may then regenerate Cu(I) from Cu(II), propagating the 
catalytic decomposition of RSNOs to NO. Transnitrosation or the direct transfer of the nitroso 
functionality to a free thiol (R’SH) also impacts RSNO stability, resulting in the formation of 
R’SNO and RSH.10 The newly generated R’SNO then decomposes by one of the 
aforementioned triggers releasing NO. 
Low molecular weight (LMW) NO donors have been used to study the influence of 
exogenous NO on a number of cardiovascular, central nervous system, and immunological-
related disorders.
8
 These compounds have demonstrated remarkable antiplatelet, 
antimicrobial, antitumor, and vasodilatory activities with great potential as therapeutics in the 
biomedical arena. However, the inability to target NO to a specific site of action, the rapid 
systemic clearance associated with LMW species, toxicity concerns, and the undesirable low 
doses of NO have hindered their clinical development. As such, much recent research has 
focused on the synthesis of macromolecular NO-releasing vehicles. 
 
1.2  Macromolecular NO donors 
An ideal NO-releasing macromolecular vehicle would be multifunctional and consist 
of multiple NO donors to achieve a desirable payload. Multifunctionalization would allow for 
advanced tailoring of the scaffold, including chemistry for targeting delivery, tuning 
biodistribution, and controlling toxicity. In this chapter, an overview of the most promising 
NO release macromolecular scaffolds including NO donor functionalization of proteins, 
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organic, inorganic, and hybrid polymeric materials is provided. For further breadth, the reader 
is directed to more extensive reviews of NO-releasing macromolecular materials.
11-15
  
 
1.2.1  Proteins 
The innate specificity associated with biological function makes proteins attractive as 
macromolecular NO donor scaffolds capable of targeting NO to a site of physiological 
interest. Seeking the ability to target NO, Hrabie et al. modified the lysine residues within 
human and bovine serum albumin (BSA) with a methoxymethyl-protected (MOM) 
diazeniumdiolated piperazine.
16
 These NO donor conjugates were characterized as having 
extremely long NO release half-lives (on the order of 20 d) due to the stability of the MOM 
protecting group that required hydrolysis prior to diazeniumdiolate decomposition to NO. The 
multiple (59) lysine residues on the albumins enabled enhanced NO donor loading, although 
mass spectroscopic analysis indicated that only ~20 of the 59 lysine residues were converted 
to NO donor form. Nevertheless, the authors reported ~40 mol NO per mol of protein with 
NO release levels approaching ~1 pmol NO mg
-1
 s
-1
. 
Due to their physiological ubiquity, more work has been done with S-nitrosothiol-
modified proteins and biomolecules with respect to NO donor modification. Although the 
single free cysteine residue on serum albumin restricts storage to 1 mole of RSNO per mole 
of protein, Stamler and coworkers reduced the 17 disulfide bonds that maintain the tertiary 
structure of BSA to increase the number of NO reactive thiol sites available for nitrosation, 
resulting in 19.2 ± 3.1 mol of NO storage (as RSNO) per mol of protein.
17
 The resulting 
protein denaturation to enable enhanced NO storage capability was an obvious drawback to 
this approach. Thus, others have developed more mild chemical modification strategies to 
store NO onto serum albumin. For example, Ewing et al. polythiolated BSA with N-
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acetylhomocysteine thiolactone to store 12 ± 3 mol of NO per mol of BSA after nitrosation.
18
 
Unfortunately, the thiolation induced protein oligomerization causing a heterogenous 
molecular mass and also affected protein activity. 
To improve the thermal stability of RSNO moieties by decreasing homolytic cleavage 
of the S–N bond via a cage effect, Katsumi et al. modified BSA with polyethylene glycol 
(PEG).
19
 The PEG-modified BSA was then reacted with N-succinimidyl S-acetylthiolate 
(SATA). Deacetylation of the thiol groups on SATA and subsequent nitrosation yielded the 
PEG-poly SNO-BSA macromolecule. This NO-releasing vehicle was estimated to have an 
average molecular mass of 250 kDA and with ~37 mol of PEG and ~10 mol of NO per mol of 
protein. As expected, the PEG modification both reduced protein aggregation and extended 
the NO release half-life (147 ± 9 h), roughly 11 times greater than that of nitrosated BSA and 
108 times greater than that of the LMW S-nitroso-N-acetyl penicillamine (SNAP). While NO-
releasing proteins represent an advancement over LMW analogues, their limited NO payloads 
ultimately restrict their potential utility. 
 
1.2.2  Encapsulation of NO and low molecular weight NO donors 
To enhance NO loading, macromolecular vesicles have been used to encapsulate large 
quantities of NO active species (e.g., gaseous NO or LMW NO donors). As shown in Figure 
1.3, NO gas encapsulation offers the distinct advantage of utilizing the active therapeutic 
directly versus only delivering a prodrug requiring an activation trigger to produce NO. The 
amount of active species encapsulated within such a macromolecular scaffold would be 
enhanced because space would not be required for the inactive portion of the prodrug. 
Cavalieri et al. developed poly(vinyl alcohol) (PVA) microbubbles loaded with gaseous 
NO.
20
 Briefly, PVA scaffolds were synthesized at pH 5 and at room temperature to yield  
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Figure 1.3 Representation of macromolecular vesicles encapsulating (A) gaseous NO or (B) 
LMW NO donor compounds (blue spheres). Nitric oxide freely diffuses from the scaffold when 
encapsulated as a gas, but water diffusion through the scaffold shell is necessary to initiate NO 
release when LMW NO donors are employed. 
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microbubbles 4.6 ± 0.4 µm in diameter. Exposure of freeze dried microbubbles to 1.5 bar of 
NO gas for 2 h resulted in NO loading within the microbubbles as verified via electron 
paramagnetic resonance spectroscopy. Approximately 3.6 µmol of NO was loaded per mg of 
microbubble with release durations in phosphate buffered saline (PBS) approaching 2 h. Of 
note, NO was released in the ambient as well indicating spontaneous loss via diffusion 
through the 0.4 µm thick shell. Unfortunately, NO gas encapsulation is hindered by the lack 
of control over NO release rates, suggesting little clinical utility for this avenue of NO 
therapy. 
The encapsulation of LMW NO donor compounds was pursued as a solution to the 
rapid NO release kinetics characteristic of encapsulated gaseous NO (Figure 1.3). Jeh et al. 
reported a double emulsion and solvent evaporation technique to encapsulate LMW 
PROLI/NO within poly-lactic-co-glycolic acid (PLGA) and polyethylene oxide-co-lactic acid 
(PELA) microparticles.
21
 The PROLI/NO encapsulation was dependent on the microparticle 
composition with only the PELA microparticles (~2.3 μm diameter) proving capable at 
trapping PROLI/NO and effectively storing 123 ± 7.6 nM NO per mg. The addition of gelatin 
as a hydrophilic binding agent only slightly increased the PROLI/NO entrapment efficiency 
for PELA, but facilitated PROLI/NO storage within the PLGA-based microparticles. 
Unfortunately, the gelatin and concomitant more hydrophilic structure resulted in accelerated 
NO release due to increased water uptake. 
 
1.2.3  Polymeric organic scaffolds 
The first tunable NO-releasing polymeric microparticles were reported by Meyerhoff 
and coworkers.
22
 Multiple secondary amine-functionalized methacrylate monomers were 
employed in free radical benzoyl peroxide-initiated polymerization to yield both 
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homopolymers and methyl methacrylate-based copolymers. A suspension polymerization was 
utilized with methyl methacrylate, the amine-bearing monomer, and 1,6-
hexanedioldimethacrylate as a cross-linking agent to yield polymeric microbeads. Scanning 
electron microscopy (SEM) indicated the size of the beads as 100–200 μm. Following a 
deprotection step, exposure to high pressures of NO in sodium methoxide resulted in NO-
releasing microbeads with tunable NO storage based on the mol% of the amine-
functionalized monomer (i.e., 20 and 40 mol%). A 40 mol% polymethacrylate microbead 
released 1.05 μmol NO mg-1 over 15 h in physiological conditions. Of note, the high density 
of amines within the particles was found to increase the local pH and slow diazeniumdiolate 
decomposition drastically, resulting in only partial (50%) release of the stored NO.  
Due to precise control over size and the ability to multifunctionalize their structures to 
enable targeting and tracking, dendrimers have become ubiquitous as drug delivery vehicles 
in the biomedical arena.
23
 Defined generations of branching and corresponding exponential 
increase in end group surface functionalities are inherent to their chain growth synthesis. As 
such, their multifunctionality has been utilized to produce NO-releasing macromolecular 
scaffolds with large reservoirs of NO (Figure 1.4).
24, 25
 The potential of dendrimers as 
powerful NO storage/release vehicles was first reported by Stasko and Schoenfisch using 
commercially available generation 3 and 5 polypropylenimine dendrimers (DAB-Am-16 and 
DAB-Am-64 with 16 and 64 primary amine end groups, respectively).
24
 Since the primary 
amine-derived dendrimers stored only small amounts of NO (0.44–0.69 μmol mg-1) due to 
low NO donor conversion, secondary amines with alky tails were synthesized by reacting the 
dendrimers with heptanoyl chloride. Upon subsequent reduction and NO donor formation at 
the secondary amine sites, the NO storage levels were dramatically improved (3.2 and 3.5 
μmol mg-1 for generation 3 and 5, respectively). Both the enhanced NO storage and NO  
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Figure 1.4 Representation of generation 3 polyamidoamine (PAMAM) dendrimer as a typical 
dendritic scaffold exhibiting highly branched and defined architecture with resulting surface 
functionalities modified as NO donors (blue spheres). 
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release durations were attributed to the stability of secondary amine-based diazeniumdiolates 
and the hydrophobic nature of the alkyl tails, limiting proton-initiated diazeniumdiolate 
breakdown. The large concentration of amines regenerated upon initial diazeniumdiolate 
decomposition was postulated to increase local pH and slow further decomposition, resulting 
in sustained NO release. To further demonstrate the utility of the dendrimers, the DAB-Am-
64 was reacted with propylene oxide to yield a scaffold with secondary amines and a more 
hydrophilic end group. The hydrophilic dendrimer adopted a fully extended conformation in 
solution that lead to increased diazeniumdiolate and NO storage (5.6 μmol mg-1), but at the 
expense of more rapid NO release kinetics. 
In a subsequent study, Stasko et al. functionalized generation 4 polyamidoamine 
(PAMAM) dendrimers with either N-acetyl,-D,L-penicillamine or N-acetyl-L-cysteine to yield 
thiol-terminated dendrimers.
25
 Nitrosating the macromolecular scaffolds yielded S-
nitrosothiol-modified dendrimers (G4-SNAP and G4-NACysNO). Both conjugates achieved 
appreciable total NO storage of ~2 μmol NO per mg of scaffold, yet their NO release kinetics 
varied based on the trigger (i.e., copper ion concentration, light). Although LMW tertiary 
RSNOs are generally regarded as more stable than their primary counterparts, the primary 
RSNO-derived G4-NACysNO exhibited greater stability/resilience than the tertiary G4-
SNAP regardless of the NO release trigger. This effect was attributed to a more compact 
solution structure for G4-NACysNO that increased the tendency for radical recombination 
between the thiyl and NO. Overall, this work showcases significant evolution of NO release 
scaffolds with respect to NO payloads, release durations, and release kinetics. 
 
1.2.4  Metallic nanoparticles 
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Metallic clusters have become widely studied in biomedicine for their unique size-
dependent properties that distinguish them from bulk materials.
26
 For example, many metallic 
particles offer the capability of surface plasmon resonance, hyperthermia, and magnetic 
targeting.
27-29
 Potential applications for these nanomaterials include molecular imaging 
diagnostics, drug delivery vehicles, and therapeutic agents. 
Rothrock et al. first reported on the synthesis of NO-releasing monolayer-protected 
cluster (MPC) gold nanoparticles.
30
 The nanoparticles (~2 nm) were synthesized via the 
Brust-Schiffrin method and capped with hexanethiol ligands. These ligands were then 
exchanged with bromoalkane thiols. Subsequent reaction with ethylendiamine, butylamine, 
hexanediamine, or DETA resulted in secondary amine functionalization that upon exposure to 
NO gas resulted in NO-releasing gold nanoparticles. Both the NO storage and NO release 
kinetics were tunable by varying the amount and/or amine structure. While these particles 
represented the smallest nanometer-sized NO-releasing scaffold to date, the total NO storage 
was limited (~0.04 μmol NO per mg of scaffold). Due to both restricted NO storage and poor 
solubility in aqueous media, the potential of these materials as NO delivery agents was 
concluded to be lacking. 
To design water soluble NO-releasing MPCs, Polizzi et al. synthesized tiopronin-
protected gold clusters.
31
 N-Hydroxy-succinimide (NHS) and N-(3-dimethylaminopropyl)-N-
ethylcarbodiimide (EDC) chemistry was then used to attach either DETA, 
tetraethylenepentamine, or pentaethylenehexamine to the carboxylic acid groups of the 
tiopronin-MPCs. Similar to the water-insoluble secondary amine MPCs, the diazeniumdiolate 
NO donor conversion efficiency was only ~1%. To increase the NO storage capacity of the 
gold nanoparticles, polyamine-stabilized MPCs (~5 nm) were synthesized directly (i.e., 
without tiopronin) with significantly enhanced NO release (up to 0.386 μmol NO per mg of 
 14 
scaffold) and durations (~16 h), depending on the polyamine. However, thermogravimetric 
analysis indicated that the polyamine ligands were attaching to the gold surface via both 
primary amine end groups, thus limiting NO donor conversion and overall NO storage. 
The gold nanoparticles reported by Schoenfisch and co-workers
30, 31
 employed N-
diazeniumdiolate-modified NO release materials characterized by spontaneous NO release in 
aqueous media (physiological pH). To enable control over NO release, Sortino and co-
workers synthesized water-soluble platinum (Pt) MPCs with a photoactive NO release 
trigger.
32
 Thioglycolic acid ligands bound to the Pt nanoparticles (~1 nm) were used to render 
the particles water soluble. A partial phase exchange of these carboxy-terminated groups with 
a nitroaromatic-terminated alkane thiol ligand resulted in NO release capable, water soluble 
particles. While not a traditional NO donor class, the aromatic nitro group proved to be a 
novel NO-releasing substituent upon irradiation with visible light. Spectroscopic analysis 
revealed ~6 NO donors per Pt cluster. The NO storage of the material was thermally stable, 
but capable of liberating NO at a rate of 1.5 pmol s
-1
 upon visible light irradiation. In a 
subsequent report, a bifunctional NO release macromolecular scaffold was synthesized with 
mapping capacity via photoluminescence.
33
 A thiol-derivatized porphyrin and the NO 
photodonor ligand were immobilized on the Pt surface via place exchange with some of the 
carboxy ligands. Neither the NO-releasing nor porphyrin ligand influenced the photobehavior 
of the other when attached to the Pt surface. However, the porphyrin did influence particle 
size and more specifically induced particle aggregation (~10 nm aggregates). Water solubility 
was still retained due to the carboxy-terminated ligands. While the amount of porphyrin and 
NO photodonor ligand was tunable by varying the reaction time and/or molar ratio used in the 
exchange, the authors noted that reaction times longer than 30 min resulted in extensive 
replacement of the carboxy ligands, thus sacrificing the aqueous solubility of the particles. As 
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expected, the NO storage of the Pt nanoparticle assemblies was stable in the dark at room 
temperature. Upon irradiation with visible light, nanomolar levels of NO were released at a 
rate of ~0.9 nM s
-1
. Unfortunately, the NO release kinetics were not normalized to mass of 
particles and thus direct comparison of these scaffolds to other NO-releasing macromolecular 
vehicles remains unclear. 
 
1.2.5  Zeolites and molecular organic frameworks 
Zeolites and metal organic frameworks (MOFs) are highly porous materials that have 
found wide utility in the fields of ion exchange, catalysis, and gas adsorption/storage.
34-37
 
Morris and coworkers have pioneered the application of zeolites and MOFs to the field of NO 
release scaffolds.
38
 For zeolitic structures, NO is chemisorbed to cations associated with the 
inorganic framework. These nitrosyl complexes may then be displaced with an appropriate 
nucleophile (e.g., water) to initiate NO release. In an initial study, Wheatley et al. used 
Zeolite-A, an alternating alumina/silica network with cobalt cations to chemisorb NO.
39
 
These materials were capable of storing ~1.2–1.3 μmol NO per mg of zeolite. Unfortunately, 
this material was not water soluble and the only way to reproducibly measure the NO release 
was by exposure to a steady stream of wet gas with controlled humidity. Using a stream of 
nitrogen at 11% relative humidity (RH), these materials were shown to release 1.02 μmol NO 
per mg of zeolite over 2500 s with an associated half-life of ~340 s. Altering the humidity of 
the gas influenced the NO kinetics. More humid gas (22% RH) decreased the half-life to 208 
s, while a drier gas (1.5% RH) increased the NO release half-life to >3000 s. The identity and 
amount of the metal ion (e.g., Co, Ni, Cu, Mn, and Na) within the zeolite channels was also 
shown to influence NO release based on the affinity of each metal to bind NO, with Co 
storing the greatest amount. 
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Xiao et al. first reported the ability to store NO using a MOF consisting of copper 
benzene tricarboxylate referred to as HKUST-1.
40
 The material was loaded with NO by 
exposure to pressurized NO gas (1 bar) at 196 K. The HKUST-1 could adsorb ~9 μmol of NO 
per mg of MOF. Desorption of the material revealed that most of the NO was physisorbed 
within the pores of the material, but roughly 2.21 μmol mg-1 was strongly chemisorbed to 
open metal sites (i.e., unsaturated with ligands) at approximately 1 NO equivalent per 
dicopper(II) tetracarboxylate group. Exposing the NO-loaded HKUST-1 to a stream of wet 
nitrogen gas resulted in water displacing only a fraction of the chemisorbed NO (~1 nmol NO 
per mg of MOF).
39
 The lack of dispersal in solution, the inaccessibility of the total NO stored 
payloads, and potential cytotoxicity to healthy cells circumvents therapeutic use or potential 
of this MOF scaffold at this stage. Of note, more recent NO-releasing MOFs have shown 
improved delivery behavior over HKUST-1 with nearly total release (~7 μmol NO per mg of 
MOF) achieved in one example.
41
 
Other researchers have focused on overcoming the rapid release of chemisorbed NO 
coordinated to metal sites in conventional MOF structures.
42-44
 For example, Nguyen et al. 
attempted to incorporate NO donors within MOF scaffolds by employing 2-amino-1,4-
benzenedicarboxylic acid as an organic linker between metal sites.
43
 By forming N-
diazeniumdiolates on pendant amines of the linker, the resulting materials released up to 
~0.51 μmol NO per mg of MOF. Unfortunately, the release was still rapid (~5 min) and the 
materials lost ~20% of their NO payload after 10 d of storage due to the well-known 
instability of primary amine-based diazeniumdiolates.
9
 Of note, the parent MOFs (i.e., 
IRMOF-3 and UMCM-1-NH2) used for these studies lack open metal sites characteristic of 
the aforementioned NO-releasing MOFs (e.g., HKUST-1). Thus, the NO was not 
chemisorbed at metal centers concomitantly with diazeniumdiolate formation on the organic 
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linkers of these scaffolds (Figure 1.5). A MOF design that incorporates both features of NO 
functionalization may hold greater therapeutic potential. 
 
1.3.  Nitric oxide-releasing silica particles 
 
1.3.1  Surface grafting 
Silica-based materials have become ubiquitous in the biomedical arena due to their 
straight forward synthesis that enables customization of size, morphology, and 
composition.
45-48
 Furthermore, silica is well regarded as a stable and nontoxic drug delivery 
vehicle. Among the first reports of silica as a macromolecular scaffold for NO release, Zhang 
et al. grafted aminosilanes to the surface of fumed silica particles (0.2–0.3 μm).49 Roughly, 
50–70% of the surface silanols were functionalized. As a result, NO storage was rather 
limited (~0.6 μmol NO per mg of silica). While the structure of the precursor amine 
influenced the rate of NO release, the dissociation kinetics were complex with little 
correlation to structure. However, the NO release half-lives of the particles were significantly 
longer than their solution phase LMW analogs. This phenomenon was attributed to local 
surface increases in pH due to the large concentration of amines at the silica surface following 
NO donor decomposition, illustrating a benefit afforded solely by the macromolecular 
scaffold. 
In subsequent work, Frost et al. grafted fumed silica particles (7–10 nm) with APTMS 
and then linked cysteine, N-acetyl-L-cysteine, or N-acetyl-DL-penicillamine to the particles 
using amide chemistry.
50
 The derivatization yielded free thiols up to ~0.142 μmol per mg of 
particles. Upon treatment with an organic nitrosating agent (i.e., t-butylnitrite), RSNOs were 
formed on the silica scaffolds, with the S-nitroso-N-acetylpenicillamine (SNAP) storing the  
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Figure 1.5 Representations of (A) a MOF with chemisorbed NO at its metal sites (red spheres) 
and (B) of IRMOF-3 with diazeniumdiolate formation on its organic bridging ligands. 
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greatest payload (~0.138 μmol NO per mg). The authors postulated that the smaller size of the 
protected thiolactone for the SNAP coupling led to more thiol and resulting NO loading. 
Similar to LMW RSNO analogs, the NO release levels of the particles were found to be 
dependent on the concentration of copper and light exposure.  
 
1.3.2  Sol-gel Chemistry 
Although capable of imparting NO release, a disadvantage of surface grafting as a 
strategy for functionalizing silica is the limited and low NO loading per particle.
49, 50
 In 
contrast, sol-gel chemistry allows for the formation of silica scaffolds with organo 
functionalities throughout, enabling unparalleled tunability in terms of particle size, 
morphology, composition, and NO release.
45
 As shown in Figure 1.6, sol-gel chemistry 
proceeds via acid or base-catalyzed hydrolysis and condensation of silane precursors to form 
a network of siloxane bonds.
51
 Use of organosilanes in conjunction with alkoxysilanes results 
in their co-condensation and the covalent attachment of desired functionality (e.g., NO donor 
precursors) throughout the silica network. Multiple synthetic parameters including the catalyst 
type, solvent, precursor silanes, and water to silane ratio affect the resulting material.
51
 
Indeed, variation of such conditions may lead to formation of materials as diverse as highly 
porous aerogels, dense ceramic xerogels, or uniform particles. These parameters also 
influence material integrity (i.e., stability). Shin et al. first reported the co-condensation of a 
number of aminoalkoxysilane precursors including N-(6-aminohexyl)-3-
aminopropyltrimethoxysilane (AHAP3), (aminoethylamino-
methyl)phenethyltrimethoxysilane (AEMP3), and N-(2-aminoethyl)-3-
aminopropyltrimethoxysilane (AEAP3) with either tetramethoxysilane (TMOS) or 
tetraethoxysilane (TEOS) in solutions of alcohol, water, and ammonia.
52
 As anticipated, both  
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Figure 1.6 Reactions involved in the sol-gel synthesis of silica-based materials. 
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the aminosilane concentration and size of the particles were tunable from ~10–77 mol% and 
~20–500 nm, respectively. Exposing the particles to NO gas (5 atm) in a mixture of N,N-
dimethylformamide, methanol, and sodium methoxide for 3 d resulted in NO storage ranging 
from ~0.05–1.78 μmol per mg of silica, with the greatest NO storage attainable for 77 mol% 
AHAP3/TMOS. Of note, this value is roughly three times larger than fumed silica grafted 
with equivalent NO donors.
49
 In addition, the sol-gel-derived silica particles released NO for 
significantly longer periods (12  vs. 2.4 h half-lives for sol-gel vs. surface grafted fumed 
silica, respectively).
49
  
Despite achieving NO release levels that were significantly greater than prior NO-
releasing silica particle systems, the authors noted limited (~5–50 %) NO donor conversion 
efficiencies.
52
 Although sol-gel chemistry allows for incorporation of amine functionalities 
throughout the silica scaffold, the limited particle porosity and amine mobility result in lower 
than expected diazeniumdiolation and NO donor stabilization, respectively. In a subsequent 
paper, Shin and Schoenfisch improved the NO storage/release from these vehicles by forming 
the diazeniumdiolate groups on the aminosilane precursors before particle synthesis.
53
 As 
shown in Figure 1.7, this synthetic strategy enhances the degree of NO donor functionality 
incorporation within the particle when compared to surface grafting and post-synthesis 
diazeniumdiolate modification routes. In addition to NO donor conversion efficiencies 
approaching 99%, the total NO storage for these particles ranged from 0.5–11.3 μmol mg-1. 
The greatest NO storage (11.3 μmol mg-1) was achieved using N-diazeniumdiolated N-(6-
aminohexyl)aminomethyltrimethoxysilane (AHAM3). While the NO release kinetics of 
AHAM3 particles were rapid (NO release half-lives of 4 min), other particle systems (e.g., 
AEMP3 and (3-trimethoxysilylpropyl)diethylenetriamine (DET3)) were shown to release NO 
for significantly greater periods (253 min and 101 h, respectively.) The assorted NO release  
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Figure 1.7 Representations of NO-releasing silica particles modified with NO donors (blue 
spheres) (A) via surface grafting, (B) after particle synthesis and (C) on silane precursors before 
particle synthesis via sol-gel chemistry. Cross section of particle interior depicts a lack of 
functionality within surface-grafted particles and the presence of non-modified precursor 
functionalities (white circles) within traditional sol-gel synthesized particles. 
A CB
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characteristics for NO donor-modified silica exemplify the benefit of the sol-gel approach for 
creating diverse NO release scaffolds.  
Extending the use of sol-gel chemistry to the synthesis of RSNO-modified silica 
particles may similarly enhance NO storage beyond that of previously reported RSNO-
modified surface-grafted silica particles.
50
 An additional benefit of RSNO-modified particles 
is the potential for tunable material  and NO release trigger characteristics by altering the 
synthetic parameters. One goal of my dissertation research was to employ sol-gel chemistry in 
the synthesis of RSNO-modified silica particles.   
 
1.4  Nitric oxide-releasing coatings 
 
1.4.1  Coatings with noncovalently incorporated LMW NO donors 
The vast NO release characteristics achievable with macromolecular scaffolds has 
enabled the development of NO release materials for specific biomedical applications. For 
applications that necessitate NO release directed at an interface (e.g., an indwelling medical 
device), NO-releasing polymeric coatings have been synthesized to elicit localized NO release 
from a surface. In the first report of NO-releasing coatings, Smith et al. doped LMW NO 
donor compounds noncovalently within polymeric matrices (Figure 1.8) to establish NO-
releasing polymers.
54
 More specifically, N-diazeniumdiolated DETA and polycaprolactone 
were mixed to yield a biodegradable polymer that released NO upon breaking down (56 nmol 
of NO per mg over 1 week). In attempting to design hydrophobic NO-releasing polyurethanes 
and poly(vinyl chloride)s (PVC), Mowery et al. observed leaching of LMW NO donors, 
raising concerns about cytotoxicity and nonlocalized NO release.
55
 To avoid leaching, 
Batchelor et al. designed LMW NO donors to be more lipophilic (e.g., N-diazeniumdiolated  
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Figure 1.8 Representations of strategies to fabricate NO-releasing surfaces including (A) doping 
of NO donors and (B) covalent tethering of NO donor functionalities to the polymer backbone. 
Potential leaching of dopants is schematically depicted. 
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dialkylhexamethylenediamines with alkyl groups ranging from methyl to didodecyl) and thus 
enhance their retention within hydrophobic polymers.
56
 In this work, a correlation between 
water uptake by dioctyl sebacate-plasticized PVC and NO release kinetics was reported. As 
expected, films with greater polymer-to-plasticizer ratio (2:1 vs. 1:2) were characterized by 
decreased water uptake and NO flux (~17 pmol cm
-2
 s
-1
 vs. ~100 pmol cm
-2
 s
-1
) with 
extended release duration (100 vs. 25 h). While leaching was not quantified, it was surmised 
to be negligible based on the NO donor structure and slowed NO release kinetics. 
 
1.4.2  Macromolecular scaffold-doped coatings 
Due to leaching of LMW NO donors, recent studies have evaluated the incorporation 
of macromolecular dopants within polymers whereby the larger size and greater reservoir of 
NO inherent to these scaffolds may circumvent their leaching and enhance NO 
storage/delivery from the coating. Indeed, a number of the aforementioned macromolecular 
scaffolds (e.g., zeolites and silica particles) have been subsequently used as NO-releasing 
dopants within polymeric coatings.
39, 49, 50, 52, 57, 58
 For example, Wheatley et al. reported on 
pressed poly(tetrafluoroethylene) and poly(dimethylsiloxane) discs using NO-releasing 
zeolites.
39
 The addition of the polymer matrix enabled zeolite immersion in water (not 
possible for zeolite powders) and extended NO release durations (half-lives approaching ~1 
h). Of note, the zeolites were loaded with NO after polymer embedding thus sacrificing the 
total achievable NO payload (only up to ~0.02 μmol per mg).  
Zhang et al. doped N-diazeniumdiolated surface-grafted silica within polyurethane at 
20 wt% to enable NO release at a flux of ~7 pmol cm
-2
 s
-1
.
49
 Likewise, Frost and Meyerhoff 
doped RSNO-modified surface-grafted silica particles within trilayer polymeric films.
50, 57
 
However, the hydrophobicity of the particle-doped silicone rubber blocked diffusion of 
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copper ions into the film. As such, light irradiation was the only means of initiating NO 
release with fluxes approaching only ~1 pmol cm
-2
 s
-1
 depending on the light intensity, 
polymer film thickness, and identity and concentration of the grafted RSNO. Shin et al. 
explored the application of N-diazeniumdiolate sol-gel synthesized particles as polymer fillers 
by doping them into polyurethane and silicone rubber films.
52
 Pronounced differences 
dictated by the water uptake of the polymer were observed for the various films. Those 
derived of more hydrophobic character (e.g. silicone rubber) were characterized by NO fluxes 
> ~2 pmol cm
-2
 s
-1
 for up to 20 h, whereas polyurethane films exhibited similar fluxes for 
only 3 h. While the concern of dopant leaching was mitigated by using macromolecular 
scaffolds, it may not be disregarded completely. Thorough characterization of dopant leaching 
for these larger scaffolds is still warranted to truly assess if this strategy for designing NO 
release coatings is superior to others.  
 
1.4.3  Coatings with covalently attached NO donors 
 As shown in Figure 1.8, an alternative strategy for alleviating dopant leaching is 
covalent binding of the NO donor or NO donor precursor to the polymer backbone. In the 
earliest report of NO-releasing polymers,
54
 Smith et al. crosslinked poly(ethylenimine) with 
1,4-dibutanediol diglycidyl to form an insoluble amine-containing polymeric coating material. 
After NO donor formation on the secondary amines, the materials released NO for up to 5 
weeks. While the NO release levels were low (i.e., ~0.33 pmol mg
-1
 s
-1
), larger levels 
approaching ~30 pmol mg
-1
 s
-1
 were achieved with thicker coatings. Additional examples of 
covalent coupling of diazeniumdiolates to polymeric scaffolds include PVC,
59
 silicone 
rubber,
60
 and polyurethane.
61
 Likewise, S-nitrosothiol NO donors have been covalently linked 
to polyester
62, 63
 and polyurethane.
64
 For a more detailed description of NO-releasing 
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polymers the reader is directed to reviews by Frost et al.,
11
 Hetrick and Schoenfisch,
12
 and 
Varu et al.
13
 
 
1.5  Nitric oxide-releasing xerogels 
 
1.5.1  N-Diazeniumdiolate–modified xerogels 
 Akin to the synthesis of silica nanoparticles, sol-gel chemistry has been used to 
prepare NO-releasing xerogel films, with the earliest reports combining aminosilanes and 
isobutyltrimethoxysilane to yield amine-modified xerogels.
65-67
 Varying the aminosilane 
concentration resulted in xerogels with tunable NO release. As expected, the chemical 
environment around the aminosilane affected NO storage and release kinetics. For example, 
xerogels comprised of DET3 exhibited the greatest diazeniumdiolate conversion efficiency 
due to the enhanced deprotonation resulting from the additional amines. Nitric oxide fluxes 
approaching 400 pmol cm
-2
 s
-1
 were achieved using AHAP3-derived xerogels on stainless 
steel substrates, illustrating versatility of the sol-gel method (for coating almost any 
substrate).
68
 In some cases, the xerogel integrity was found to be compromised upon 
immersion in physiological solution (i.e., PBS). Nablo et al. applied thin (i.e., 10–30 μm) 
PVC films over the N-diazeniumdiolated xerogels to inhibit undesirable continued hydrolysis 
of the siloxane backbone, thus enhancing stability and reducing fragmentation.
69
 
Additionally, the hydrophobic PVC was shown to hinder water diffusion, thus reducing the 
initial NO flux and prolonging NO release duration. 
 
1.5.2  S-Nitrosothiol–modified xerogels 
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 In a subsequent study, sol-gel chemistry was used to design thiol-modified xerogels 
derived from MPTMS and methyltrimethoxysilane.
70
 Subsequent nitrosation resulted in the 
formation of S-nitrosothiols. These xerogel films exhibited negligible network fragmentation 
and NO fluxes dependent on the MPTMS concentration, analogous to the N-
diazeniumdiolate-modified xerogels. Furthermore, NO release could be triggered thermally 
and/or upon copper or light exposure. Under physiological conditions, the films released NO 
for up to 2 weeks with a maximum NO flux and total payload of ~600 pmol cm
-2
 s
-1
 and 1.31 
μmol mg-1, respectively. While the enhanced stability and larger NO storage suggest these 
films may be highly promising for biomedical applications, the lack of commercially 
available mercaptosilane precursors limits the tunability of NO release kinetics from these 
materials. Furthermore, they must be stored at cold temperatures and in the dark to 
circumvent premature breakdown of the RSNO NO donor.  The MPTMS silane features a 
primary thiol that is known to lack thermal stability. Tertiary RSNOs feature additional steric 
hindrance on the alpha carbon, thus making thermal breakdown of the nitroso moiety more 
difficult.
8
 The use of tertiary RSNOs represents a potential avenue for increasing NO release 
duration of RSNO-modified xerogels and possibly enabling control over the NO release 
kinetics via other decomposition pathways (e.g., photolysis). The design and synthesis of 
tertiary RSNO-modified xerogels as novel thermally stable, photoactivatable stores of NO 
was another goal of my work. 
 
1.6  S-Nitrosothiol detection 
 
1.6.1  S-Nitrosothiols in physiology 
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 Beyond use as exogenous NO-based therapeutics, RSNOs exist endogenously as 
stable NO transporters.
10
 It is widely debated how RSNOs are formed in vivo as synthetic 
techniques employed on the benchtop (e.g., exposure to acidified nitrite) are not 
physiologically pertinent. Nevertheless, their prevalence as stable reservoirs of NO and the 
ubiquity of NO-dependent processes in physiology suggest that RSNOs are potent transducers 
of NO bioactivity. Indeed, biological effects attributed to NO including reduction in platelet 
aggregation and relaxation of vascular tone are also observed upon treatment with RSNOs. 
71
 
Furthermore, some effects produced by RSNOs more closely match that of EDRF than pure 
NO gas, leading some researchers to question if RSNOs better account for EDRF activity.
72
  
 Disease states typically associated with NO fluctuations are also characterized by 
erratic RSNO levels, implicating RSNO as a potential biomarker.
73
 Physiological RSNO 
levels have been shown to increase with disease state severity in sepsis, pneumonia, and 
arthritis.
73
 For asthma and cystic fibrosis, RSNOs are depressed in sick individuals.
73
 Beyond 
diagnosis, it is known that malfunction and dysregulation in RSNO signaling pathways may 
be the cause of such disease states at the molecular scale. Careful monitoring of RSNO levels 
may thus have prognostic implications as well. Clearly, the ability to detect RSNO levels is 
beneficial for the biomedical community to potentially aid in clinical diagnosis and enhance 
fundamental NO and RSNO research. What is readily apparent from the literature is that 
although comparisons between disease and non-disease states are feasible with traditional 
analytical methodology, definitive quantification of RSNO levels in physiological milieu are 
lacking.
74-76
 For example, a review of published work indicates a four order of magnitude 
discrepancy of RSNO values in blood and plasma. One must assume that problems exist in 
the sample preparation and analytical methodology for blood RSNO measurements and thus 
new methods are warranted in the goal to develop clinically useful devices. 
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1.6.2  Methods of RSNO cleavage 
 Reports of direct RSNO detection in physiological matrices are limited. As such, 
indirect detection is commonly employed by cleaving the RS–NO bond and measuring the 
liberated NO or its derivatives.
75, 76
 Traditional cleavage methods have utilized the well 
characterized pathways of RSNO decomposition, namely reduction and photolysis (Figure 
1.2). Arguably, the most efficient method for decomposing RSNOs is reaction with mercuric 
chloride with near quantitative decomposition to nitrite and high selectivity for the S–N bond 
over other possible endogenous interferents (e.g., nitrosamines and nitrosyls).
77
 A general 
practice has evolved to analyze physiological samples with and without mercuric chloride 
treatment to infer the contribution of RSNOs from differential signals.  
 Reduction has also been widely employed via the triiodide and copper/cysteine 
methods.
75, 76, 78
 The principle of both methods is the conversion of the nitroso group to NO 
(opposed to nitrite). The triiodide method is performed under acidic conditions where 
background signal from endogenous nitrite becomes problematic. Pretreatment of biological 
samples with sulfanilamide is therefore necessary to complex nitrite and render it unable to 
generate NO in the acidic triiodide solution.
78
 The benefit of the copper/cysteine method is 
that it is performed at neutral pH so that nitrite does not interfere.
75
 However, the method is 
knwon to inefficiently cleave the S–N bond (e.g., 34% NO yield from S-nitrosated albumin) 
due to low solubility of the CuCl reagent at neutral pH. 
 Ultraviolet photolysis of RSNO samples is characterized by conversion of RSNO to 
free NO at high yields (approaching 100% for some commercial systems).
76
 However, 
irradiation at wavelengths <300 nm may result in spurious signal from NO generated from 
nitrite
76
 or nitrate.
75
 The lack of selectivity towards these species and the potential to liberate 
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NO from nitrosamines and metal nitrosyls have led many researchers to suspect UV 
photolysis overestimates RSNO levels.
75
 Of note, Alpert et al. have shown that visible 
photolysis selectively cleaves RSNOs and eliminates contribution from nitrite, albeit at a 
lower conversion efficiency of RSNO to NO.
79
 Obviously, the range of S–N cleavage 
techniques offer distinct advantages and disadvantages with regards to their selectivity and 
efficiency, some even requiring further sample handling (i.e., pretreatment with 
sulfanilamide). In part, the wide array of reported RSNO concentrations in blood may be 
attributed to S–N cleavage method disparity. 
 
1.6.3  Methods of indirect RSNO detection 
 The application of RSNO detection to physiological matrices necessitates 
consideration beyond selecting the most efficient and selective cleavage method. For 
example, addition of potassium ferricyanide to oxidize hemoglobin to methemoglobin, which 
binds NO less effectively, is a common procedure to prevent heme-based capture of liberated 
NO.
75, 78
 However, such additional procedures contribute to extensive sample handling that 
further complicates analysis and increases the likelihood of error as RSNOs are inherently 
labile. Nevertheless, once RSNOs are decomposed, the byproducts may be detected by a wide 
array of applicable methods.
75-78
 Spectroscopic determination (i.e., the Saville/Griess assay)
80
 
is most commonly coupled with mercuric chloride cleavage.
75, 76, 78
 The generated nitrite is 
treated with sulfanilamide and N-(1-naphthyl)ethylenediamine to produce an azo dye that is 
easily qunatified at 540 nm. Although a simple detection scheme, the main drawback is poor 
sensitivity (0.2 μM detection limit).75  
 The release of NO from RSNOs (opposed to nitrite) allows for the use of a number of 
sensitive NO measurement techniques including fluorescence, chemiluminescence, electron 
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paramagnetic resonance spectroscopy, and electrochemistry.
7
 For application to RSNO 
detection, the most common method has been chemiluminescence.
75
 In this process, liberated 
NO is detected via its reaction in the gas phase with ozone to form excited NO2
*
 that emits 
light (in the 600–1200 nm range) upon its relaxation to the ground state.81 This highly 
sensitive technique has been coupled to both reductive and photolytic cleavage methods to 
enable sensitive RSNO detection.
75, 76, 78
 An additional advantage of applying this technique 
to the analysis of biological fluids is that the low aqueous solubility of NO aids its 
displacement into the gas phase for detection.
75
 However, the required additional equipment 
(e.g., vacuum pump, inert carrier gas, and oxygen tanks) and instrumentation expense limits 
the prospect of rapid point-of-care or clinical RSNO analysis via chemiluminescent means. 
Due to the potential for miniaturization and instrumentation simplicity, RSNO detection by 
electrochemistry is arguably more suited for biological analysis. 
 
1.6.4  Electrochemical RSNO sensing 
 Nitric oxide is commonly measured by its three electron oxidation to nitrate at applied 
potentials of 0.6–0.9 V vs. Ag/AgCl.82 Nitrite is a major interference as it is also oxidized at 
these potentials. Thus, NO-permselective sensor membranes have been designed to enable the 
selective detection of NO, an important consideration specifically for physiological samples 
that contain large amounts of endogenous nitrite. The most prominent example of such a 
sensor is that of Shibuki.
83
 In this early design, the sensor was outfitted with a gas-permeable 
chloroprene rubber membrane to facilitate NO diffusion to the electrode surface while 
hindering interference from ionic compounds (i.e., nitrite). Other designs that are based on the 
concept of reduced interference permeability have since arisen. The interested reader s 
directed to more extensive reviews of this area.
7, 82
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 The high sensitivity, selectivity, and rapid real time monitoring gained from 
amperometric NO sensors suggest their promise in the detection of physiological RSNO 
levels. However, few reports of amperometric RSNO sensors exist. Pfeiffer et al. first 
reported the coupling of an NO selective electrode with aqueous solutions of copper nitrate 
and reducing agents to generate the Cu(I) species and decompose RSNOs in situ.
84
 Improving 
upon this design, Zhang et al. used a nano-sized NO sensor (tip diameter of 100 nm) in 
conjunction with a microsyringe to inject saturated CuCl into solution near the electrode tip.
85
  
 The most sophisticated RSNO sensors to date have been developed by Meyerhoff and 
coworkers, with the earliest incorporating various catalytic copper sites (e.g., Cu(II)-ligand 
complex, Cu(II)-phosphate salt, or 3 μm metallic copper particles) within a polyurethane 
membrane.
86
 The film was then physically immobilized and affixed over a 
poly(tetrafluoroethylene) membrane that housed a Pt electrode. S-Nitrosothiol decomposition 
catalyzed by the immobilized copper sites thus occurred directly at the membrane and the gas 
permeable membrane allowed only NO to diffuse to the electrode surface. However, this 
integrated (i.e., capable of cleavage and detection) RSNO sensor required the addition of 
reducing agents to the solution to generate enough active Cu(I) species for adequate RSNO 
decomposition and sensor response. Although all compositions of the sensors were 
characterized by response times of ≤5 min and linear response to RSNO concentration up to 
40 μM, sensors containing copper particles exhibited the highest sensitivity towards RSNO 
species due to the larger amount of catalytic species. Additional examples have since been 
reported whereby the catalytic layer includes organoselenium catalysts,
87
 glutathione 
peroxidase,
88
  or organoditelluride species.
89
 Immobilization methods for the organoselenium 
and organoditelluride species were based on covalently attaching the catalysts within a 
hydrogel and then crosslinking and tethering the hydrogel to a dialysis membrane. This 
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dialysis membrane was then affixed over a gas permeable membrane housing the Pt electrode. 
Although not typically used as reducing agents for the cleavage of RSNOs, these species all 
provided linear response to varied RSNO concentrations. However, these designs were unable 
to directly detect nitrosated proteins stemming from the molecular-weight cut-off of the 
dialysis membrane. The most recent formulation improved upon these designs by covalently 
tethering an organoselenium species to the outside of the dialysis membrane.
90
 The simpler 
construction of this sensor (it lacked the inner hydrogel layer) enabled a 5-fold increase in 
sensitivity to LMW RSNOs (~1 nA per μM) and a resulting detection limit of <20 nM. 
Furthermore, the detection of nitrosated proteins (i.e., S-nitrosoalbumin) was seemingly 
possible due to attachment of the catalyst on the outside of the membrane. Sensor response 
was observed for the RSNO protein in the presence of cysteine as a reducing agent to once 
again convert the catalytic species into its active form. However, closer examination of the 
response led the researchers to determine that the protein itself was not being detected, but 
rather nitrosated cysteine formed from a transnitrosation between the protein with the added 
reducing agent constituting the response.  
 It is evident from a brief review of electrochemical RSNO sensors to date that current 
designs are hindered by complex and irreproducible immobilization of catalytic species to the 
sensor surface. The necessity of introducing reducing agents into the solution to maintain the 
catalytic ability is also a detriment to future utility of these approaches. The direct detection 
of nitrosated proteins remains elusive in the field of electrochemical RSNO detection. Also 
apparent is a lack of exploration of RSNO cleavage techniques other than reduction (e.g., 
photolysis). The use of photolytic cleavage may circumvent both complex sensor fabrication 
and the necessity for additional reducing reagents while potentially enabling direct analysis of 
nitrosated proteins. A final goal of my doctoral work was to examine the coupling of 
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photolytic cleavage and amperometric NO sensing as a means for the indirect detection of 
RSNOs in physiological fluids. 
 
1.7   Summary of dissertation research 
 
 To summarize, the focus of my dissertation research included the development of 
novel RSNO-modified materials for potential NO-releasing therapeutics and strategies for 
detecting endogenous RSNOs in physiological fluids. This work has made use of sol-gel 
chemistry in the synthesis of silica-based vehicles modified with RSNOs functionalities (NO 
release vehicles) and xerogel-derived NO sensors (RSNO detection). The specific aims of my 
research included: 
 1) the sol-gel synthesis and material characterization of monodisperse, spherical 
 RSNO-modified silica particles; 
 2) the design, synthesis, and material development of tertiary-based RSNO-modified 
 xerogel films; and, 
 3) the design and evaluation of photolytic-based RSNO cleavage and amperometric 
 NO sensing to indirectly detect RSNOs in physiological fluids. 
 The goal of this introduction chapter was to provide an overview of the current field 
of macromolecular NO-releasing scaffolds and coatings functionalized with multiple NO 
donors for use as novel therapeutics, specifically with attention to strategies aimed at 
enhancing NO storage and controlling NO release. Additionally, I provided an overview of 
analytical methodology for RSNO detection with current disadvantages hindering the accurate 
detection of endogenous RSNOs. In Chapter 2, the synthesis, optimization, and 
characterization of monodisperse, spherical RSNO-modified silica nanoparticles as NO-
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releasing macromolecular scaffolds will be detailed. Chapter 3 will discuss the design of 
RSNO precursors and their use as light-controlled NO-releasing xerogels with enhanced 
stability and antimicrobial properties. A novel analytical scheme for the visible light-based 
cleavage and subsequent detection of RSNOs in physiological fluids is discussed in Chapter 
4. Finally, my work is summarized in Chapter 5 with a description of future studies necessary 
to extend this work. 
 37 
1.8  References 
(1) Ignarro, L. J. "Nitric oxide: A unique endogenous signaling molecule in vascular biology 
(Nobel lecture)." Angewandte Chemie-International Edition 1999, 38, 1882-1892. 
 
(2) Walford, G.; Loscalzo, J. "Nitric oxide in vascular biology." Journal of Thrombosis and 
Haemostasis 2003, 1, 2112-2118. 
 
(3) Fang, F. C. "Mechanisms of nitric oxide-related antimicrobial activity." Journal of 
Clinical Investigation 1997, 99, 2818-2825. 
 
(4) Luo, J. D.; Chen, A. F. "Nitric oxide: a newly discovered function on wound healing." 
Acta Pharmacologica Sinica 2005, 26, 259-264. 
 
(5) Mocellin, S.; Bronte, V.; Nitti, D. "Nitric oxide, a double edged sword in cancer biology: 
Searching for therapeutic opportunities." Medicinal Research Reviews 2007, 27, 317-352. 
 
(6) Ignarro, L. J., Nitric Oxide: Biology and Pathobiology. Academic Press: San Diego, 
2000. 
 
(7) Hetrick, E. M.; Schoenfisch, M. H. "Analytical chemistry of nitric oxide." Annual Review 
of Analytical Chemistry 2009, 2, 409-433. 
 
(8) Wang, P. G.; Xian, M.; Tang, X. P.; Wu, X. J.; Wen, Z.; Cai, T. W.; Janczuk, A. J. 
"Nitric oxide donors: Chemical activities and biological applications." Chemical Reviews 
2002, 102, 1091-1134. 
 
(9) Hrabie, J. A.; Keefer, L. K. "Chemistry of the nitric oxide-releasing diazeniumdiolate 
("nitrosohydroxylamine") functional group and its oxygen-substituted derivatives." 
Chemical Reviews 2002, 102, 1135-1154. 
 
(10) Williams, D. L. H. "The chemistry of S-nitrosothiols." Accounts of Chemical Research 
1999, 32, 869-876. 
 
(11) Frost, M. C.; Reynolds, M. M.; Meyerhoff, M. E. "Polymers incorporating nitric oxide 
releasing/generating substances for improved biocompatibility of blood-contactincy 
medical devices." Biomaterials 2005, 26, 1685-1693. 
 
(12) Hetrick, E. M.; Schoenfisch, M. H. "Reducing implant-related infections: active release 
strategies." Chemical Society Reviews 2006, 35, 780-789. 
 
(13) Varu, V. N.; Tsihlis, N. D.; Kibbe, M. R. "Nitric oxide-releasing prosthetic materials." 
Vascular and Endovascular Surgery 2009, 43, 121-131. 
 
(14) Seabra, A. B.; Duran, N. "Nitric oxide-releasing vehicles for biomedical applications." 
Journal of Materials Chemistry 2010, 20, 1624-1637. 
 
 38 
(15) Sortino, S. "Light-controlled nitric oxide delivering molecular assemblies." Chemical 
Society Reviews 2010, 39, 2903-2913. 
 
(16) Hrabie, J. A.; Saavedra, J. E.; Roller, P. P.; Southan, G. J.; Keefer, L. K. "Conversion of 
proteins to diazeniumdiolate-based nitric oxide donors." Bioconjugate Chemistry 1999, 
10, 838-842. 
 
(17) Simon, D. I.; Mullins, M. E.; Jia, L.; Gaston, B.; Singel, D. J.; Stamler, J. S. 
"Polynitrosylated proteins: Characterization, bioactivity, and functional consequences." 
Proceedings of the National Academy of Sciences of the United States of America 1996, 
93, 4736-4741. 
 
(18) Ewing, J. F.; Young, D. V.; Janero, D. R.; Garvey, D. S.; Grinnell, T. A. "Nitrosylated 
bovine serum albumin derivatives as pharmacologically active nitric oxide congeners." 
Journal of Pharmacology and Experimental Therapeutics 1997, 283, 947-954. 
 
(19) Katsumi, H.; Nishikawa, M.; Yamashita, F.; Hashida, M. "Development of polyethylene 
glycol-conjugated poly-S-nitrosated serum albumin, a novel S-nitrosothiol for prolonged 
delivery of nitric oxide in the blood circulation in vivo." Journal of Pharmacology and 
Experimental Therapeutics 2005, 314, 1117-1124. 
 
(20) Cavalieri, F.; Finelli, I.; Tortora, M.; Mozetic, P.; Chiessi, E.; Polizio, F.; Brismar, T. B.; 
Paradossi, G. "Polymer microbubbles as diagnostic and therapeutic gas delivery device." 
Chemistry of Materials 2008, 20, 3254-3258. 
 
(21) Jeh, H. S.; Lu, S.; George, S. C. "Encapsulation of PROLI/NO in biodegradable 
microparticles." Journal of Microencapsulation 2004, 21, 3-13. 
 
(22) Parzuchowski, P. G.; Frost, M. C.; Meyerhoff, M. E. "Synthesis and characterization of 
polymethacrylate-based nitric oxide donors." Journal of the American Chemical Society 
2002, 124, 12182-12191. 
 
(23) Mintzer, M. A.; Grinstaff, M. W. "Biomedical applications of dendrimers: a tutorial." 
Chemical Society Reviews 2011, 40, 173-190. 
 
(24) Stasko, N. A.; Schoenfisch, M. H. "Dendrimers as a scaffold for nitric oxide release." 
Journal of the American Chemical Society 2006, 128, 8265-8271. 
 
(25) Stasko, N. A.; Fischer, T. H.; Schoenfisch, M. H. "S-nitrosothiol-modified dendrimers as 
nitric oxide delivery vehicles." Biomacromolecules 2008, 9, 834-841. 
 
(26) Bhattacharya, R.; Mukherjee, P. "Biological properties of "naked" metal nanoparticles." 
Advanced Drug Delivery Reviews 2008, 60, 1289-1306. 
 
(27) Cherukuri, P.; Glazer, E. S.; Curleya, S. A. "Targeted hyperthermia using metal 
nanoparticles." Advanced Drug Delivery Reviews 2010, 62, 339-345. 
 
 39 
(28) Hao, R.; Xing, R. J.; Xu, Z. C.; Hou, Y. L.; Gao, S.; Sun, S. H. "Synthesis, 
functionalization, and biomedical applications of multifunctional magnetic 
nanoparticles." Advanced Materials 2010, 22, 2729-2742. 
 
(29) Liao, H. W.; Nehl, C. L.; Hafner, J. H. "Biomedical applications of plasmon resonant 
metal nanoparticles." Nanomedicine 2006, 1, 201-208. 
 
(30) Rothrock, A. R.; Donkers, R. L.; Schoenfisch, M. H. "Synthesis of nitric oxide-releasing 
gold nanoparticles." Journal of the American Chemical Society 2005, 127, 9362-9363. 
 
(31) Polizzi, M. A.; Stasko, N. A.; Schoenfisch, M. H. "Water-soluble nitric oxide-releasing 
gold nanoparticles." Langmuir 2007, 23, 4938-4943. 
 
(32) Caruso, E. B.; Petralia, S.; Conoci, S.; Giuffrida, S.; Sortino, S. "Photodelivery of nitric 
oxide from water-soluble platinum nanoparticles." Journal of the American Chemical 
Society 2007, 129, 480-481. 
 
(33) Barone, M.; Mascali, A.; Sortino, S. "Bifunctional nanoparticle assemblies: 
photoluminescent and nitric oxide photodelivering monolayer protected platinum 
clusters." New Journal of Chemistry 2008, 32, 2195-2200. 
 
(34) Ferey, G. "Hybrid porous solids: past, present, future." Chemical Society Reviews 2008, 
37, 191-214. 
 
(35) Natarajan, S.; Mahata, P. "Metal-organic framework structures - how closely are they 
related to classical inorganic structures?" Chemical Society Reviews 2009, 38, 2304-2318. 
 
(36) Rosseinsky, M. J. "Recent developments in metal-organic framework chemistry: design, 
discovery, permanent porosity and flexibility." Microporous and Mesoporous Materials 
2004, 73, 15-30. 
 
(37) McKinlay, A. C.; Morris, R. E.; Horcajada, P.; Ferey, G.; Gref, R.; Couvreur, P.; Serre, 
C. "BioMOFs: Metal-organic frameworks for biological and medical applications." 
Angewandte Chemie-International Edition 2010, 49, 6260-6266. 
 
(38) Hinks, N. J.; McKinlay, A. C.; Xiao, B.; Wheatley, P. S.; Morris, R. E. "Metal organic 
frameworks as NO delivery materials for biological applications." Microporous and 
Mesoporous Materials 2010, 129, 330-334. 
 
(39) Wheatley, P. S.; Butler, A. R.; Crane, M. S.; Fox, S.; Xiao, B.; Rossi, A. G.; Megson, I. 
L.; Morris, R. E. "NO-releasing zeolites and their antithrombotic properties." Journal of 
the American Chemical Society 2006, 128, 502-509. 
 
(40) Xiao, B.; Wheatley, P. S.; Zhao, X. B.; Fletcher, A. J.; Fox, S.; Rossi, A. G.; Megson, I. 
L.; Bordiga, S.; Regli, L.; Thomas, K. M.; Morris, R. E. "High-capacity hydrogen and 
nitric oxide adsorption and storage in a metal-organic framework." Journal of the 
American Chemical Society 2007, 129, 1203-1209. 
 40 
 
(41) McKinlay, A. C.; Xiao, B.; Wragg, D. S.; Wheatley, P. S.; Megson, I. L.; Morris, R. E. 
"Exceptional behavior over the whole adsorption-storage-delivery cycle for NO in porous 
metal organic frameworks." Journal of the American Chemical Society 2008, 130, 10440-
10444. 
 
(42) Ingleson, M. J.; Heck, R.; Gould, J. A.; Rosseinsky, M. J. "Nitric oxide chemisorption in 
a postsynthetically modified metal-organic framework." Inorganic Chemistry 2009, 48, 
9986-9988. 
 
(43) Nguyen, J. G.; Tanabe, K. K.; Cohen, S. M. "Postsynthetic diazeniumdiolate formation 
and NO release from MOFs." CrystEngComm 2010, 12, 2335-2338. 
 
(44) Wei, F.; Yang, J. Y.; Hou, Q. A.; Zhu, J. H. "Moisture-saturated zeolites - A new strategy 
for releasing nitric oxide." New Journal of Chemistry 2010, 34, 2897-2905. 
 
(45) Gupta, R.; Kumar, A. "Bioactive materials for biomedical applications using sol-gel 
technology." Biomedical Materials 2008, 3. 
 
(46) Rosenholm, J. M.; Sahlgren, C.; Linden, M. "Towards multifunctional, targeted drug 
delivery systems using mesoporous silica nanoparticles - opportunities & challenges." 
Nanoscale 2010, 2, 1870-1883. 
 
(47) Slowing, II; Vivero-Escoto, J. L.; Wu, C. W.; Lin, V. S. Y. "Mesoporous silica 
nanoparticles as controlled release drug delivery and gene transfection carriers." 
Advanced Drug Delivery Reviews 2008, 60, 1278-1288. 
 
(48) Vivero-Escoto, J. L.; Slowing, II; Trewyn, B. G.; Lin, V. S. Y. "Mesoporous silica 
nanoparticles for intracellular controlled drug delivery." Small 2010, 6, 1952-1967. 
 
(49) Zhang, H. P.; Annich, G. M.; Miskulin, J.; Stankiewicz, K.; Osterholzer, K.; Merz, S. I.; 
Bartlett, R. H.; Meyerhoff, M. E. "Nitric oxide-releasing fumed silica particles: Synthesis, 
characterization, and biomedical application." Journal of the American Chemical Society 
2003, 125, 5015-5024. 
 
(50) Frost, M. C.; Meyerhoff, M. E. "Synthesis, characterization, and controlled nitric oxide 
release from S-nitrosothiol-derivatized fumed silica polymer filler particles." Journal of 
Biomedical Materials Research Part A 2005, 72A, 409-419. 
 
(51) Brinker, C. J.; Scherer, G. W., Sol-gel science : the physics and chemistry of sol-gel 
processing. Academic Press: Boston, 1990. 
 
(52) Shin, J. H.; Metzger, S. K.; Schoenfisch, M. H. "Synthesis of nitric oxide-releasing silica 
nanoparticles." Journal of the American Chemical Society 2007, 129, 4612-4619. 
 
(53) Shin, J. H.; Schoenfisch, M. H. "Inorganic/organic hybrid silica nanoparticles as a nitric 
oxide delivery scaffold." Chemistry of Materials 2008, 20, 239-249. 
 41 
 
(54) Smith, D. J.; Chakravarthy, D.; Pulfer, S.; Simmons, M. L.; Hrabie, J. A.; Citro, M. L.; 
Saavedra, J. E.; Davies, K. M.; Hutsell, T. C.; Mooradian, D. L.; Hanson, S. R.; Keefer, 
L. K. "Nitric oxide-releasing polymers containing the [N(O)NO](-) group." Journal of 
Medicinal Chemistry 1996, 39, 1148-1156. 
 
(55) Mowery, K. A.; Schoenfisch, M. H.; Saavedra, J. E.; Keefer, L. K.; Meyerhoff, M. E. 
"Preparation and characterization of hydrophobic polymeric films that are 
thromboresistant via nitric oxide release." Biomaterials 2000, 21, 9-21. 
 
(56) Batchelor, M. M.; Reoma, S. L.; Fleser, P. S.; Nuthakki, V. K.; Callahan, R. E.; Shanley, 
C. J.; Politis, J. K.; Elmore, J.; Merz, S. I.; Meyerhoff, M. E. "More lipophilic 
dialkyldiamine-based diazeniumdiolates: Synthesis, characterization, and application in 
preparing thromboresistant nitric oxide release polymeric coatings." Journal of Medicinal 
Chemistry 2003, 46, 5153-5161. 
 
(57) Frost, M. C.; Meyerhoff, M. E. "Controlled photoinitiated release of nitric oxide from 
polymer films containing S-nitroso-N-acetyl-DL-penicillamine derivatized fumed silica 
filler." Journal of the American Chemical Society 2004, 126, 1348-1349. 
 
(58) Fox, S.; Wilkinson, T. S.; Wheatley, P. S.; Xiao, B.; Morris, R. E.; Sutherland, A.; 
Simpson, A. J.; Barlow, P. G.; Butler, A. R.; Megson, I. L.; Rossi, A. G. "NO-loaded 
Zn2+-exchanged zeolite materials: A potential bifunctional anti-bacterial strategy." Acta 
Biomaterialia 2010, 6, 1515-1521. 
 
(59) Saavedra, J. E.; Booth, M. N.; Hrabie, J. A.; Davies, K. M.; Keefer, L. K. "Piperazine as a 
linker for incorporating the nitric oxide-releasing diazeniumdiolate group into other 
biomedically relevant functional molecules." Journal of Organic Chemistry 1999, 64, 
5124-5131. 
 
(60) Zhang, H. P.; Annich, G. M.; Miskulin, J.; Osterholzer, K.; Merz, S. I.; Bartlett, R. H.; 
Meyerhoff, M. E. "Nitric oxide releasing silicone rubbers with improved blood 
compatibility: preparation, characterization, and in vivo evaluation." Biomaterials 2002, 
23, 1485-1494. 
 
(61) Reynolds, M. M.; Hrabie, J. A.; Oh, B. K.; Politis, J. K.; Citro, M. L.; Keefer, L. K.; 
Meyerhoff, M. E. "Nitric oxide releasing polyurethanes with covalently linked 
diazeniumdiolated secondary amines." Biomacromolecules 2006, 7, 987-994. 
 
(62) Coneski, P. N.; Rao, K. S.; Schoenfisch, M. H. "Degradable nitric oxide-releasing 
biomaterials via post-polymerization functionalization of cross-linked polyesters." 
Biomacromolecules 2010, 11, 3208-3215. 
 
(63) Seabra, A. B.; da Silva, R.; de Oliveira, M. G. "Polynitrosated polyesters: Preparation, 
characterization, and potential use for topical nitric oxide release." Biomacromolecules 
2005, 6, 2512-2520. 
 
 42 
(64) Coneski, P. N.; Schoenfisch, M. H. "Synthesis of nitric oxide-releasing polyurethanes 
with S-nitrosothiol-containing hard and soft segments." Polymer Chemistry 2011, 2, 906-
913. 
 
(65) Marxer, S. M.; Rothrock, A. R.; Nablo, B. J.; Robbins, M. E.; Schoenfisch, M. H. 
"Preparation of nitric oxide (NO)-releasing sol-gels for biomaterial applications." 
Chemistry of Materials 2003, 15, 4193-4199. 
 
(66) Nablo, B. J.; Chen, T. Y.; Schoenfisch, M. H. "Sol-gel derived nitric-oxide releasing 
materials that reduce bacterial adhesion." Journal of the American Chemical Society 
2001, 123, 9712-9713. 
 
(67) Nablo, B. J.; Schoenfisch, M. H. "Antibacterial properties of nitric oxide-releasing sol-
gels." Journal of Biomedical Materials Research Part A 2003, 67A, 1276-1283. 
 
(68) Nablo, B. J.; Rothrock, A. R.; Schoenfisch, M. H. "Nitric oxide-releasing sol-gels as 
antibacterial coatings for orthopedic implants." Biomaterials 2005, 26, 917-924. 
 
(69) Nablo, B. J.; Schoenfisch, M. H. "Poly(vinyl chloride)-coated sol-gels for studying the 
effects of nitric oxide release on bacterial adhesion." Biomacromolecules 2004, 5, 2034-
2041. 
 
(70) Riccio, D. A.; Dobmeier, K. P.; Hetrick, E. M.; Privett, B. J.; Paul, H. S.; Schoenfisch, 
M. H. "Nitric oxide-releasing S-nitrosothiol-modified xerogels." Biomaterials 2009, 30, 
4494-4502. 
 
(71) Richardson, G.; Benjamin, N. "Potential therapeutic uses for S-nitrosothiols." Clinical 
Science 2002, 102, 99-105. 
 
(72) Al-Sa'doni, H. H.; Ferro, A. "Current status and future possibilities of nitric oxide-donor 
drugs: Focus on S-nitrosothiols." Mini-Reviews in Medicinal Chemistry 2005, 5, 247-254. 
 
(73) Foster, M. W.; McMahon, T. J.; Stamler, J. S. "S-nitrosylation in health and disease." 
Trends in Molecular Medicine 2003, 9, 160-168. 
 
(74) Giustarini, D.; Milzani, A.; Colombo, R.; Dalle-Donne, I.; Rossi, R. "Nitric oxide, S-
nitrosothiols and hemoglobin: is methodology the key?" Trends in Pharmacological 
Sciences 2004, 25, 311-316. 
 
(75) Giustarini, D.; Milzani, A.; Dalle-Donne, I.; Rossi, R. "Detection of S-nitrosothiols in 
biological fluids: A comparison among the most widely applied methodologies." Journal 
of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences 2007, 
851, 124-139. 
 
(76) Gow, A.; Doctor, A.; Mannick, J.; Gaston, B. "S-nitrosothiol measurements in biological 
systems." Journal of Chromatography B-Analytical Technologies in the Biomedical and 
Life Sciences 2007, 851, 140-151. 
 43 
 
(77) Jourd'heuil, D.; Jourd'heuil, F. L.; Lowery, A. M.; Hughes, J.; Grisham, M. B., Detection 
of nitrosothiols and other nitroso species in vitro and in cells. In Nitric Oxide, Pt E, 
Elsevier Academic Press Inc: San Diego, 2005; Vol. 396, pp 118-131. 
 
(78) Basu, S.; Wang, X. D.; Gladwin, M. T.; Kim-Shapiro, D. B. "Chemiluminescent 
detection of S-nitrosated proteins: Comparison of tri-iodide, copper/CO/cysteine, and 
modified copper/cysteine methods." Nitric Oxide, Part F: Oxidative and Nitrosative 
Stress in Redox Regulation of Cell Signaling 2008, 440, 137-156. 
 
(79) Alpert, C.; Ramdev, N.; George, D.; Loscalzo, J. "Detection of S-Nitrosothiols and other 
nitric oxide derivatives by photolysis-chemiluminescence spectrometry." Analytical 
Biochemistry 1997, 245, 1-7. 
 
(80) Saville, B. "A Scheme for the colorimetric determination of microgram amounts of 
thiols." Analyst 1958, 83, 670-672. 
 
(81) Bates, J. N. "Nitric oxide measurement by chemiluminescence detection." 
Neuroprotocols 1992, 1, 141-149. 
 
(82) Privett, B. J.; Shin, J. H.; Schoenfisch, M. H. "Electrochemical nitric oxide sensors for 
physiological measurements." Chemical Society Reviews 2010, 39, 1925-1935. 
 
(83) Shibuki, K. "An Electrochemical microprobe for detecting nitric-oxide release in brain-
tissue." Neuroscience Research 1990, 9, 69-76. 
 
(84) Pfeiffer, S.; Schrammel, A.; Schmidt, K.; Mayer, B. "Electrochemical determination of S-
nitrosothiols with a Clark-type nitric oxide electrode." Analytical Biochemistry 1998, 258, 
68-73. 
 
(85) Zhang, X. J.; Kislyak, Y.; Lin, H.; Dickson, A.; Cardosa, L.; Broderick, M.; Fein, H. 
"Nanometer size electrode for nitric oxide and S-nitrosothiols measurement." 
Electrochemistry Communications 2002, 4, 11-16. 
 
(86) Cha, W.; Lee, Y.; Oh, B. K.; Meyerhoff, M. E. "Direct detection of S-nitrosothiols using 
planar amperometric nitric oxide sensor modified with polymeric films containing 
catalytic copper species." Analytical Chemistry 2005, 77, 3516-3524. 
 
(87) Cha, W.; Meyerhoff, M. E. "S-nitrosothiol detection via amperometric nitric oxide sensor 
with surface modified hydrogel layer containing immobilized organoselenium catalyst." 
Langmuir 2006, 22, 10830-10836. 
 
(88) Musameh, M.; Moezzi, N.; Schauman, L. M.; Meyerhoff, M. E. "Glutathione peroxidase-
based amperometric biosensor for the detection of S-nitrosothiols." Electroanalysis 2006, 
18, 2043-2048. 
 
 44 
(89) Hwang, S.; Cha, W.; Meyerhoff, M. E. "Amperometric nitrosothiol sensor using 
immobilized organoditelluride species as selective catalytic layer." Electroanalysis 2008, 
20, 270-279. 
 
(90) Cha, W. S.; Anderson, M. R.; Zhang, F. H.; Meyerhoff, M. E. "Amperometric S-
nitrosothiol sensor with enhanced sensitivity based on organoselenium catalysts." 
Biosensors & Bioelectronics 2009, 24, 2441-2446. 
 
 
 
 
Chapter 2: 
Stöber Synthesis of Nitric Oxide-Releasing S-Nitrosothiol-Modified Silica Particles 
 
 
2.1  Introduction 
 
Since the discovery of the physiological roles of nitric oxide (NO),
1-3
 much 
research has focused on the synthesis of NO-releasing materials/vehicles to elicit NO’s 
characteristics as an antimicrobial agent, mediator of wound repair, or angiogenic 
cofactor.
4-7
 S-Nitrosothiols (RSNOs) are one class of endogenous NO donor believed to 
store/transport the majority of the body’s natural reservoir of NO.8-12 As such, a large 
body of work has utilized low molecular weight RSNOs (e.g., S-nitroso-glutathione 
(GSNO), S-nitroso-N-acetylcysteine (SNAC), and S-nitroso-N-acetyl-penicillamine 
(SNAP)) as donors to spontaneously release NO.
13-18
 Although promising, the clinical 
application of low molecular weight NO donors has been slow due to both low NO 
storage (per donor molecule) and uncontrollable NO release kinetics. To address such 
shortcomings, we and others have conjugated NO donor precursors to larger scaffolds 
(e.g., proteins
19-21
, dendrimers
22, 23
, and nanoparticles
24-28
), thus enabling high NO storage 
per delivery vehicle and release profiles similar to their small molecule analogues. 
Silica particles are among the most widely employed macromolecular scaffolds 
for biomedical applications due to facile synthetic strategies and minimal cytotoxicity.
29
 
Previously, Frost and Meyerhoff grafted the surface of fumed silica particles (7–10 nm 
diameter) with SNAP, SNAC, and S-nitrosocysteine (CysNO) to create S-nitrosothiol-
 46 
modified silica particles.
30
 However, the NO storage was limited to 0.021–0.138 
µmol mg
-1
 because the thiol functionalization was restricted to the exterior of the particle. 
Alternatively, the hydrolysis and co-condensation of organosilane and tetraalkoxysilane 
precursors via sol-gel chemistry may represent a method for preparing a silica network 
with a higher concentration of organic functionalites.
31
  Indeed, the Stöber process
32
  (sol-
gel chemistry with an alcohol solvent and an ammonia catalyst) has proven effective for 
synthesizing N-diazeniumdiolate-modified silica particles of diverse size and NO storage 
capacity.
24, 25
 The advantage of the Stöber method over surface grafting is that the co-
condensation provides uniform incorporation of the organic (i.e., NO donor) functionality 
throughout the resulting silica network as opposed to restricted functionalization at the 
surface alone. As a result, such particles should exhibit significantly increased NO 
storage. 
While reports have detailed the co-condensation of 
mercaptopropyltrimethoxysilane (MPTMS) and tetraethoxysilane (TEOS) to yield thiol-
functionalized particles
33-41
 and mesoporous materials,
42-44
 NO storage/release was not 
their intended application. Although mesoporous materials offer a high degree of 
functionality, they consist of a vast, interconnected network and typically lack discrete 
particle morphology that would be required for biomedical therapies.
42-44
 Thus, 
mesoporous materials are more suited as adsorbents in environmental applications.
42-44
 
To date, co-condensation strategies for synthesis of MPTMS-containing particles have 
involved numerous, complex synthetic steps,
34, 35, 37, 40
 resulted in polydisperse 
aggregates,
33, 38, 39, 41
 and/or yielded particles with sizes in the 1–100 micron range.34, 36, 37 
Herein, we describe the Stöber synthesis of thiol-containing silica particles as a simple 
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approach for creating spherical, monodisperse scaffolds for RSNO donors <1 μm in 
diameter. The effects of specific synthetic conditions (e.g., concentrations of water, 
ammonia, and silane and structure of silane precursors) on the resulting particle size and 
morphology are studied and optimized to yield monodisperse particles of tunable size, 
thiol functionality, and NO release. 
 
2.2  Materials and Methods 
All solvents and chemicals were analytical-reagent grade and used as received 
unless noted otherwise. Tetramethoxysilane (TMOS) and N’N-diisopropylethylamine 
were purchased from Sigma Aldrich (St. Louis, MO). 3-Mercaptopropyltrimethoxysilane 
(MPTMS), 3-mercaptopropylmethyldimethoxysilane (MPMDMS), and tetraethoxysilane 
(TEOS) were purchased from Gelest (Tullytown, PA). Diethylenetriamine pentaacetic 
acid (DTPA) was purchased from Fluka (Buchs, Switzerland). 5,5’-Dithiobis-(2-
nitrobenzoic acid) (DTNB, Ellman’s reagent) was purchased from Invitrogen Molecular 
Probes (Eugene, OR). L-Cysteine-HCl-H2O was purchased from Pierce-Thermo Fisher 
Scientific (Rockford, IL). Methyl sulfoxide was purchased from Acros (Morris Plains, 
NJ). Ethanol (EtOH), methanol (MeOH), and ammonia solution (NH4OH, 30 wt% in 
water) were purchased from Fisher Scientific (Fair Lawn, NJ). Nitric oxide calibration 
gas (26.39 ppm; balance N2) was purchased from National Welders Supply Co. (Durham, 
NC).  Incandescent bulbs were purchased from Lowe’s (Chapel Hill, NC). Distilled water 
was purified to 18.2 M∙cm with a Millipore Milli-Q Gradient A-10 water purification 
system (Bedford, MA). 
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2.2.1  Synthesis of Mercaptosilane-based Silica Particles.  
Ratios of mercaptosilane and alkoxysilane (25–85 mol% MPTMS, balance TMOS 
or TEOS) (total silane volumes of 0.48–1.91 mL) were added either as a bolus injection 
or dropwise via a Kent Scientific Genie Plus syringe pump at a flow rate of 0.25–3.0 
mL/min through an 18.5 gauge needle to a solution of ethanol (7.7–20.0 mL), water (0.0–
17.7 mL), and ammonium hydroxide (1.0–12 mL). For all syntheses with a water 
concentration of 8.0 M, total solution volume was 26.0 mL. When the water 
concentration was 16.1 M, the total volume of solution used varied with the ammonia and 
silane concentrations as follows. The total solution volume was 26.7 and 28.8 mL when 
the silane concentration was 0.1 M and the ammonia concentrations were 3.3 and 5.5 M, 
respectively. The total solution volume was 22.8, 26.2, and 31.1 mL when the silane 
concentration was 0.2 M and the ammonia concentrations were 1.9, 3.3, and 5.5 M, 
respectively. The total solution volume was 21.9, 24.9, and 27.4 mL when the silane 
concentration was 0.4 M and the ammonia concentrations were 1.9, 3.3, and 5.5 M, 
respectively. For syntheses with a water concentration exceeding 16.1 M, the total 
solution volume was 28.8 mL. Reactions were stirred for 2 h at room temperature, 
collected via centrifugation at 3645x g (10 min), washed twice with 40 mL EtOH, 
recollected, and dried overnight at ambient conditions. 
 
2.2.2  Nitrosation of Mercaptosilane-based Silica Particles 
Thiols within the particles were nitrosated via reaction with nitrous acid.
12
 
Particles (~200 mg) were first added to 4 mL methanol (MeOH). While stirring, 2 mL of 
hydrochloric acid (5 M) was added to the suspension. A 2 mL aqueous solution 
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containing sodium nitrite (2x molar excess to thiol) and DTPA (500 µM) was then added 
to the particle suspension, and the mixture stirred for 2 h in the dark and on ice.  Particles 
were collected by centrifugation at 3645 x g (5 min), washed with 40 mL chilled 500 µM 
DTPA(aq), recollected, washed with 40 mL chilled MeOH, recollected, and vacuum dried 
for 30 min while shielded from light. Particles were stored at –20 °C in vacuo until 
further study. 
 
2.2.3  Characterization of Mercaptosilane-based Silica Particles 
 Solid-state cross polarization/magic angle spinning (CP/MAS) 
29
Si (71.548 MHz 
frequency) nuclear magnetic resonance (NMR) spectroscopy was performed on a Bruker 
360 MHz DMX spectrometer (Billerica, MA). Particles were packed into 4 mm rotors 
and spun at 8.0 kHz. Spectra were collected at 5000 scans with the determination of 
chemical shifts in parts per million relative to an external TMS standard. Nitric oxide 
release was measured in real time (1 sec intervals) using a Sievers NOA
TM
 280i 
Chemiluminescence Nitric Oxide Analyzer (NOA) (Boulder, CO).  Calibration of the 
NOA was performed with both air passed through a Sievers NO zero filter and 26.39 ppm 
NO gas (balance N2).  Nitric oxide-releasing particles were immersed in 25 mL of 
deoxygenated solution and sparged with an 80 mL min
-1
 N2 stream. Additional N2 was 
supplied to the reaction flask to match the collection rate of the NOA at 200 mL min
-1
. 
Temperature control was maintained using a water bath at 37 °C. Thermal and photo-
initiated NO release were studied by conducting the experiments in 500 µM DTPA (pH 
7.4 PBS) to chelate trace copper and illuminating the sample flask with 60, 100, and 200 
W incandescent bulbs, respectively. Copper-initiated NO release was studied by adding 
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the particles to 25 mL of 10 or 25 µM CuBr2(aq). The NOA sample flask was shielded 
from light with aluminum foil for experiments where light was not the intended initiator 
of NO release. Particle size was determined using a Zetasizer Nano ZS Particle Size and 
Zeta Potential Dynamic Light Scattering (DLS) Instrument (Malvern, UK). Samples were 
suspended in PBS at a concentration of 1 mg mL
-1
 and sonicated for 15 min prior to 
analysis. Scanning electron micrographs were recorded on a Hitachi S-4700 Scanning 
Electron Microscope (Pleasanton, CA). Nitrogen adsorption/desorption isotherms were 
obtained on a Micromeritics Tristar II 3020 Surface Area Analyzer (Norcross, GA). 
Samples were outgassed at 110 °C for 18 h and the specific surface area was calculated 
using the Brunauer-Emmett-Teller (BET) method. Ellman’s assay to test for free thiols 
was performed via adding known masses of particles to 2.5 mL of methyl sulfoxide and 
1.5 mL of 10 mM Ellman’s reagent stock in methyl sulfoxide. The solutions were diluted 
to a final volume of 6 mL with methanol, basified with 20 uL of diisopropylethylamine, 
and incubated for 1 h at room temperature. Thiol standards were prepared from a 15 mM 
cysteine stock solution in methyl sulfoxide and treated identically to the samples. 
Aliquots of 200 uL were pipetted into a 96-well microtiter plate and absorbance was 
recorded using a Labsystems Multiskan RC plate reader with an optical filter of 405 nm 
(Helsinki, Finland). 
 
2.3  Results and Discussion 
 
2.3.1  Synthesis of Mercaptosilane-based Silica Particles 
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 Particle formation under the Stöber process proceeds upon hydrolysis and 
condensation of silane precursors where the relative hydrolysis rates for the precursors 
dictate both the speed of particle growth and the likelihood of each silane’s incorporation 
into the silica network.
31, 32, 45, 46
 Excessive disparities between reaction rates of different 
silanes may lead to absence of particle formation upon attempted co-condensation. Our 
initial attempt to synthesize thiol-containing silica particles was based on a bolus 
injection of 3-mercaptopropyltrimethoxysilane (MPTMS) and alkoxysilane into 
EtOH/NH4OH solution. The resulting concentrations of ammonia, water and total silane 
were 3.3, 8.0, and 0.2 M, respectively. Tetramethoxysilane (TMOS) proved to be a 
sufficient backbone silane for co-condensation with MPTMS as their combination (at 
various mole percentages) resulted in the formation of a white precipitate (~300 mg 
yield). Considering the slower hydrolysis rates of organosilanes compared to 
tetraalkoxysilanes, we expected that particles with greater mole percentages of TMOS 
would form more quickly than those with increasing amounts of MPTMS.
31, 46
 As 
indicated by visual onset of solution opacity, a marked increase in reaction time was 
observed upon increasing the concentration of MPTMS up to 85 mol%. At this 
concentration, the time to form a visible product after combining the silanes was roughly 
15 min. Product formation at MPTMS concentrations >85 mol% was not observed. The 
inability to form particles at greater MPTMS concentrations may be attributed to the 
disparate hydrolysis rates between the silanes, suggesting that co-condensation requires a 
minimum concentration of the more readily hydrolyzable silane (i.e., TMOS) to initiate 
particle growth.
31, 46
 Materials synthesized via the co-condensation of MPTMS and 
tetraethoxysilane (TEOS) formed only in the concentration range of 75–85 mol% 
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MPTMS. In contrast to the TMOS system, products with lower concentrations of 
MPTMS (e.g., 25 mol%) did not form using TEOS as a backbone, even at prolonged 
reaction times (up to 48 h). This result was not unexpected based on the slower 
hydrolysis rate for TEOS compared to TMOS.
31, 46
 
We also evaluated the ability to form particles using 3-
mercaptopropylmethyldimethoxysilane (MPMDMS) in our goal to understand the NO 
storage/release properties of another thiol-modified particle system. Unfortunately, the 
product yield (~5 mg) formed using MPMDMS with either TMOS or TEOS was 
significantly lower than MPTMS. The substitution of one of the hydrolyzable methoxy 
groups with a nonhydrolyzable methyl linkage in MPMDMS (vs. MPTMS) likely 
decreases the resulting hydrolysis rate under basic conditions due to the inductive effect 
of electron density donation to the Si atom.
31, 45, 46
 As a result, the reaction with hydroxide 
anion to hydrolyze the silane may be inhibited. Particle formation may even be further 
limited as each MPMDMS molecule is capable of forming only two siloxane bridges. 
Consequently, particle formation using MPMDMS was unsuccessful. Further studies 
were thus conducted using MPTMS-based particles.  
To confirm the incorporation of mercaptosilane within the silica network and 
compare various compositions, solid-state 
29
Si cross polarization/magic angle spinning 
nuclear magnetic resonance (CP/MAS NMR) was used to characterize the 
MPTMS/TMOS products as a function of MPTMS concentration. Silicon atoms of 
tetraalkoxysilanes appear in the NMR spectra as Q
n
 bands while those of 
organotrialkoxysilanes appear as T
n
 bands. In both cases, n denotes the number of 
siloxane bonds attached to the Si atom.
47
 The greater number of siloxane bonds to the Si 
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atom, the further the NMR band shifts upfield. As shown in Figure 2.1, particles 
synthesized entirely from TMOS exhibited only Q bands. With increasing MPTMS 
concentration in the solution used to prepare the particles, the T bands increased relative 
to the Q bands, confirming greater incorporation of MPTMS in the silica particle.  
Sulfur weight percent of each composition was determined using elemental 
analysis and further corroborated the covalent incorporation of the mercaptosilane. The 
weight percent of sulfur in the silica was 4.9, 7.1, 11.7, 13.6 and 17.3 for the 25, 40, 60, 
75 and 85 mol% MPTMS (balance TMOS) compositions, respectively. The TEOS-based 
particles were found to have sulfur weight percents of 16.2 and 19.3 for 75 and 85 mol% 
MPTMS, respectively. As expected, the weight percent of sulfur increased linearly with 
increasing MPTMS concentration in the initial solution. 
Dynamic light scattering (DLS) measurements indicated that the sample was too 
polydisperse to accurately measure the particle size. Scanning electron micrographs 
(SEMs) further indicated that the thiol-containing silica was polydisperse and exhibited 
nonspherical morphology more indicative of colloidal silica than individual particles 
(data not shown).  
We thus systematically varied synthetic parameters (i.e., water, ammonia, and 
silane concentrations) to tune the resulting particle morphology and achieve a more ideal 
spherical shape. The composition of 25 mol % MPTMS (balance TMOS) was chosen as 
the model system for comparison due to minimal organic character. Thus, the trends 
observed and previously reported for pure silica systems (i.e., TEOS)
32, 48, 49
 could be 
applied to this system to guide the synthesis towards achieving spherical, monodisperse 
particles. 
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Figure 2.1 Solid-state cross polarization/magic angle spinning (CP/MAS) 
29
Si NMR 
spectra of silica synthesized with (A) 0, (B) 25, (C) 40, (D) 60, (E) 75, and (F) 85 mol % 
MPTMS (balance TMOS). Note: The Q and T bands have been designated. 
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2.3.2  Ammonia Concentration and Water to Silane Ratio 
 The effects of reaction parameters and concentrations on particle morphology and 
size have been explored previously
32, 48-54
 For MPTMS particles, we found that increasing 
the water content from 8.0 to 16.2 M promoted the formation of spherical particles and 
prevented aggregation/fusion. This trend has been reported previously in the synthesis of 
TEOS particles where greater hydrolysis rates and larger, more spherical particles 
occurred with increasing water content.
50, 53
 Stöber et al. and Van Helden et al. also 
remarked that spherical particles were only observed in the presence of sufficient 
ammonia to promote complete hydrolysis of the silanes.
32, 49
 Lower ammonia 
concentrations were shown to result in particles that lacked spherical shape and 
aggregated.
52
 Thus, we discovered that the ratio of water and ammonia to silane was a 
critical factor during particle synthesis. Upon considering all the data, we determined that 
the most ideal (spherical and monodisperse) 25 mol% MPTMS (balance TMOS) particles 
were formed using 5.5 M ammonia, 0.1 M total silane, and 16.2 M water.  Of note, the 
product yield (~70 mg) with this synthesis was lower than that obtained for the 
polydisperse colloidal silica. The decreased yield was expected due to the 4-fold decrease 
in the silane concentration used in the optimized synthesis. 
 
2.3.3  Molar Percentage of MPTMS 
Next, the concentration of MPTMS in the solution was increased to enhance the 
degree of thiol functionality and potential NO storage of the particles. Figure 2.2 depicts 
the resulting particles as the concentration of MPTMS was increased from 25–85 mol% 
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Figure 2.2 Scanning electron micrographs of (A) 25, (B) 40, (C) 60, (D) 75 and (E) 85 
mol% MPTMS (balance TMOS) and (F) 75 and (G) 85 mol % MPTMS (balance TEOS) 
particles synthesized with 16.0 M water, 5.5 M ammonia, and 0.1 M silane. 
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 and backbone alkoxysilane varied between TMOS and TEOS. As with the 
polydisperse colloidal silica system, the formation of particles was not observed for 25–
60 mol% MPTMS (balance TEOS). Only 75 and 85 mol% MPTMS concentrations 
yielded particles with TEOS, illustrating how disparities in hydrolysis and condensation 
kinetics adversely affect and hinder particle formation. The 75 mol% MPTMS (balance 
TEOS) particles formed in a narrow size distribution and exhibited spherical 
morphologies (Figure 2.2F). In contrast, 85 mol% MPTMS (balance TEOS) particles 
appeared aggregated (Figure 2.2G). When using TMOS, 25 mol% MPTMS was the only 
concentration that yielded spherical, monodisperse particles (Figure 2.2A). Particles with 
≥40 mol% MPTMS (balance TMOS) exhibited ideal morphologies, but with concomitant 
bimodal size distributions (Figure. 2.2B-E). 
 
2.3.4  Silane Feed Rate.  
Others have reported improvement in silica particle size monodispersity when 
using a syringe pump to flow one or more reactants (e.g., silane) into a vessel containing 
the other reactants at a constant rate.
53, 55, 56
 Such a semi-batch strategy decreases the 
instantaneous concentration of silane precursors allowing for a shorter particle nucleation 
period that narrows the size distribution of the resulting particles by generating nuclei of 
similar sizes.
53
 To remedy the bimodal size distribution that was observed for certain 
MPTMS compositions, we evaluated the effect of a silane feed rate of 0.5 mL min
-1
 on 
particle morphologies throughout the range of compositions (Figure 2.3). As expected, 
the slower feed rate improved the dispersity of the already narrow size distribution for 25 
mol% MPTMS (Figure 2.3A). A pronounced improvement in the monodispersity was  
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Figure 2.3 Scanning electron micrographs of (A) 25, (B) 40, (C) 60, (D) 75 and (E) 85 
mol% MPTMS (balance TMOS) and (F) 75 and (G) 85 mol % MPTMS (balance TEOS) 
particles synthesized via a semi-batch process with a silane feed rate of 0.5 mL min
-1
. 
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also noted for 40 mol% MPTMS (balance TMOS, Figure 2.3B), with SEM indicating a 
particle diameter of 293 ± 24 nm. Slower silane feed rates (e.g., 0.25 mL min
-1
) resulted 
in slight monodispersity improvements (data not shown), but at lower yields (e.g., ~40 vs. 
70 mg for 40 mol% MPTMS (balance TMOS) composition). Thus, 0.5 mL min
-1
 was 
determined to be the optimal feed rate as it allowed for a balance between sufficient 
particle yield and monodispersity. Similar to 25 mol% MPTMS (balance TMOS), the 
monodispersity of 75 mol% MPTMS (balance TEOS) improved, while the 85 mol% 
MPTMS (balance TEOS) system remained aggregated (Figure 2.3F and 2.3G, 
respectively). Additionally, the product yield increased to ~170 mg for these two 
compositions and can be attributed to the greater concentration of the larger MPTMS in 
the particles. Unfortunately, the semi-batch process proved problematic for 60, 75, and 85 
mol% MPTMS (balance TMOS) particles. As shown in Figure 2.3C-E, the slowed silane 
addition resulted in both aggregation and the formation of a large silica network rather 
than monodisperse, spherical particles. To examine this phenomenon further, silane feed 
rates were varied (0.25–3.0 mL min-1) for 60 mol% MPTMS (balance TMOS). Feed rates 
<2.0 mL min
-1
 resulted in polydisperse, aggregated silica, while faster feed rates (2.0–3.0 
mL min
-1
) produced particles of a bimodal size (data not shown). 
 
2.3.5  Water concentration.  
While tailoring the size of their silica particles, Bogush et al.
48
 and Stöber et al.
32
 
both reported similar polydispersity and bimodal size distributions, exclusively for larger 
TEOS-based particles. Thus, we attempted to decrease the size of the particles to improve 
particle monodispersity. The 75 mol% MPTMS (balance TEOS) particles were chosen as 
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a model system to examine the effect of the water concentration on particle size and 
morphology. As shown in Figure 2.4, water concentrations ≥40.6 M favored rapid silane 
hydrolysis and condensation kinetics, leading to a highly condensed network rather than 
discrete, spherical particles. At a water concentration of 36.5 M, discrete particles were 
formed, but with morphologies featuring excessive aggregation. Monodisperse particles 
(333 ± 48 nm) were first observed at a slightly lower water concentration (32.5 M). As 
expected, particle size increased with decreasing water concentrations (456 ± 68 nm and 
635 ± 63 nm for 24.9 and 16.2 M, respectively).  Furthermore, the smaller particle sizes 
were accompanied with slightly lower yields for each composition. The yields for 75 
mol% MPTMS (balance TEOS) particles were ~65, 150, and 170 mg for water 
concentrations of 32.5, 24.9, and 16.2 M, respectively.  The differences in yield may be 
factors of the efficiency of particle collection (i.e., centrifugation rpm and duration) for 
the smaller particles rather than chemical differences. 
The optimal water concentrations (32.5 and 24.9 M) were next used to tune 
particle size and reduce the bimodal distribution characteristic of the 60, 75, and 85 mol% 
MPTMS (balance TMOS) particles. As shown in Figure 2.5, the intermediate water 
concentration (24.9 M) yielded particles with sizes of 179 ± 22 and 196 ± 25 nm for the 
25 and 40 mol% MPTMS (balance TMOS) compositions, respectively. The greater water 
concentration (32.5 M) drastically increased the reaction kinetics for the mostly TMOS-
based systems, resulting in highly-fused silica networks. Increasing the concentration of 
MPTMS (75 mol%) yielded monodisperse, spherical particles of 363 ± 51 and 279 ± 49 
nm using 24.9 and 32.5 M water, respectively. Aggregated and fused particles were 
formed for the greatest MPTMS concentration (85 mol%) when using 24.9 M water.  
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Figure 2.4 Scanning electron micrographs of 75 mol% MPTMS (balance TEOS) 
synthesized with (A) 47.0, (B) 42.0, (C) 40.6, (D) 36.5, (E) 32.5, and (F) 24.9 M water. 
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Figure 2.5 Scanning electron micrographs of (A-B) 25, (C-D) 40, (E-F) 60, (G-H) 75, and 
(I-J) 85 mol% MPTMS (balance TMOS) and (K-L) 85 mol % MPTMS (balance TEOS) 
particles synthesized with (A, C, E, F, G, I, K) 32.5  and (B, D, F, H, J, L) 24.9 M water. 
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However, monodisperse particles (440 ± 84 nm) were formed when synthesized 
with 32.5 M water. The TEOS-based counterpart to this system behaved similarly by 
yielding only discrete particles (506 ± 77 nm) when synthesized with the higher water 
concentration. At lower water amounts, the formation of aggregated particles was noted. 
The trend of decreasing particle yield with increasing water content that was observed for 
the 75 mol% MPTMS (balance TEOS) composition was mirrored for all other 
compositions evaluated. The yields for the 75 mol% (balance TMOS) particles decreased 
from ~120 to 60 mg upon increasing the water content from 24.9 to 32.5 M. Likewise, 
the 25 mol% MPTMS (balance TMOS) particle yield decreased from ~90 to 20 mg while 
the 40 mol% MPTMS system exhibited a decrease from ~50 to 9 mg upon increasing the 
water concentration from 16.2 to 24.9 M. The yields for both 85 mol% MPTMS 
compositions (i.e., TMOS and TEOS balance) at a water concentration of 32.5 M were 
~160 mg.  
Perhaps of greatest significance, the elevated water concentrations used to 
synthesize the thiol-modified particles successfully resolved the bimodal nature of certain 
compositions not resolvable using a semi-batch process alone. Of note, 60 mol% 
MPTMS (balance TMOS) was the only composition that consistently yielded particles of 
a bimodal nature. Increasing the water content regardless of addition method (bolus vs. 
semi-batch) always resulted in a highly-fused silica network. Branda et al. have shown 
that when alkoxides are mixed during co-condensation, the size distribution of formed 
nuclei is widest when the ratio of the alkoxides is closest to 0.5 as is the case for this 
composition that contains a mixture of organosilane and alkoxysilane in almost equal 
amounts.
57
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 Particle sizes were also measured by DLS to corroborate particle monodispersity 
and size measured using SEM. The combination of DLS and SEM analysis was crucial 
for obtaining an accurate characterization of particle size. Although not often used 
together for characterizing silica particles, their combination was necessary to affirm 
spherical particle morphology for DLS size determination. As shown in Table 2.1, the 
DLS measurements were in agreement with the sizes calculated from the SEM images. 
The slightly increased average diameters observed with DLS may be attributed to the 
solvent sphere that increases the hydrodynamic radius or via direct hydration of the silica 
particles themselves. (DLS measurements conducted in solution). Like SEM, the DLS 
measurements indicated a narrow size distribution, as evidenced by low polydispersity 
indices for each composition. For monodisperse silica particles, the PDI was <0.070 
while aggregated silica (e.g., 85 mol% MPTMS particles synthesized with 24.9 M water) 
were characterized as having a PDI of 0.16–0.20. Of note, PBS was used as a dispersant 
for compositions with large MPTMS concentrations. However, smaller particles with a 
large degree of inorganic character (i.e., ≤40 mol% MPTMS) aggregated in this 
dispersant resulting in erratic DLS measurements (i.e., increasing photon count rate 
indicative of sample aggregation). This aggregation may be attributed to a large surface 
density of protonated silanol groups leading to unfavorable particle interaction. While 
basic conditions resulted in inconsistent DLS measurements due to particle dissolution, 
ethanol was a viable alternative dispersant as evidenced by the correlation between DLS 
and SEM measurements.  
Elemental analysis was used to characterize the composition of the particles. As 
expected, the weight percentages of sulfur in the particles increased accordingly with the  
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Table 2.1 Particle diameters of S-nitrosothiol-modified silica particles. 
Particle 
composition 
(mol%) 
Water 
content 
(M) 
Particle 
size
a
 (nm) 
 Z-Average size
b
 
(nm) 
Polydispersity 
index 
75 (balance TEOS) 32.5 333 ± 48 416.2 ± 23.4 0.027 
75 (balance TEOS) 24.9 456 ± 68 529.6 ± 23.7 0.018 
75 (balance TEOS) 16.2 635 ± 63 718.0 ± 51.7 0.046 
85 (balance TEOS) 32.5 506 ± 77  668.7 ± 46.0 0.04 
25 (balance TMOS) 24.9 179 ± 22  258.4 ± 15.1
c
 0.031 
25 (balance TMOS) 16.2 252 ± 20  469.0 ± 24.8
c
 0.025 
40 (balance TMOS) 24.9 196 ± 25  240.7 ± 17.9
c
 0.064 
40 (balance TMOS) 16.2 293 ± 24  404.8 ± 28.2 0.045 
75 (balance TMOS) 32.5 279 ± 49  431.2 ± 29.5 0.043 
75 (balance TMOS) 24.9 363 ± 51 507.6 ± 30.8 0.032 
85 (balance TMOS) 32.5 440 ± 84  696.2 ± 44.4 0.042 
a
Size calculated from scanning electron micrographs of n ≥ 120 particles  
b
Sizes acquired from dynamic light scattering measurements in pH 7.4 PBS for n = 3 syntheses  
c
Ethanol used as dispersant   
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MPTMS mol% used to make the particles indicating incorporation of the thiol 
functionality (Table 2.2). Syntheses promoting the formation of discrete, spherical 
particles tended to be preferentially derived from one precursor as evidenced by a large 
gap in the transition from 40 to 75 mol% MPTMS (wt% 3.08 ± 2.57 and 15.62 ± 1.90, 
respectively). These values were in marked contrast to the sulfur wt% of the colloidal 
silica. Although the increased sulfur wt% values were more linearly proportional for the 
colloidal silica, the lack of discrete, spherical particles was not ideal. The comparison of 
the two syntheses and systems (colloidal vs. discrete particles) reveals that a delicate 
balance exists between silane incorporation and certain design criteria (i.e., spherical 
particle formation). 
 
2.3.6.  Nitrosation of Mercaptosilane-based Silica Particles 
 The MPTMS-modified particles were nitrosated to enable NO storage and release. 
Briefly, the particles were treated with acidified sodium nitrite, generating nitrous acid, a 
nitrosating agent that reacts with thiols to form RSNOs (Eq 2.1).
12
 
    RSH + HNO2 ⇄ RSNO + H2O        (2.1) 
Since S-nitrosothiols prepared from primary thiols absorb light at 330–350 and 550–600 
nm,
12, 58, 59
 successful RSNO formation was confirmed by the resulting red color of the 
particles after nitrosation. Furthermore, the intensity of the color increased with MPTMS 
mol% indicating greater RSNO formation. 
S-Nitrosothiols decompose via a multitude of pathways.
12, 58
 Both photo and 
thermal irradiation of RSNOs result in homolytic cleavage of the S–N bond, yielding NO 
and a thiyl radical. The thiyl radical may subsequently react with an RSNO to generate a  
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Table 2.2 Elemental analysis, nitric oxide storage, and porosity of S-nitrosothiol-modified 
silica particles 
 
Particle composition 
(mol% MPTMS) 
Water 
content 
(M) 
Sulfur 
content
a
 
(wt %) 
Total NO 
released
c
 
(μmol mg-1) 
Nitrosation 
efficiency 
(%) 
Specific 
surface area
d
 
(m
2
 g
-1
) 
75 (balance TEOS) 32.5 13.8 ± 3.0 3.24 ± 0.61 75.1 ± 21.6 8.99 ± 0.24 
75 (balance TEOS) 24.9 16.0 ± 1.7 3.58 ± 0.39 71.7 ± 10.9 7.69 ± 0.16 
75 (balance TEOS) 16.2 15.6 ± 1.9 3.15 ± 0.60 64.7 ± 14.6 3.87 ± 0.13 
85 (balance TEOS) 32.5 20.0 ± 3.9  3.95 ± 0.66  63.3 ± 16.2 4.16 ± 0.19  
25 (balance TMOS) 24.9 < 0.0
b
  0.09 ± 0.02  NA 54.90 ± 1.53  
25 (balance TMOS) 16.2 0.5 ± 0.4 0.10 ± 0.02 62.9 ± 45.7 60.11 ± 1.93 
40 (balance TMOS) 24.9 1.1 ± 0.6  0.34 ± 0.02  100.3 ± 53.8 51.85 ± 0.74  
40 (balance TMOS) 16.2 3.1 ± 2.6 0.52 ± 0.22 54.2 ± 50.7 91.39 ± 4.03 
75 (balance TMOS) 32.5 18.3 ± 5.3  3.31 ± 0.85  58.0 ± 22.6 10.76 ± 0.30  
75 (balance TMOS) 24.9 15.3 ± 5.3 3.73 ± 0.62 78.2 ± 30.1 6.77 ± 0.13 
85 (balance TMOS) 32.5 20.6 ± 5.7  4.39 ± 0.02  68.5 ± 19.0 4.09 ± 0.25  
a
Average weight percents are calculated from n = 3 syntheses  
b
Weight percent was less than instrument limit of detection  
c
Averages are calculated from n = 3 syntheses and after 5 h of 200 W irradiation  
d
Calculated from nitrogen adsoprtion and Brunauer Emmett Teller analysis of n=3 measurements.  
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disulfide and an additional equivalent of NO.
12, 58
 Dicks et al. have shown that 
Cu(I), resulting from the reduction of Cu(II) via trace thiolate ions, is active in a catalytic 
RSNO decomposition mechanism.
60
 Transnitrosation between a thiol and an RSNO may 
also occur, resulting in the transfer of the nitroso functionality and formation of a new 
RSNO species that may decompose via the aforementioned pathways. 
12, 58
 
To assess the NO storage and release, RSNO-modified particles (~2 mg) were 
added to 500 µM DTPA (pH 7.4 PBS) at a temperature of 0 °C, while measuring the 
ensuing NO release as a function of photolytic decomposition. As shown in the 
representative curves depicted in Figure 2.6, RSNO-modified silica particles exhibited 
photo-initiated NO release upon exposure to broadband, white light. Greater irradiation 
levels (i.e., power) resulted in elevated NO release from the particles. Of note, low levels 
of NO release (~15 ppb mg
-1 
s
-1
) were observed at 0 °C and in the dark (Figure 2.6 inset) 
illustrating an inherent thermal instability of these particles, as is common with primary-
derived RSNOs.
58
 Others have shown that oxygen may react with NO to form dinitrogen 
trioxide (N2O3), an oxidant that also decomposes RSNOs.
61
 These issues evoke concern 
regarding the stability of these particles and their eventual utility in biomedical 
applications. Elimination of oxygen from the storage environment of the RSNO-modified 
particles as well as lower temperatures would be expected to increase the NO storage 
stability of the particles. Indeed, the NO release capacity after 2 months of storage at -20 
°C in vacuo and in the dark was identical to freshly nitrosated particles illustrating that 
proper storage conditions extend particle stability and maintain their potential utility for 
biomedical applications. Furthermore, doping within a polymeric matrix has been shown 
to enhance the thermal stability of low molecular weight RSNOs due to a cage effect  
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Figure 2.6 Representative nitric oxide release from RSNO-modified 75 mol% MPTMS 
(balance TEOS) particles in the presence of (A) 0, (B) 60, (C) 100, and (D) 200 W 
irradiation at 0 °C [Inset: Enlarged view of A.] 
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resulting in recombination of thiyl and NO radicals after homolysis.
62
 This 
suggests that doping the RSNO-modified particles presented here within polymers, as a 
potential biomedical application, may further enhance their stability. Indeed, this is the 
subject of current research in our laboratory. 
Due to the rapid kinetics of the photo-initiated decomposition, total NO storage of 
the particles was assessed by exposing the particles to 200 W of broadband light. Indeed, 
>95 % of the NO stored was released after 5 h of irradiation at 200 W. As given in Table 
2.2, the total NO released from the particles ranged from 0.09–4.39 µmol mg-1. These 
levels of NO storage are an order of magnitude larger than previously reported RSNO-
modified silica particles.
30
 Using the average sulfur weight percents in conjunction with 
the average NO storage values, the percent conversion of thiol to RSNO for each particle 
composition was calculated (Table 2.2). It can be seen that although high, the nitrosation 
efficiency does not reach 100% for the majority of compositions. Thiols that exist as 
disulfides or that are inaccessible to the nitrosating agent may be contributing to 
incomplete nitrosation. To investigate these hypotheses, the Ellman’s assay was used to 
quantify the amount of reduced thiols for comparison to the total sulfur content of the 
particles as discerned from CHN/S elemental analysis. For the 25 and 40 mol% 
compositions, the elemental analysis results were comparable to the free thiol content 
deduced by the Ellman’s assay (data not shown). However, the free thiol values for 
compositions above these MPTMS concentrations were superficially low when viewed in 
relation to the total NO storage that they obtained. We hypothesized this discrepancy was 
due to the thiols being accessible to nitrous acid, but not to the larger, bulkier Ellman’s 
reagent. The molecular size of Ellman’s reagent has been cited previously to be 
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problematic in quantifying thiols embedded within materials.
63
 Furthermore, the assay 
requires significant method development when attempting to analyze thiols attached to 
solid supports as opposed to proteins.
64
 To date, the assay has been most useful in 
quantifying thiols grafted onto the surface of solid supports that are not disadvantaged by 
inaccessibility issues.
30
 Thus, is it not unexpected that these co-condensed particles 
proved problematic in being analyzed via this assay.  
The particles exhibit very limited surface areas and this corroborates the 
hypothesis of thiol inaccessibility both interfering with the Ellman’s assay and limiting 
nitrosation efficiency (Table 2.2). A concomitant decrease in porosity is observed as the 
concentration of MPTMS in the particles increases from 40–75 mol%, which 
corroborates that the Ellman’s assay was better suited for the more porous materials. 
Furthermore, incubating the 75 mol% MPTMS (balance TEOS, 718.0 ± 51.7 nm) 
particles with a reducing agent (dithiothreitol) before nitrosation did not significantly 
increase the NO storage of the system (2.73 μmol mg-1) illustrating that the thiols 
accessible to nitrous acid do exist in the reduced form. Thus, the nitrosation efficiencies 
below 100% are attributed to thiols buried deep within the non-porous particles that are 
solvent inaccessible. Of note, the porosity does not trend with the degree of nitrosation 
efficiency as might be expected. Indeed, the lower nitrosation efficiencies for the more 
porous particles (i.e., the 25 and 40 mol% MPTMS) are attributed to the large error 
associated with measuring the low NO release and limited sulfur content of particle 
compositions that have low MPTMS concentrations. 
The effect of copper on NO release was investigated as a function of copper 
concentration. These assays were performed using Cu(II) via CuBr2 due to the 
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insolubility of Cu(I) compounds in aqueous solutions.
65
 As expected, the NO release 
from the RSNO-modified particles correlated with the copper concentration (Figure 2.7) 
with the greatest copper concentration examined (25 µM) generating the maximum NO 
release (~45 ppb mg
-1 
s
-1
).  
 The use of RSNO-modified particles for biomedical application likely 
necessitates an NO release trigger other than light or large concentrations of free copper 
ions.
66-68
 We thus evaluated NO release from the particles via thermal degradation at 37 
°C using 75 mol% MPTMS (balance TEOS, 718.0 ± 51.7 nm) as a model system. 
Particles were introduced into 500 µM DTPA (pH 7.4 PBS), maintained at 37 °C and 
shielded from external light while monitoring NO release over 48 h (Table 2.3). Under 
these conditions, the particles released a total of 1.17 μmol NO mg-1 with a corresponding 
half life of 2.95 h. When compared to the total amounts released after 5 h using 200 W 
irradiation (3.15 μmol mg-1, Table 2.2), the discrepancy may be attributed to inability to 
measure NO at low levels beyond 48 h and/or loss of NO through its reaction with 
oxygen present in the soak solutions.
61
 As evident by a pink hue, the particles still 
contained a portion of their NO payload even after 48 h of thermally initiated release.  
Upon comparison to numerous NO-releasing vehicles previously reported in the 
literature, the total amount of NO loading on RSNO-modified particles  reported here 
exceeds or is comparable to previously published values. Stöber-synthesized N-
diazeniumdiolate-modified silica particles
24
 have been characterized to store 1.7 μmol 
mg
-1
 while dendrimers
22
 and surface-grafted silica particles
30
 modified with RSNO 
moieties have been shown to store up to ~2 and ~0.138 μmol mg-1, respectively. Some 
macromolecular scaffolds have NO storage that exceeds what is reached with the RSNO- 
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Figure 2.7 Representative nitric oxide release from RSNO-modified 75 mol% MPTMS 
(balance TEOS) particles in the presence of (A) 0, (B) 10, and (C) 25 µM CuBr2/PBS 
solution at 0 °C. Note: 0 µM CuBr2 is 500 µM DTPA (pH 7.4 PBS).  
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Table 2.3 Instantaneous NO release levels of S-nitrosothiol-modified silica particles at 37 
°C in 500 μM DTPA (pH 7.4 PBS) and shielded from light. 
 
Time (h) Instantaneous NO 
release (ppb mg
-1
 s
-1
)
a
 
0 1205.7 ± 22.4 
0.5 481.2 ± 7.7 
1 355.7 ± 7.7 
6 74.9 ± 0.7  
12 33.2 ± 0.4  
24 12.6 ± 0.2 
48 2.50 ± 0.07 
a
Averages are calculated from n = 3 syntheses   
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modified silica particles reported here. Metal organic frameworks (MOFs) 
modified as NO-releasing scaffolds  have been found to store extremely large payloads of 
NO (~7 μmol mg-1).69 However, these vehicles lack the ability to control decomposition 
and rapidly release their adsorbed NO upon exposure to and exchange with water. Thus, 
RSNO-modified particles offer the added benefit of extended NO release for 2 d under 
physiological conditions.  
Whereas pharmacological studies have yet to be undertaken with our materials, 
others have examined vehicles (e.g., zeolites, MOFs, dendrimers, and silica particles) that 
store less or equivalent amounts of NO and found they exhibit significant efficacy in 
inhibition of platelet aggregation,
22, 70, 71
 and bactericidal activity.
72
 Based on these 
findings, the amounts and kinetics of NO release for our materials suggest great 
pharmacological and biomedical potential and will be the focus of future studies. 
 
2.4 Conclusions 
The Stöber process enabled the facile synthesis of silica particles with tunable 
amounts of thiol functionality. Both the size and shape (spherical) of these organically-
modified particles were highly monodisperse. Furthermore, the size of the particles was 
readily tunable by varying the amount of water used in their synthesis. Nitrosating the 
thiols after particle formation resulted in the formation of macromolecular NO-donor 
scaffolds that store and release NO in proportion to the molar percentage of MPTMS 
used in their preparation. Under physiological conditions in the absence of light, the NO 
release durations from the particles exceeded 48 h. Based on these characteristics, the 
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particles hold great promise as NO-based therapeutics and/or dopants for NO-releasing 
polymeric coatings.
4-6
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Chapter 3: 
Photoinitiated Antimicrobial Efficacy of Tertiary S-Nitrosothiol-Modified Nitric 
Oxide-Releasing Xerogels 
 
 
3.1  Introduction  
 Reactive radical species (e.g., hydroxyl radical and superoxide) are well-suited as 
antimicrobial agents as their biocidal activity is broad-spectrum, lessening the likelihood 
of bacterial resistance and improving efficacy against multiple microbial species and 
strains.
1
 Light-activated antimicrobial surfaces including titanium dioxide films and 
photosensitizer-modified polymers represent new strategies for eliciting antibacterial 
activity by light-induced generation of reactive radicals and singlet oxygen.
1-4
 Medical 
implants, catheters, and hospital-associated surfaces that are plagued by bacterial 
contamination would greatly benefit from the associated disinfection/sanitization 
capabilities of such surfaces. 
 Nitric oxide (NO) is another radical species with potent broad-spectrum 
antimicrobial activity as evidenced by its role in the innate immune response to 
pathogens.
5
 The antimicrobial therapeutic utility of exogenous NO delivery via NO 
donors (i.e., compounds that store and release NO) has been an active area of research.
5-8
 
However, the clinical success of NO-based antimicrobial therapies is hindered by the 
inability to store and controllably release enhanced payloads of NO. Macromolecular 
vehicles (e.g., silica nanoparticles, metallic clusters, and dendrimers) and polymers have 
been functionalized with multiple NO donor moieties to enable larger reservoirs of 
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deliverable NO.
6, 9
 The application of these materials as coatings provides localized NO 
release at a desired interface (e.g., an indwelling medical device) with effective 
mitigation of bacterial adhesion.
6, 9
 Nevertheless, the lack of a suitable NO release trigger 
has limited the ultimate utility of these vehicles as most formulations spontaneously 
liberate NO upon immersion in physiological solution.  
 Irradiation with light would represent a suitable trigger for enabling both spatial 
and temporal control over NO release. Fortunately, numerous NO donors exist that are 
susceptible to photoinitiated NO release.
10, 11
 Of note, S-nitrosothiols (RSNOs) are a class 
of endogenous NO transporter that undergo photolysis to release NO upon homolytic 
cleavage of the S–N bond.11, 12 The light initiated NO release from donors such as these  
has led to the development of macromolecular scaffolds and polymers featuring 
controlled NO release.
13
 Specifically, silica nanoparticles,
14, 15
 dendrimers,
16
 self-
assembled monolayers,
17
 polyurethanes,
18
  and polyesters
19-21
 have been modified with 
RSNO functionalities to design photoactivatable NO release vehicles. Macromolecular 
RSNO-bearing particles may be used as dopants within traditional polymers to fabricate 
photoactivated NO-releasing surfaces. Indeed, Frost and Meyerhoff doped S-nitroso-N-
acetyl-DL-penicillamine (SNAP) surface-grafted silica particles into the middle of trilayer 
silicone rubber films at 20 wt%.
22
 The hydrophobic nature of the polymer prohibited NO 
generation from RSNO decomposition pathways other than photolysis (i.e., copper ion-
mediated decomposition). While the films enabled precise control over NO release by 
light, total NO storage was limited by the dopant concentration as higher weight percents 
may compromise polymer stability (i.e., dopant leaching).
23
 
 Covalent modification of a polymer backbone with NO donor functionalities 
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represents an alternative strategy for fabricating NO-releasing coatings with enhanced 
NO storage.
6, 24, 25
 Silica-based xerogel polymers are particularly appealing as sol-gel 
chemistry (i.e., the hydrolysis and co-condensation of organosilanes and backbone 
alkoxysilanes) allows for tunable concentrations of organic functionalities to be 
covalently incorporated throughout the siloxane bond network.
26, 27
 Our laboratory has 
reported the use of sol-gel chemistry in the fabrication of aminosilane-based xerogels that 
are easily adapted to store NO via N-diazeniumdiolate modification.
28-32
 More recently, 
we reported the synthesis of RSNO-modified xerogels using mercaptopropyl- and 
methyltrimethoxysilane (MPTMS and MTMOS, respectively).
33
 Nitrosation of the 
primary thiol groups covalently attached throughout the polymer network yielded 
materials with NO release behavior dependent on light and copper exposure. The ability 
of RSNOs to liberate NO under visible irradiation coupled with the attractive features of 
xerogels (i.e., optical transparency, formation under mild synthetic conditions, and 
amenability to coating various substrates) suggest these materials may prove useful as 
photoantimicrobial surfaces. However, thermally-induced cleavage of the S–N bond on 
the primary thiol led to considerable NO release in the dark at physiologically relevant 
temperatures (i.e., 37 °C). While the labile nature of the S–N bond proved useful in 
reducing bacterial adhesion, the thermal instability prohibits use of these xerogels as 
solely photoactivatable stores of NO. 
 S-Nitrosothiol stability is determined by chemical structure.
11
 Tertiary RSNOs 
(e.g., SNAP) are more stable than their primary analogues due to steric hindrance 
surrounding the sulfur atom.
34, 35
 We thus hypothesize that xerogels featuring tertiary 
derived-RSNOs may exhibit enhanced NO storage stability at physiological temperatures 
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compared to xerogels prepared with primary thiols. Unfortunately, tertiary thiol silanes 
are not readily available. As such, the synthesis and characterization of a tertiary thiol-
bearing silane was necessary prior to the study of whether such precursors could be 
incorporated into xerogel films. Subsequently, the chemistry required to form stable, 
photoactivatable NO release materials was optimized. Characterization of the materials 
included investigation of the NO release properties in the dark and under irradiation at 
37 °C, material stability, and resistance to bacterial adhesion to evaluate the potential of 
the xerogels as photoantimicrobial NO-releasing surfaces. 
 
3.2  Materials and Methods 
3-aminopropyltrimethoxysilane (APTMS), tetraethoxysilane (TEOS), and 
isobutyltrimethoxysilane (BTMOS) were purchased from Gelest (Tullytown, PA). 
Methyltrimethoxysilane (MTMOS) and diethylenetriamine pentaacetic acid (DTPA) 
were purchased from Fluka (Buchs, Switzerland). Tetramethoxysilane (TMOS) was 
purchased from Sigma (St. Louis, MO). D(–)-Penicillamine, ethanol, and tetrahydrofuran 
(THF) were obtained from Fisher Scientific, (Fair Lawn, NJ). Pseudomonas aeruginosa 
(ATCC #19143) was obtained from American Type Culture Collection (Manassas, VA). 
Nitric oxide calibration gas (26.8 ppm; balance N2) was purchased from National 
Welders Supply Co. (Durham, NC).  Type A19 60 and 100 W General Electric and type 
A21 200 W Sylvania incandescent light bulbs were purchased from Lowe’s (Chapel Hill, 
NC). Tecoflex SG-80A polyurethane was a gift from Thermedics (Woburn, MA). Other 
solvents and chemicals were analytical-reagent grade and used as received. Distilled 
water was purified to 18.2 M∙cm with a Millipore Milli-Q Gradient A-10 water 
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purification system (Bedford, MA). 
 
3.2.1 Synthesis of N-Acetyl Penicillamine (NAP) Thiolactone 
 Acetic anhydride (96 mmol, 9.80 g) was added dropwise to a well stirred solution 
of D-(-) penicillamine (40 mmol, 5.97 g) in pyridine (50 mL) at 0 °C.  After 30 min, the 
flask was removed from ice and allowed to stir at room temperature for 15 h. The 
resultant orange solution was partitioned between chloroform and dilute HCl and washed 
4x with dilute HCl.  After drying over MgSO4, the organic phase was evaporated to yield 
an orange residue. The residue was first dissolved in absolute ethanol (20 mL), and then 
precipitated in pentane at -78 °C. The light yellow crystalline product was isolated by 
filtration (2.07 g, 30%). 
1
H NMR (CDCl3) δ1.65 (s, CH3), 1.86 (s, CH3), 2.05 (s, 
NHCOCH3), 5.68-5.70 (d, CH(CH3)2), 6.56 (NHCOCH3).  
13
C NMR (CDCl3) δ 22.52 
(NHCOCH3), 26.20 (CH(CH3)2), 30.22 (CH(CH3)2), 51.23 (CH), 169.37 (NHCOCH3), 
192.21 (SCO).   
 
3.2.2 Synthesis of N-Acetyl Penicillamine Propyltrimethoxysilane (NAPTMS) 
 APTMS (10 mmol, 1.78g). was added to a stirring solution of NAP thiolactone 
(10 mmol, 1.72 g) in methylene chloride (20 mL). The light yellow solution was stirred 
for 4 h at room temperature before distillation of the methylene chloride to yield 
NAPTMS as a viscous clear oil. 
1
H NMR (CDCl3) δ 0.54 (t, SiCH2), 1.24 and 1.39 (s, 
CH(CH3)2SH), 1.54 (m, SiCH2CH2), 1.96 (s, NHCOCH3), 2.96 and 3.21 (m, 
SiCH2CH2CH2), 3.44 (s, Si(OCH3)3), 4.63 (d, CHC(CH3)2SH), 6.99 (d, CHNHCOCH3), 
7.70 (t, CH2NHCOCH).  
13
C
 
NMR (CDCl3) δ CH2), 22.42 and 22.97 
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(CH(CH3)2SH), 28.64 (NHCOCH3), 30.80 (SiCH2CH2), 41.93 (CHC(CH3)2SH), 46.23 
(SiCH2CH2CH2), 50.35 (Si(OCH3)3), 60.32 (CHC(CH3)2SH), 169.64 (CHNHCOCH3), 
170.17 (CHCONH). 
 
3.2.3 Synthesis of NAPTMS-derived Xerogels 
Xerogel coatings were prepared as follows. Sols containing 10–40 mol% 
NAPTMS (balance MTMOS, BTMOS, TMOS, or TEOS) were prepared by shaking 
ethanol (1050 µL), backbone alkylalkoxy- or alkoxysilane (86–201 µL), NAPTMS (53–
210 mg; total silane molar amount = 1 mmol), water (46 μL) and 0.5 M HCl (136 µl) for 
30 min–4 h. All substrates were sonicated in ethanol for 20 min, dried under N2, and 
ozone (UV) cleaned for 20 min in a BioForce TipCleaner (Ames, IA) prior to casting. 
Aliquots of 30–120 µl were cast onto 9 x 25 mm2 precleaned glass substrates. After 
casting of the sol, all physisorbed films were allowed to dry at room temperature 
overnight, and then transferred to a 45 °C oven for 2 d. S-Nitrosothiols were then formed 
on the room temperature-cooled films. 
 
3.2.4 S-Nitrosothiol Formation.  
Thiols of xerogels were nitrosated by reaction with acidified nitrite. Films were 
protected from light and incubated for fixed intervals in solution (2 mL) containing a 
100-fold molar excess of NaNO2 and HCl (vs. moles thiol) and 500 µM DTPA. The 
xerogels were washed with 500 µM DTPA and stored in the dark at -20 °C until used.  
Spectral characterization of RSNO formation was performed by affixing the slides 
normal to the light path of a PerkinElmer Lambda 40 UV/vis spectrophotometer 
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(Norwalk, CT) in cuvettes containing 2 mL phosphate buffered saline (PBS; 10 mM 
phosphate, pH 7.4). Absorbance at 590 nm was monitored as a function of nitrosation 
reaction time and concentration of excess nitrosating agent for each composition of 
xerogel. 
 
3.2.5 Characterization of NO Release 
Nitric oxide release from RSNO-modified xerogels was monitored in 1 s intervals 
using a Sievers model 280i chemiluminescence nitric oxide analyzer (NOA) (Boulder, 
CO).  Calibration of the instrument was performed prior to each experiment using 26.8 
ppm NO gas (balance N2) and air passed through a Sievers NO zero filter. Individual 
slides were immersed in 25 mL PBS containing 500 µM DTPA and sparged with a 200 
mL/min N2 stream. Temperature of the sample was maintained at 37 °C during 
irradiation by circulating thermostatted water through a custom-made flow cell. The 
water was circulated between the flow-cell housing the sample flask and a thermostatted 
water bath shielded from the lamp. Light-initiated NO release was examined by using 
incandescent bulbs of various wattages placed 0.6 m above the sample flask to monitor 
light induced fluxes and at a distance of 0.3 m without thermostatting for assaying total 
NO storage. The sample flask was shielded from light with aluminum foil when light was 
not the intended initiator of NO release. 
 
3.2.6 Xerogel Film Stability  
Nitrosated xerogel films on glass slides (n = 3) were immersed in 10 mL PBS and 
incubated at 37 °C. Films were removed and transferred to fresh solutions of PBS at fixed 
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intervals of 6, 12, 24 h and 7 d.  Silicon (Si) concentrations in the PBS soak solutions 
were determined using a Teledyne Leeman Labs Prodigy inductively coupled plasma 
optical emission spectrometer (ICP-OES) (Hudson, NH) calibrated with 0–50 ppm Si 
standard solutions in PBS. Blank glass slides as well as slides cast with 30 μL of a 20 mg 
mL
-1
 polyurethane in THF solution (to examine Si leaching of glass substrates with one 
side coated with a polymer) were assessed as controls. 
 
3.2.7 Film Thickness Measurements 
 
Film thicknesses measurements of the RSNO-modified xerogels were acquired 
with a KLA Tencor P15 Profilometer (Milpitas, CA) at a scan speed of 100 μm s-1, 200 
Hz sampling rate, and a scan length of 2000 μm. Half of the RSNO-modified xerogel 
coating was physically removed from the glass substrate and this interface probed to 
acquire film thickness. 
 
3.2.8 Elemental analysis of  RSNO Xerogels 
 
Samples were analyzed for sulfur weight percent by Midwest Microlab, LLC 
(Indianapolis, IN) to deduce the sulfur concentration within the resulting xerogels. 
 
3.2.9 Bacterial Adhesion to RSNO Xerogels 
 
 P. aeruginosa was cultured at 37 °C in tryptic soy broth (TSB), pelleted by 
centrifugation, resuspended in 15% glycerol (v:v in PBS), and stored at -80 °C. Cultures 
for bacterial adhesion studies were grown from a -80 °C stock in 37 °C TSB overnight. A 
1 mL aliquot of overnight culture was inoculated into 100 mL fresh TSB, incubated at 
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37 °C with rotation, and grown to a concentration of 10
8
 colony forming units (cfu) mL
-1
 
(verified by 10-fold serial dilutions in PBS, plating on tryptic soy agar nutrient plates, and 
subsequent cfu enumeration). The bacteria were pelleted by centrifugation, rinsed with 
ultrapure water, and resuspended in sterile PBS. Control (unnitrosated) and RSNO-
modified xerogels were immersed in 4 mL aliquots of bacterial suspension and incubated 
at 37 °C in dark or light conditions (200 W at a distance of 0.6 m). Temperature was 
maintained during irradiation by circulating thermostatted water through a custom-made 
flow cell housing the samples. The xerogel substrates were removed from the bacterial 
suspension after 1 h, gently immersed in ultrapure water to dislodge loosely adhered cells, 
and dried under a stream of N2. To quantify bacterial adhesion, substrates were imaged in 
phase-contrast mode using a Zeiss Axiovert 200 inverted optical microscope (Chester, 
VA) at 20X magnification. Digital micrographs were captured with a Zeiss Axiocam 
digital camera (Chester, VA). To determine the percent surface coverage of bacteria, each 
image was digitally processed by applying a threshold value to differentiate adhered cells 
from the background. The number of pixels corresponding to adhered bacterial cells was 
digitally enumerated with the extent of bacterial adhesion reported as the percent of the 
xerogel substrate surface covered with bacterial cells. 
 
3.3 Results and Discussion 
 
3.3.1 Xerogel Development 
 The preparation of tertiary thiol-based precursors is necessary for the 
development of biomedical devices/therapeutics with continuous and photoactivatable 
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NO release.
35
 A NAP thiolactone was thus synthesized to design such a precursor for the 
synthesis of NO-releasing xerogels. Penicillamine was reacted in the presence of acetic 
anhydride to generate the NAP thiolactone in situ. After characterization by 
1
H and 
13
C 
NMR, the NAP thiolactone was directly coupled with APTMS to result in a tertiary thiol-
bearing silane, referred to as NAPTMS (Figure 3.1). Successful synthesis of this tertiary 
thiol-bearing silane was verified via 
1
H NMR characterization (Figure 3.2). 
 Nitric oxide-releasing xerogels have traditionally been composed of organosilanes 
hydrolyzed and co-condensed with alkoxy- or alkylalkoxysilanes (termed “backbone 
silanes”). The backbone silanes impart both structural stability and tunable NO payloads 
by varying silane molar ratio.
28
 Unfortunately, co-condensation of silanes is not a trivial 
objective. Disparate hydrolysis and condensation rates between mixed silanes impact 
xerogel formation, at times preventing it altogether.
36, 37
 As NAPTMS is a novel silane 
with uncharacterized reaction rates, a systematic examination of the most favorable 
conditions to form NAPTMS-based xerogels was necessary. Co-condensation of 
NAPTMS was attempted with backbones of varying reaction rates, including 
tetramethoxysilane (TMOS), tetraethoxysilane (TEOS), methyltrimethoxysilane 
(MTMOS), and isobutyltrimethoxysilane (BTMOS), to determine which composition 
facilitated optimal xerogel synthesis (Figure 3.3). 
 Nitric oxide-releasing aminosilane-based xerogels have previously been restricted 
to aminosilane concentrations ≤34 mol% because compositions above this threshold 
materials are opaque, brittle, and/or lack homogeneity.
28
 We, previously reported on the 
synthesis of MPTMS-derived xerogels that resulted in smooth, transparent, and stable 
films using mercaptosilanes up to 75 mol%.
33
 Initial investigations into the synthesis of  
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Figure 3.1 Synthesis of N-acetylpenicillamine propyltrimethoxysilane (NAPTMS). 
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Figure 3.2 An 
1
H NMR spectrum of NAPTMS compound. Peak assignments are noted. 
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Figure 3.3 Chemical structures of backbone alkylalkoxy- and alkoxysilanes. 
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tertiary thiol-modified films began with 40 mol% NAPTMS as a plausible mid-range 
concentration to produce films that release significant amounts of NO while maintaining 
desirable physical characteristics (e.g., smooth, crack-free, and optically transparent). 
Unlike previously published NO-releasing xerogels,
28, 33
 these compositions are 
expressed in terms of mole rather than volume percentages due to the high viscosity of 
NAPTMS that prohibits accurate volume measurements and necessitated addition by 
mass. 
 After being dried, these NAPTMS films appeared well-formed regardless of 
backbone identity. However, each composition became opaque when immersed in water, 
indicating insufficient network formation. Such behavior may be attributed to the 
presence of unreacted silicate oil within the xerogel network, leading to phase separation 
from reacted silanes.
38
 Exposure of the xerogels to ethanol resulted in complete film 
dissolution as unreacted and partially reacted silanes were washed away,
26
 indirectly 
corroborating the hypothesis that these 40 mol% compositions resulted in incomplete 
xerogel formation. The significant disparity in hydrolysis/condensation rates between the 
two silane precursors is likely the cause for incomplete film formation. Substantial steric 
hindrance surrounding the Si atom of NAPTMS decreases its condensation rate under 
acid-catalyzed conditions because the reaction is dependent upon the interaction of the 
two silicon sites.
36, 37
 Furthermore, acid catalyzed sol-gel processes are characterized by 
rapid hydrolysis and a slower, rate-limiting condensation of the silane species.
26
 
Incomplete formation of 40 mol% NAPTMS xerogels is thus a combination of the slow 
condensation of NAPTMS and the more rapid reaction of backbone silanes. Multiple 
synthetic parameters that influence silane reaction rates were tuned to remedy this 
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problem. Traditional strategies such as altering the water to total silane ratio (1:4, 2:1, 4:1, 
10:1, and 20:1) did not lead to improved stability, nor did modifications to the reaction 
time (0.5–5 h), acid catalyst concentration (0.01–0.20 M), catalyst type (NaOH vs. HCl), 
ethanol solvent volume (25–1050 μL), drying time (0.25–5 d), and drying temperature 
(25–70 °C). In the end, the high concentration of NAPTMS (i.e., ≥ 40 mol%) was 
concluded to be prohibitive for xerogel formation under the wide range of conditions 
assessed. 
 As expected, lowering the amount of NAPTMS in the sols proved critical to 
achieving stable xerogels. Films were optimized by systematically adjusting a wide range 
of synthetic parameters in the sol-gel synthesis using a model composition consisting of 
20 mol% NAPTMS balanced with MTMOS. Previous research has shown that the water 
to silane ratio significantly impacts silane reaction rates.
26, 39
 While not entirely stable, the 
initial 40 mol% NAPTMS films indicated that a 10:1 water to silane ratio resulted in 
slightly better formulations (i.e., xerogels turned less opaque in aqueous solution). This 
water to silane ratio (based on a 1 mmol total silane amount) was thus selected for study. 
 The amount of acid catalyst may also influence the resulting xerogel formation.
26
 
NAPTMS-based xerogels synthesized with 0.025, 0.05, and 0.075 M HCl exhibited 
markedly different properties upon drying. Greater amounts of catalyst led to non-
uniform coatings and often resulted in opaque xerogels with severe topographical 
heterogeneity. While reactions with the lowest amount of catalyst (i.e., 0.025 M HCl) did 
not adequately promote xerogel formation. The films later exhibited phase separation 
(e.g., increase in opacity upon water submersion) identical to the 40 mol% NAPTMS 
films. Fortunately, films synthesized with 0.05 M HCl were almost ideally formed. To 
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deduce whether this behavior was a result of the molarity or the molar amount of acid, 
the molar values used in the 0.075 M HCl synthesis were diluted with ethanol to achieve 
a concentration of 0.05 M HCl. Xerogels synthesized from the diluted sol retained their 
smoothness and optical transparency when soaked in water. The importance of diluting 
sols has been previously observed when fabricating xerogel coatings with highly viscous 
sols to ensure a homogenous casting solution.
39
 Based on these preliminary experiments, 
a large volume of ethanol (1050 μL) and an acid concentration of 0.05 M were used for 
all subsequent investigations. 
 Using the optimized water to silane ratio and acid catalyst molarity, xerogel 
composition was varied by altering the backbone silane structure. Initially, films were 
formed using TMOS because of its similar hydrolysis/condensation kinetics to 
MTMOS.
37
 We hypothesized that comparable well-formed xerogels would be produced 
when co-condensed with NAPTMS. Unfortunately, TMOS-derived solutions did not coat 
substrates uniformly with resulting xerogels fracturing upon drying/curing. During 
xerogel drying, a meniscus at the vapor/liquid interface causes a pressure gradient within 
the polymer structure.
26, 38, 40
 If the network is not sufficiently pliant or porous to deal 
with such stress, evaporation will proceed non-uniformly resulting in cracking.
26
 The 
inflexible and regimented silica network observed when using TMOS with other silanes 
may be attributed to its four bridging ligands (i.e., enhancing polymer crosslinking). The 
main strategy to decrease the pressure gradient and resulting xerogel fracture is to reduce 
the evaporation rate.
40
 However, applying this strategy (e.g., drying at 25 °C) to 
NAPTMS/TMOS xerogels still led to cracking. 
  While Tan and Rankin have observed a slight increase in acid-catalyzed reaction 
 100 
kinetics for MTMOS compared to TMOS due to inductive contributions from the methyl 
group, branching and steric factors at the silicon site are more influential in dictating 
reaction kinetics.
37
 The similarities in size and associated steric hindrance between 
TMOS and MTMOS suggest that another reason might be responsible for the successful 
film formation using MTMOS and failure (i.e., cracking) with TMOS. Incorporation of 
silane precursors with nonhydrolyzable ligands has been used previously as a viable 
strategy for creating more pliant networks and circumventing xerogel fracturing.
26
 Thus, 
the incorporation of one nonhydrolyzable ligand when using MTMOS as compared to 
TMOS lessens steric constraints and interchain cohesion within the silica network. Thus, 
we conclude that the lessened steric constraints and interchain cohesion is the 
predominant factor for preparing films with high integrity upon drying MTMOS-based 
xerogels. Indeed, others have specifically used MTMOS to impart flexibility to sol-gel 
derived materials.
41
 
 Varying the backbone from TMOS to TEOS represents a less significant 
alteration to the structure of the backbone (i.e., ethoxy instead of methoxy ligands at the 
silicon center) yet resulted in a significant improvement to xerogel stability and 
uniformity. The increase in steric hindrance that accompanies the increased carbon chain 
length effectively decreases the rate of hydrolysis and condensation under acid-catalyzed 
sol-gel reactions.
26, 42
 Successful xerogel formation in this instance likely results from the 
similar kinetic rates of TEOS and NAPTMS, thus facilitating successful co-condensation. 
Similar to TMOS, TEOS features four bridging ligands and therefore should also form 
non-pliant networks. However, cracking was not observed in NAPTMS/TEOS xerogels. 
Successful xerogel formation may be attributed to more successful incorporation of 
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NAPTMS within the network, affording greater flexibility of the network as a result of 
the nonhydrolyzable ligand. Additionally, reactions with TEOS produced films of greater 
integrity at shorter reaction times (i.e., 30 min vs. 1 h) than MTMOS. If the TEOS 
precursor retained a large degree of unhydrolyzed ligands due to the shorter reaction time, 
the resulting network would be more pliant and avoid fracture upon drying.
26
 
 Increasing the size of the nonhydrolyzable ligand in the backbone silane from a 
methyl (MTMOS) to a branched isobutyl group (BTMOS) represents a large contribution 
to steric hindrance and should greatly decrease condensation rates for acid-catalyzed sol-
gel reactions.
26, 37
 Akin to the 40 mol% NAPTMS films, xerogels derived from BTMOS 
were initially smooth and optically transparent upon drying. However, the films were 
easily scratched and turned opaque when immersed in water, indicative of incomplete co-
condensation. It can be assumed that although BTMOS and NAPTMS may have 
similarly matched reaction rates, both rates are too slow for adequate xerogel formation. 
Increasing the catalyst amount or the reaction time to promote reaction between the two 
silanes did not improve xerogel stability for BTMOS-based films. 
  Since the NAPTMS concentrations were limited to ≤30 mol%, alternative 
strategies were necessary to increase/tune NO release kinetics and payloads, we thus 
focused on increasing the amount of sol cast per surface area of substrate. To evaluate 
xerogel thickness and NAPTMS concentration as means of affecting NO release, 30–120 
μL aliquots of 10, 20, and 30 mol% NAPTMS compositions with either TEOS or 
MTMOS were cast on glass substrates. Marked differences in xerogel stability were 
observed for the variations in mol%, casting volume, and backbone. Xerogels formed 
from casting volumes ≥60 μL cracked upon drying regardless of backbone identity or 
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mol%. An upper threshold was expected as increasing the thickness would contribute to 
an enhanced pressure gradient within the xerogel that causes fracturing upon drying.
26
 
Unfortunately, 30–60 μL of MTMOS-derived compositions that contained 10 mol% 
NAPTMS were opaque and did not uniformly coat substrates. These films were stable in 
ethanol, indicating that xerogel formation was complete despite the opacity. Thus, the 
opacity is attributed to microsyneresis or the clustering of the silica network that results 
in phase separation from the residual solvent.
26
. Xerogels lacking optical transparency 
were considered undesirable since photoinitiated NO release is the intended application 
of such materials. While 30 μL cast from a 20 mol% NAPTMS balance MTMOS 
composition also formed glassy, homogenous films (7.84 ± 0.91 μm), 45 and 60 μL casts 
were similar in opaque appearance to the 10 mol% compositions. Xerogels consisting of 
30 mol% NAPTMS balance MTMOS at 30, 45, and 60 μL casting volumes formed, 
optically transparent xerogels with resulting thicknesses of 10.03 ± 1.42, 15.43 ± 2.28, 
and 19.05 ± 2.05 μm, respectively.  
 Similarly, ideal TEOS films were formed using 20 mol% NAPTMS at 30, 45, and 
60 μL casting volumes and 30% NAPTMS at 30 μL cast with corresponding thicknesses 
of 8.65 ± 0.81, 14.35 ± 0.34, 19.33 ± 3.32, and 10.28 ± 1.95 μm, respectively. Greater 
casting volumes for the 30% NAPTMS balance TEOS films exhibited cracking upon 
drying. Compositions derived from 10 mol% NAPTMS balance TEOS cracked upon 
drying as well, ostensibly due to an excessive concentration of TEOS in the silica 
network causing a lack of pliance within the xerogel framework. Altogether, eight stable 
xerogel formulations composed of NAPTMS/MTMOS and NAPTMS/TEOS as a 
function of silane mol% and casting volumes were subsequently pursued as novel NO-
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releasing photoantimicrobial surfaces. 
 
3.3.2 Xerogel nitrosation  
 Thiols are readily converted to NO donor form (i.e., RSNOs) by exposure to 
nitrosating agents such as nitrous acid (commonly generated in situ from acidified nitrite 
solutions).
12
 S-Nitrosothiol formation is accompanied by a color change with primary 
RSNOs red in appearance and tertiary RSNOs green. Thus, characteristic RSNO 
absorbance bands in the UV (330–350nm; nO → π
*
) and visible (550–600 nm; nN → π
*
) 
regions are used to monitor RSNO formation.
11
 Previously, we reported the synthesis of 
primary RSNO-modified xerogels using a 10-fold molar excess of sodium nitrite (vs. 
moles of thiol) to obtain optimal nitrosation efficiency.
33
 Initial UV/vis spectroscopy 
studies indicated that optimal nitrosation of the NAPTMS-derived films required a 100-
fold molar excess of acidified nitrite. With the associated steric hindrance surrounding 
the tertiary thiol functionality, an increase in the required amount of acidified nitrite for 
nitrosation is expected.
11
 The optimal nitrosation time was studied as a function of 
backbone and casting volume and determined after absorbance at 590 nm no longer 
increased, indicating extent of nitrosation had ceased. As shown in Figure 3.4, the degree 
of nitrosation was not enhanced with reaction times >3 h for MTMOS-based films 
(casting volume of 30 μL). Identical analysis revealed that 45 and 60 μL casts of 
MTMOS-based films (regardless of NAPTMS mol%) required slightly longer reaction 
time (4 h), presumably due to slowed diffusion of the nitrosating agent through the 
thicker coatings. Xerogels derived from TEOS reacted more rapidly and were nitrosated 
to a maximum extent after 1 h incubation, regardless of casting volume. The difference  
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Figure 3.4 Absorbance spectrum of a 20 mol% NAPTMS balance MTMOS (30 μL cast) 
xerogel film after 1 (dashed dotted black line), 2 (dashed red line), 3 (dotted blue line) 
and 4 h (solid green line) of nitrosation in a 100x molar excess (vs. thiols) of acidified 
nitrite. 
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between TEOS and MTMOS may be attributed to the less organic character associated 
with TEOS-based network that facilitates more rapid penetration of the aqueous 
nitrosating agent within the xerogel network. 
 
3.3.3 NO release characterization 
 Although more stable than their primary counterparts, tertiary RSNOs still 
undergo decomposition (and NO release) by typical RSNO pathways including thermal 
and photolytic-based S–NO cleavage and copper ion-mediated reduction.11, 12 However, 
minimal amounts of “free” copper ions are found physiologically, suggesting this method 
NO release may be physiologically irrelevant.
43-45
 While Dicks and Williams have 
reported a potential for copper-initiated NO-release in vivo due to copper complexed to 
biomacromolecules, the decomposition is markedly slow to produce NO.
46
 While 
previous primary RSNO-modified xerogels exhibited NO release that had a slight 
dependence on copper ion concentration, thermal and photoinitiated fluxes led to more 
substantial NO.
33
 Due to this knowledge and the intended photoinitiated release of NO 
from these tertiary RSNO-modified xerogels, the effect of copper on NO release was 
deemed extraneous. Additionally, trace copper ions in PBS buffer were chelated with 
diethylenetriaminepentaacetic acid (DTPA) to inhibit any Cu-ion mediated 
decomposition when characterizing the NO release of these films. 
 Photoinitiated NO release from RSNO-modified xerogels was measured in real 
time using chemiluminescence. Individual films were immersed in 500 μM DTPA (pH 
7.4 PBS) at 37 °C. As expected, exposure to visible irradiation greatly influenced the NO 
release from the coatings. As shown in Figure 3.5, the NO flux from a representative  
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Figure 3.5 Nitric oxide flux from a 30 mol% NAPTMS balance TEOS (30 μL cast) 
xerogel at 37 °C and under periods of visible irradiation. Increasing bulb wattages are 
noted. Successive steps under each period of irradiation correspond to distances between 
the light source and sample of 0.9, 0.6, and 0.3 m.  
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xerogel film (30 mol% NAPTMS balance TEOS, 30 μL cast) increased with both greater 
bulb wattage and decreasing distance between the lamp and sample flask. The rapid NO 
release kinetics associated with the 200 W light at a distance of 0.3 m were ideal for 
quantifying the total amount of NO stored within the films. A period of 16 h of 
irradiation under these conditions was sufficient to completely liberate all of the NO from 
the films as indicated by both a return to baseline on the instrument and the absence of a 
greenish hue within assayed films.  
 To aid in comparison among different compositions as well as previous materials, 
two criteria should be met when reporting the total NO storage. The total should be 
reported relative to the surface area of the coating as well as normalized per mass of 
deposited material. As shown in Table 3.1, the tertiary RSNO-modified xerogels were 
found to store 0.20–0.62 μmol NO per mg of material. Of note, the mass-normalized NO 
storage was not equivalent at different casting volumes of the same composition. For 
example, 30 mol% NAPTMS/MTMOS compositions stored 0.47 ± 0.10 μmol mg-1 when 
cast at 30 μL (~5 mg of xerogel upon drying), but only 0.28 ± 0.07 μmol mg-1 when 60 
μL was cast (~12 mg of deposited material). Although nitrosation times were optimized 
for individual casting volume, this nonlinearity indicates the extent of nitrosation for each 
film differs and is presumably limited by casting volume (thickness). For example, thiols 
located within the interior of the coating may be inaccessible to the nitrosating agent. 
Indeed, the dense structure and limited porosity of acid-catalyzed xerogels are well 
known.
26
  
 Although thicker films stored less NO per mass of identical xerogel for all 
compositions, the difference was more pronounced for MTMOS-derived films. This was  
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Table 3.1 Total NO stored, sulfur content, and degree of thiol to S-nitrosothiol conversion  
for tertiary RSNO-modified xerogels. 
NAPTMS 
(mol%) 
 
 
Backbone 
Casting 
volume 
(μL) 
Total NO released                               
(μmol cm-2)      (μmol mg-1) 
Sulfur 
content
(weight %) 
RSNO 
conversion 
efficiency 
(%) 
20 TEOS 30 1.02 ± 0.26 0.25 ± 0.06 3.89 20.2 
20 TEOS 45 1.16 ± 0.44 0.20 ± 0.08 3.89 16.9 
20 TEOS 60 1.48 ± 0.29 0.24 ± 0.05 3.89 19.9 
30 TEOS 30 1.78 ± 0.09 0.62 ± 0.03 5.05 39.2 
20 MTMOS 30 0.87 ± 0.31 0.31 ± 0.11 2.51 39.3 
30 MTMOS 30 1.13 ± 0.23 0.47 ± 0.10 4.57 32.9 
30 MTMOS 45 1.22 ± 0.48 0.27 ± 0.11 4.57 19.1 
30 MTMOS 60 1.64 ± 0.39 0.28 ± 0.07 4.57 19.9 
 109 
somewhat expected as these films also required different nitrosation times dependent on 
casting volume, whereas TEOS-based films reached optimal nitrosation at equivalent 
times regardless of casting volume. Nevertheless, the variation in NO storage per mass 
was small enough such that when total NO storage is normalized to surface area of 
coating, a are clear correlation was observed between xerogel thickness and NAPTMS 
mol% (Table 3.1). Increasing either the thickness or NAPTMS concentration of the 
coating enhanced NO storage to the range of 0.87–1.78 μmol cm-2. When comparing 
equivalent concentrations of NAPTMS and casting volumes, the TEOS-based films 
stored slightly more NO than MTMOS-based films. The large reservoirs of NO stored 
within these coatings are comparable to previously reported NO-releasing xerogels that 
have shown efficacy in reducing bacterial adhesion,
30-33, 47
 fighting infection,
48
 and 
mitigating the foreign body response,
49
 illustrating the biomedical potential of these 
tertiary RSNO-modified xerogels. 
 To confirm that the degree of nitrosation varied for each composition, elemental 
analysis of the films was used to deduce the amount of sulfur in the xerogels. As 
provided in Table 3.1, 20 mol% NAPTMS balance TEOS films consisted of 3.89 wt% 
sulfur while the equivalent MTMOS counterpart contained 2.51 wt% sulfur.  Likewise, 
the 30 mol% NAPTMS xerogels contained 5.05 and 4.57 wt% for films formed with 
TEOS and MTMOS, respectively. The sulfur wt% can be converted to moles of sulfur 
per mg of coating with knowledge of the molecular mass of sulfur. The NO release 
normalized per mass essentially provides the number of moles of RSNO per mg of 
coatings. Thus, dividing the two values allowed for the determination of the nitrosation 
efficiency. As shown in Table 3.1, nitrosation efficiencies for 20 mol% NAPTMS/TEOS 
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films were ~17–20 % regardless of casting volume. Increasing the NAPTMS 
concentration to 30 mol% resulted in a greater nitrosation efficiency (~39 %), suggesting 
that higher thiol incorporation increases thiol accessibility to the nitrosating agent (i.e., 
nearer to the surface). Xerogels derived from MTMOS were characterized by similar 
conversion efficiencies at 20 and 30 mol% NAPTMS, but the nitrosation efficiency 
decreased for greater casting volumes (i.e., ~33 vs. ~20% for 30 and 60 μL casting 
volume, respectively). These results again indicate that thicker films limit the extent of 
nitrosation, due most likely to the dense structure of the xerogel and a large degree of 
thiols being solvent inaccessible. 
 The motivation for employing tertiary RSNO-modified xerogels as 
photoantimicrobials is that the enhanced stability would negate substantial thermal 
decomposition leading to NO release in the absence of light. To verify such thermal 
stability, NO fluxes were measured from xerogels immersed in 500 μM DTPA (pH 7.4 
PBS) at 37 °C without light. As expected, little if any NO was released under these 
conditions (Table 3.2). Any initial NO release (~6–40 pmol cm-2 s-1) rapidly subsided 
within 10 min to fluxes <4 pmol cm
-2
 s
-1
. The initial NO release is attributed to RSNO 
decomposition resulting from the sudden temperature increase when films at room 
temperature are immersed in 37 °C PBS. The fluxes monitored over the one week period 
to be stable yet low, dropping to <1 pmol cm
-2
 s
-1
 for all compositions after 48 h. After 7 
d at 37 °C in the dark, the xerogels released 0.24–0.54 μmol NO per cm-2, corresponding 
to an average of ~32% of the total NO storage. Shorter periods (i.e., 24 h) resulted in an 
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Table 3.2  Nitric oxide flux from tertiary RSNO-modified films at 37 °C and in the dark. 
   Nitric oxide flux (pmol cm
-2 s-1) 
NAPTMS 
(mol%) Backbone 
Casting 
volume 
(μL) 0 h 1 h 6 h 12 h 1 d 2 d 3 d 5 d 1 week 
20 TEOS 30 21.6 ± 0.7 2.20 ± 0.02 1.23 ± 0.06 0.55 ± 0.01 0.25 ± 0.01 0.43 ± 0.01 0.29 ± 0.01 0.28 ± 0.01 0.22 ± 0.01 
20 TEOS 45 18.5 ± 0.6 2.90 ± 0.50 1.84 ± 0.02 0.87 ± 0.01 0.54 ± 0.08 0.40 ± 0.03 0.31 ± 0.01 0.40 ± 0.01 0.29 ± 0.01 
20 TEOS 60 31.9 ± 1.0 3.95 ± 0.04 2.73 ± 0.03 1.29 ± 0.02 0.97 ± 0.02 0.67 ± 0.01 0.44 ± 0.01 0.37 ± 0.01 0.31 ± 0.01 
30 TEOS 30 40.0 ± 0.5 2.70 ± 0.03 2.07 ± 0.02 1.27 ± 0.02 1.17 ± 0.02 0.91 ± 0.01 0.51 ± 0.01 0.39 ± 0.01 0.41 ± 0.01 
20 MTMOS 30 6.3 ± 0.9 3.05 ± 0.03 2.03 ± 0.02 1.44 ± 0.03 0.95 ± 0.02 0.72 ± 0.01 0.61 ± 0.01 0.38 ± 0.10 0.22 ± 0.05 
30 MTMOS 30 9.5 ± 0.7 2.10 ± 0.02 1.86 ± 0.04 1.26 ± 0.02 0.83 ± 0.02 0.61 ± 0.01 0.52 ± 0.01 0.60 ± 0.01 0.28 ± 0.07 
30 MTMOS 45 30.3 ± 6.8 2.07 ± 0.02 2.32 ± 0.04 1.38 ± 0.02 0.89 ± 0.02 0.80 ± 0.03 0.58 ± 0.01 0.49 ± 0.01 0.39 ± 0.01 
30 MTMOS 60 26.9 ± 2.0 2.26 ± 0.02 2.26 ± 0.03 1.67 ± 0.02 1.33 ± 0.03 0.91 ± 0.01 0.61 ± 0.01 0.66 ± 0.01 0.51 ± 0.01 
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average of only ~11% of the NO reservoir being depleted, illustrating a stronger than 
expected thermal stability for the RSNO-modified films. Furthermore, xerogels still 
retained their greenish hue (indicative of tertiary RSNOs) after 1 week of soaking at these 
conditions with irradiation of these xerogels at that time resulting in NO liberation with 
fluxes comparable to freshly nitrosated xerogels (data not shown). 
 Although minimal at 37 °C, thermally-induced NO release may be quite 
significant at elevated temperatures caused by localized heating from the light source. In 
order to deconvolute thermal and photolytic NO release, the sample temperature was 
maintained during irradiation with the broadband source. Despite the use of a water bath 
set to 37 °C, a gradual temperature increase was still noted and attributed to heating from 
the incandescent bulb at extended irradiation times (e.g., >10 min). Such heating 
enhanced NO release levels after initial periods of steady light-induced fluxes, resulting 
in a gradual increase in the NO flux (Figure 3.6). Similar behavior was observed when a 
heating mantle was used to thermostat the temperature of the sample flask. Circulating 
water from a thermostatted bath shielded from direct irradiation was found to properly 
maintain the sample temperature at 37 °C, allowing for photoinitiated NO release to be 
assessed at physiological temperature. A 200 W light was kept at a distance of 0.6 m 
above the sample as a closer working distance increased sample heating, even with the 
circulating water bath. As shown in Table 3.3, the average NO flux over 1 h of irradiation 
was steady for each composition (21.9–39.0 pmol cm-2 s-1). When compared to the 
average NO fluxes for identical compositions assayed in the dark, a marked contrast is 
observed as illustrated in Figure 3.7. Photoactivation enhanced NO release from the 
materials by an order of magnitude compared to the strictly thermally-induced fluxes  
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Figure 3.6 Nitric oxide flux from a 20 mol% NAPTMS balance TEOS (60 μL cast) 
xerogel thermostatted with a water bath at 37 °C and irradiated with 200 W light. 
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Table 3.3 Average NO flux from RSNO-modified xerogels over 1 h at 37 °C either 
irradiated or in the dark. 
 
   Nitric oxide flux (pmol cm
-2
 s
-1
) 
NAPTMS 
(mol%) Backbone 
Casting volume 
(μL) 200 W irradiation Dark 
20 TEOS 30 22.7 ± 3.0 2.7 ± 0.4 
20 TEOS 45 27.3 ± 3.2 3.4 ± 0.4 
20 TEOS 60 27.4 ± 3.6 4.2 ± 0.4 
30 TEOS 30 39.0 ± 6.5 3.2 ± 0.5 
20 MTMOS 30 23.8 ± 2.4 3.3 ± 0.1 
30 MTMOS 30 21.9 ± 2.1 2.3 ± 0.2 
30 MTMOS 45 22.4 ± 2.3 2.3 ± 0.2 
30 MTMOS 60 28.0 ± 2.9 2.5 ± 0.2 
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Figure 3.7 Nitric oxide flux from a 20 mol% NAPTMS balance TEOS (30 μL cast) 
xerogel at 37 °C in the dark (solid line) and irradiated with 200 W light at a distance of 
0.6 m (dotted line).  
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(Table 3.3). While increasing mol% and casting volume (i.e., xerogel thickness) led to 
slight increases in the observed NO fluxes, the backbone identity had seemingly no effect 
on light-induced NO fluxes from the xerogels. In general, the photoinitiated fluxes were 
comparable across all compositions. Thus, the variation in mol% and casting volume 
seemingly has a greater impact on the total reservoir of stored NO rather than the 
achievable fluxes under irradiation. Methods to achieve varied fluxes may be restricted to 
alterations to irradiation intensity (Figure 3.5). 
 
3.3.4  Material stability  
 The structural stability of a biomaterial is important to its potential utility for a 
particular biomedical application. The stability of the xerogel films was thus evaluated by 
soaking the RSNO-modified coatings in pH 7.4 PBS for 1 week. Film degradation was 
evaluated at specific intervals by monitoring the silicon concentration in solution using 
ICP-OES. In this manner, observed silicon in the soak solutions would represent 
fragmentation or instability of the siloxane bonds constituting the xerogel network. As 
the xerogels were cast on glass substrates, a measurable background of silicon was 
expected for controls.
33
 Surprisingly, the background measured for control xerogels was 
lower than glass alone (blanks). This behavior was attributed to the xerogels masking 
~50% of the surface of the substrates and reducing leached silicon from the glass. To 
control for this when assessing the fragmentation of tertiary RSNO-modified xerogels, 
both bare glass substrates and glass substrates coated with polyurethane (a non Si-
containing polymer) were employed as controls. As expected, the polyurethane-coated 
films exhibited roughly half the silicon observed for glass slides alone up to 24 h, after 
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which the difference was narrower due to delamination of the polyurethane from the 
glass substrate. Thus, the polyurethane-coated substrates are more suitable controls and 
were used for background correction to quantify xerogel leaching.  
 More leaching due to xerogels instability was observed for thicker xerogel 
coatings (controlled by casting volumes). As shown in Figure 3.8, xerogels formed using 
60 μL of sol exhibited the most fragmentation for both backbone groups. Coatings 
derived from TEOS exhibited greater fragmentation than MTMOS-based films. The 
presence of the methyl group on MTMOS likely sterically hinders cleavage of the 
siloxane backbone and provides one less hydrolyzable ligand in the network. 
Additionally, the longer reaction time for MTMOS-based films may contribute to 
enhanced condensation and stability compared to TEOS-based films. Although some Si 
leached from the xerogels, the level of leaching was still less than controls at 24 h with 
the exception of the 20 mol% NAPTMS/TEOS compositions. Longer incubation times 
(i.e., 7 d) resulted in greater observed leaching for all materials and controls. After 7 d 
PBS immersion, the MTMOS-based films were still characterized by less leaching than 
controls, while the 20 mol% NAPTMS/TEOS films leached up to 2.4 ppm silicon into 
solution at levels proportional to the thickness. Visual inspection of the films after this 
soaking verified material instability for the xerogels cast from 60 μL. However, those of 
30 and 45 μL casting volumes appeared intact, implicating the detected silicon to be due 
to microleaching and not a major detriment to material stability. Nevertheless, the 
potential toxicity concerns of such a degree of xerogel fragmentation remain unknown 
and warrant future evaluation. Although the thicker films did exhibit more fragmentation, 
Nablo et al. reported improving xerogel stability by applying thin polymer (PVC) films  
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Figure 3.8 Fragmentation for (A) TEOS and (B) MTMOS-derived xerogels during 
soaking in PBS at 37 °C for 1 week. Controls of uncoated glass substrates ( open triangle) 
and glass substrates coated with polyurethane (open circles) were treated similarly. The 
compositions are as follows: (A) 20 mol% NAPTMS, 30 μL cast (black square), 45 μL 
cast (red circle), and 60 μL cast (green triangle); 30 mol% NAPTMS, 30 μL cast (blue 
inverted triangle). (B) 20 mol% NAPTMS, 30 μL cast (blue inverted triangle); 30 mol% 
NAPTMS 30 μL cast (black square), 45 μL cast (red circle), and 60 μL cast (green 
triangle). Measurements are mean ± SD for n=3. 
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on top of NO-releasing xerogels that reduced network fragmentation when soaked in 
solution.
32
 
 The shelf-life of NO-releasing xerogels was evaluated as a function of storage 
conditions to assess the suitability of these materials for future applications and clinical 
potential. As NO release is photoinitiated from these materials, exposure to ambient light 
during storage may reduce the material’s NO release capacity. Moreover, thermally-
induced NO release may still prove to be a factor even for tertiary-derived RSNOs for 
extended storage periods. If appreciable levels of NO were liberated (either photolytically 
or thermally) in the presence of oxygen, the formation of NO2 and N2O3 would result,
50
 
making the autocatalytic decomposition of RSNOs by N2O3 a concern.
51
 Indeed, 
MPTMS-modified silica particles have previously been shown to lose NO storage 
capacity within minutes of being stored sealed under aerobic conditions, even at 
decreased temperatures (-20 °C).
15
  
 The effects of ambient light exposure, temperature, and under vacuum on NO 
payload after 30 d of storage were thus tested to evaluate the shelf life of RSNO-modified 
20 mol% NAPTMS balance TEOS (30 μL cast) xerogels. As shown in Figure 3.9, 
storage in vacuo in the dark at -20 °C were effective at preserving RSNO functionalities; 
xerogels stored in this manner exhibited the greatest NO fluxes and payloads. RSNO-
modified xerogels stored at ambient pressure in the dark at -20 °C resulted in a slight 
decrease in both achievable NO fluxes and payloads. Storage in vacuo in the dark and 
room temperature further decreased the available NO, yet yielded similar total NO 
storage to conditions of ambient pressure in the dark at -20 °C. Lastly, films stored at 
ambient pressure in the dark and room temperature were characterized as having slightly  
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Figure 3.9 Effect of various storage conditions on (A) NO flux and (B) total NO released 
for 20 mol% NAPTMS (balance TEOS, 30 μL cast) xerogels after 30 d under the 
following conditions:  in vacuo dark and -20 °C (black dashed line);  in ambient air dark 
and -20 °C (purple solid line); in vacuo dark and room temperature (blue dash dot dotted 
line);  in ambient air dark and room temperature (green dotted line); and in ambient air 
ambient light and room temperature (red dash dotted line). 
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less NO storage capacity. Overall, the total NO released for xerogels stored under these 
conditions were not vastly different from each other. As expected, the storage of films at 
ambient pressure in ambient light and room temperature was the most detrimental to NO 
storage and flux. As a whole, the results suggest that light exposure even at ambient 
levels most negatively affects long-term stability. The presence of oxygen is only 
problematic if sufficient NO is generated to result in autocatalytic decomposition of 
RSNO groups by N2O3. Due to the stability of the tertiary RSNO to thermally-induced 
cleavage, the levels of NO generated via this pathway were minimal at room temperature 
and did not lead to significant additional NO loss. The only means where enough NO was 
generated in the presence of oxygen to drastically reduce the stored NO was ambient light 
exposure. While long-term tertiary RSNO-modified xerogel stability would benefit from 
storage under anaerobic conditions at reduced temperatures, protection from light is the 
most pressing condition that must be met to ensure sufficient NO donor stability within 
xerogels. 
.  
3.3.5  Potential of RSNO-modified xerogels as photoantimicrobial surfaces  
 Prior reports of the antimicrobial nature of NO-releasing xerogels have shown 
efficacy against both gram positive (e.g., Staphylococcus aureus )
48, 52
 and gram negative 
(e.g., Pseudomonas aeruginosa)
28, 33, 52, 53
 species, as well as Candida albicans.
54
 Nablo 
and Schoenfisch indicated a threshold of ~20 pmol NO cm
-2
 s
-1
 as crucial for observing 
reduction in P. aeruginosa adhesion.
32
 The xerogels described here exhibit light-initiated 
fluxes exceeding this threshold, indicating their potential to reduce bacterial adhesion as 
well. To evaluate the anti-fouling potential of these materials, we investigated the 
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antibacterial adhesion properties for a model composition (20 mol% NAPTMS balance 
TEOS, 30 μL cast) under various NO release conditions. P. aeruginosa (108 CFU mL-1) 
were incubated under static conditions (i.e., non-nutrient, PBS) with nitrosated and 
control (unnitrosated) xerogels for 1 h at 37 °C either with exposure to 200 W irradiation 
(at a distance of 2 ft) or in the dark. The extent of bacterial adhesion was subsequently 
determined by phase-contrast optical microscopy. Light irradiation itself did not reduce 
bacterial adhesion to control xerogels (Figure 3.10). The minimal NO release from the 
RSNO-modified xerogels in the dark proved ineffective at reducing bacterial adhesion as 
expected for NO fluxes below the previously determined thresholds capable of reducing 
bacterial adhesion.
32
 Upon exposing the RSNO-modified xerogels to visible irradiation, 
the observed bacterial adhesion was significantly reduced relative to controls. Indeed, 
bacterial adhesion was reduced by 88, 87, and 87 % on RSNO-modified xerogels in the 
presence of light when compared to controls under irradiation, controls in the dark, and 
RSNO-modified xerogels in the dark, respectively (Figure 3.11). Clearly, the decrease in 
bacterial adhesion is solely due to the photoinitiated release of NO. The amount of NO 
released during this 1 h period of irradiation was ~0.08 μmol cm-2, corresponding to only 
<10% of the large reservoir of NO stored within the materials. As such, the potential of 
these materials to reduce bacterial adhesion for prolonged time is promising. Overall, 
these results illustrate the promise of these films as photoantimicrobial NO-releasing 
surfaces with enhanced NO storage stability at physiological temperatures. 
 
3.4  Conclusions 
 Future development of successful NO-based therapies hinge on the ability to store  
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Figure 3.10 Representative optical micrographs of bacterial adhesion to unnitrosated 
control (A, B) and RSNO-modified (C, D)  xerogels at 37 °C in the dark (A, C) and under 
irradiation (B, D). Black regions are the adhered bacteria. 
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Figure 3.11 P. aeruginosa adhesion to control, unnitrosated (dark) and RSNO-modified 
(light gray) 20 mol% NAPTMS balance TEOS (30 μL cast) xerogels at 37 °C in the dark 
or under irradiation. Bacterial adhesion reported as percent surface coverage. 
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and release NO in a controlled manner. The RSNO-modified xerogels described herein 
represent materials that offer such control over relase via photoinitiation. Furthermore, 
the stability of the NO reservoir is enhanced over previous NO release coatings by using 
sterically-hindered tertiary RSNOs rather than thermally labile primary RSNOs. 
Exposure to physiological temperature (i.e., 37 °C) does not significantly deplete the NO 
payload, indicating these films may be suitable for biomedical applications necessitating 
precisely controlled delivery of NO via light. The reduced bacterial adhesion observed 
for these substrates under 200 W irradiation warrants future study to determine what 
levels of irradiation result in the most ideal antifouling characteristics. Indeed, the 
generation of NO under ambient room lighting, evident by the loss of NO storage after 30 
d of ambient light exposure, suggest these materials may prove useful for common 
household or hospital surfaces requiring from bacterial disinfection. With UV irradiation, 
even more powerful antibacterial action is envisioned since such irradiation alone also 
kills microbes.
55
 
 Xerogel materials are amenable to several forms including stand-alone coatings, 
particles and dopants that allow their application to different substrates and devices. For 
example, optical fibers have been dipcoated with NO-releasing aminosilane-derived 
xerogel films to design fluorimetric pH sensors.
56
 Similar application of tertiary RSNO-
modified xerogels to optical fibers would enable NO generation from a point source. 
Akin to an endoscope, such a device could be positioned at a specific location in the body 
(e.g., a tumor mass) to facilitate localized NO release when coupled to a light source of 
appropriate intensity.  
 Alterations to the impinging irradiation proved to be more critical in achieving 
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varied NO flux as xerogel compositions of different mol% and casting volume exhibited 
diverse total NO storage but similar NO fluxes under a set irradiation intensity. The 
ability to deliver a specific NO flux determined solely by the irradiation intensity may 
allow for the systematic examination of concentration-dependant roles of NO within 
physiological systems. As NO plays a highly concentration-dependent role in tumor 
biology
57
 and the immune response,
5
 such knowledge would be beneficial in the design 
of future anticancer therapies.. As such, the potential of tertiary RSNO-modified xerogels 
encompass both their application as novel therapeutics as well as tools in elucidating 
NO’s flux-dependant role in physiology. Of course, xerogel stability and the extent of 
tolerable silicon leaching with respect to cytotoxicity require further careful study. 
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Chapter 4: 
Visible Photolysis and Amperometric Detection of S-Nitrosothiols 
 
4.1  Introduction 
 S-Nitrosothiols (RSNOs) have been determined to be highly important 
endogenous transporters of nitric oxide (NO).
1, 2
 Disease states (e.g., sepsis and asthma) 
characterized by abnormal NO levels also display similarly erratic (i.e., elevated or 
depressed) RSNO concentrations.
3
 Although comparisons of RSNO concentrations 
between disease and non-disease states have been reported,
4-6
 reliable methodology for 
quantifying basal levels of RSNOs in biological fluids remains unrealized. As such, the 
poor existing analytical methodology has resulted in a wide discrepancy of reported 
RSNO levels that span several orders of magnitude (i.e., nM–μM) in blood and plasma.5  
 To date, RSNO species are primarily measured indirectly by monitoring NO after 
S–N bond cleavage. Several methods exist for measuring NO including fluorescence,7, 8 
chemiluminescence,
9
 and electrochemistry.
10
 Similarly, varied approaches have been 
used to cleave S–N bonds, the most common being reduction and UV photolysis.4-6, 11 
While reductive cleavage is inherently encumbered by immobilization and/or the addition 
of external reagents (e.g., copper sources and reducing agents), UV photolysis is 
criticized for overestimating RSNO values due to the presence of endogenous interferents 
(e.g., nitrite) that release NO upon UV irradiation.
12
 Often overlooked, RSNOs also 
exhibit a weaker absorbance in the visible region of ~550–600 nm. Sexton and coworkers 
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have demonstrated that RSNOs may be homolytically cleaved to liberate NO via 
irradiation at either UV or visible maxima.
13
 
 The concept of coupling photolytic cleavage with electrochemical detection 
represents new analytical methodology for RSNO detection. Although previous 
electrochemical RSNO sensors have added or affixed redox reactive catalysts (e.g., 
copper nitrate and organoselenium species) and reducing agents (e.g., glutathione and 
cysteine) to NO permselective sensors, none have evaluated the use of photocatalytic 
cleavage to liberate NO.
14-21
 In this chapter, the coupling of photolytic cleavage with an 
amperometric NO sensor to facilitate RSNO detection in physiological fluids (i.e., 
plasma) is described. The restriction of photolysis to the visible region circumvents 
overestimation of RSNO values associated with UV photolysis and nitrite-derived NO.
12
 
 
4.2 Materials and Methods  
Methyltrimethoxysilane (MTMOS) was purchased from Fluka (Buchs, 
Switzerland). (Heptadecafluoro-1,1,2,2-tetrahydrodecyl)trimethoxysilane (17FTMS) was 
purchased from Gelest (Tullytown, PA). Glutathione (GSH), bovine serum albumin 
(BSA), dithiothreitol (DTT), and Antifoam B emulsion were purchased from Sigma 
Aldrich (St. Louis, MO).  L-Cysteine-HCl-H2O (Cys) was obtained from Pierce-Thermo 
Fisher Scientific (Rockford, IL.). Copper (II) nitrate was obtained from Acros Organics 
(Geel, Belgium). Type A21 200 W Sylvania incandescent light bulbs were purchased 
from Lowe’s (Chapel Hill, NC). A LDCU3/3663 10 mW 532 nm laser was obtained from 
Power Technology, Inc. (Alexander, AR) and coupled via a SMA905 connector and bare 
fiber adaptor to a 1000 μm fiber from Ocean Optics (Dunedin, FL). An X-Cite 120 
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Fluorescence Illumination System with a 120 W lamp was obtained from Lumen 
Dynamics (Mississauga, Ontario). The source was outfitted with a green filter at the end 
of the liquid wave guide to restrict the output from 500–550 nm. Distilled water was 
purified to 18.2 M∙cm with a Millipore Milli-Q Gradient A-10 water purification 
system (Bedford, MA). All other solvents and chemicals were analytical-reagent grade 
and used as received. 
 
4.2.1  Preparation of NO-permselective Xerogel-Modified Electrode  
Xerogel-modified electrodes were prepared according to Shin et al.
22
 Briefly, 
platinum disk (2 mm diameter) electrodes sealed in Kel-F (total 6 mm diameter, CH 
instruments) were mechanically polished. A 20% 17FTMS, balance MTMOS (v:v) silane 
solution was prepared by dissolving 60 μL of MTMOS in 300 μL of ethanol. Sequential 
addition of 15 μL of 17FTMS, 80 μL of water, and 5 μL of 0.5 M HCl was followed by 
gentle agitation. The resulting solution was mixed for 1 h at room temperature. After the 
1 h of mixing, 1.5 μL of solution was cast on the electrode surface and the electrode was 
gently rotated to ensure even coating. The xerogel was allowed to cure for 24 h at 
ambient conditions. 
 
4.2.2  Preparation of S-Nitrosothiols 
A modified procedure that has previously been reported for preparing low 
molecular weight RSNOs was used in this study.
18
 Briefly, equal volumes of 5 mM thiol 
(i.e., GSH or Cys) in 120 mM sulfuric acid and of 5 mM sodium nitrite with 20 μM 
ethylenediaminetetraacetic acid (EDTA) were mixed to promote nitrosation of the thiols. 
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To prepare S-nitrosoalbumin (AlbSNO), a modified procedure reported by Stamler et 
al.
23
 was used whereby an aqueous solution of BSA (200 mg mL
-1
, ~3 mM) was prepared 
and mixed with 1.5 mM sodium nitrite in 0.5 M HCl for 30 min at room temperature. A 
less than stoichiometric amount of acidified nitrite was used to minimize nitrosamine 
formation on tryptophan residues of BSA.
24, 25
 Resulting RSNO concentrations were 
verified via their UV absorption maxima at 335 nm (ε = 503, 586, and 3869 M-1 cm-1 for 
S-nitrosocysteine (CysNO), S-nitrosoglutathione (GSNO), and AlbSNO, respectively.
26
 
 
4.2.3  Chemiluminescent Analysis of S-Nitrosothiols  
Gas phase NO release from RSNOs was measured using a Sievers 280i 
Chemiluminescence Nitric Oxide Analyzer (NOA) (Boulder, CO). Calibration was 
performed with air passed through a Sievers NO zero filter and 26.8 ppm NO (balance 
N2) gas. Samples were injected into 25 mL of deoxygenated pH 7.4 phosphate buffered 
saline (PBS) containing 500 μM diethylenetriaminepentaacetic acid (DTPA) to chelate 
trace copper and sparged with 80 mL min
-1
 N2 stream. Additional N2 was supplied to the 
reaction vessel to match the instrument collection rate of 200 mL min
-1
. Nitric oxide 
analysis was performed in the dark at room temperature and by irradiating the reaction 
flask normal to its side with the light source at a distance of ~5 inches. 
 
4.2.4  Electrochemical Analysis of S-Nitrosothiols in Phosphate Buffered Saline 
Electrodes were placed in a three-electrode configuration consisting of an 
Ag/AgCl reference electrode (3.0 M KCl, CH Instruments (Austin, TX)), a Pt counter 
electrode, and the xerogel-modified NO-selective working electrode. Sensors were 
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polarized at 0.8 V (vs. Ag/AgCl) for ≥1 h and tested in 40 mL of deoxygenated PBS with 
DTPA (prepared via sparging with nitrogen during polarization) with constant stirring at 
room temperature. Electrooxidation currents were recorded with a CH Instruments 660A 
potentiostat. Analyses were run first in the dark while monitoring background current 
from photoelectric interference. This background was subtracted from amperometric 
responses to NO. Calibrations were carried out via a separate solution method for each 
concentration. 
 
4.2.5  Electrochemical Analysis of S-Nitrosothiols in Plasma 
Fresh, whole porcine blood was drawn into EDTA as an anticoagulant at a 
volume ratio of 9:1 (final EDTA concentration 5 mM). Platelet-rich plasma was obtained 
by centrifuging the blood at 2000xg for 30 min. Plasma was either analyzed as 
oxygenated or deoxygenated (with addition of 0.1% v:v Antifoam B emulsion and 
nitrogen sparging). 
 
4.3  Results and Discussion 
 
4.3.1  Analysis of Low Molecular Weight RSNOs  
 The xerogel-modified NO-selective sensor used in this study has been previously 
characterized.
22
 In that report, sensor membrane fabrication was optimized (e.g., 
fluorosilane content of the membrane and thickness) to provide the largest permeability 
to NO while maintaining the greatest selectivity over common interferents (e.g., nitrite). 
A thickness of 9.6 μm was reported to yield the greatest response and thus this was used 
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in the studies described in this chapter. As the validity of the electrochemical sensor 
membrane for accurate NO measurements has been well characterized (reported 83 pM 
detection limit for xerogel-modified microelectrodes), initial studies focused on 
evaluating the photolytic cleavage of RSNOs. 
 Conventional chemiluminescence nitric oxide detection was used to investigate 
the feasibility of detecting liberated NO from S-nitrosoglutathione (GSNO) and S-
nitrosocysteine (CysNO), two common endogenous low molecular weight (LMW) 
RSNOs, after irradiation with visible light. Selection of a suitable light source had a 
significant impact on the feasibility of this RSNO detection scheme. White light 
generated from 200 W incandescent bulbs adequately liberated NO from LMW RSNOs. 
Unfortunately, concomitant temperature increases during irradiation convoluted the NO 
data as thermally-induced RSNO decomposition proved considerable under these 
conditions. To circumvent irradiating the entire sample with broadband light (to lessen 
any temperature increases), fiber optic light guides were coupled with a 532 nm laser 
source to direct high intensity light at the sample. Using this geometry the highly focused 
light source did not effectively irradiate enough bulk solution, resulting in minimal if any 
signal from the RSNOs. Light from a 120 W mercury vapor arc lamp was next filtered to 
500–550 nm to irradiate more sample. This light source setup was sufficiently diffuse and 
of high enough intensity to generate appreciable response to RSNOs without undesirable 
sample heating. As shown in Figure 4.1, this setup triggered near constant levels of NO 
release from the RSNOs during the course of irradiation. Nitric oxide levels subsided 
when irradiation ceased and were observed to increase again upon re-irradiation  
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Figure 4.1 Chemiluminescent detection of 5.0 μM solutions of GSNO (dashed line) and 
CysNO (solid line). The 7 min period of irradiation with visible light is noted. 
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illustrating the photoswitchable NO liberation typical of RSNOs.
1
 As such, periods of 
visible irradiation resulted in controlled RSNO decomposition and NO generation.  
 Gas phase detection of NO is amenable to the indirect measurement of RSNOs 
because of the gaseous nature and low aqueous solubility of NO.
5
 While more 
analytically challenging, the benefits associated with solution-based NO detection via 
electrochemistry include enhanced sensitivity, rapid response, inexpensive 
instrumentation, and potential for miniaturization and application to physiological 
milieu.
8, 10
 With the use of an NO sensitive and selective sensor,
22
 the amperometric 
response of LMW RSNOs during visible irradiation was examined by positioning the 
light source near/on the electrode to yield an amperometric response to RSNOs. While 
we believed that irradiation directed to the electrode surface would enhance response 
since RSNO decomposition would occur in close proximity to the electrode surface, 
significant photoelectric interference (a steady response in the absence of analyte) was 
observed instead. The light source was then positioned normal to the side of the electrode 
(i.e., perpendicular to the electrode surface) for subsequent experiments to minimize this 
interference. As shown in Figure 4.2, irradiation of RSNOs in oxygenated solutions of 
PBS resulted in minimal amperometric signal. We attribute such behavior to NO’s rapid 
reaction with oxygen to form NO2 which may be further oxidized to nitrite and nitrate in 
oxygenated solutions. In this manner, NO is rapidly removed from solution, thus 
diminishing the NO-dependant response.
27
 Deoxygenating the solution by sparging with 
nitrogen gas before analysis allowed significantly greater response during the irradiation 
period. As shown in Figure 4.3, a typical sensor response exhibited a linearly increasing 
current once irradiation was initiated. This response stabilized only after irradiation was  
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Figure 4.2 Representative amperometric response to 2.5 μM GSNO in oxygenated 
(dashed line) and deoxygenated (solid line) PBS. The 7 min period of irradiation with 
visible light is noted. 
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Figure 4.3 Representative amperometric response to 5.0 μM GSNO in deoxygenated 
PBS. The 7 min period of irradiation with visible light is noted. 
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ceased. The increasing current corresponded to a linearly increasing concentration of NO 
due to the near steady rate of RSNO decomposition as corroborated with the 
chemiluminescence data (Figure 4.1). The benefit of such behavior is that the irradiation 
time may be used to tune the analytical utility of this methodology. For example, longer 
irradiation periods may promote greater NO production thus enhancing the measured 
current and lowering the RSNO detection limits for this scheme. In contrast, shorter 
periods would yield smaller signals more rapidly (i.e., decreased analysis time). RSNO 
analysis employing this methodology is in turn customizable to meet the needs of a 
specific study. Although calibration was assessed using separate solutions for each RSNO 
concentration, multiple injections into the same solution enables calibration of sensor 
response by plotting the change in current during each irradiation period (i.e., not the 
additive current from all previous injections and irradiation periods, but only the change 
for each subsequent irradiation period). This behavior is shown in Figure 4.4 whereby the 
enhanced rates of current production (i.e., increased slope of sensor response) due to the 
pseudo first-order kinetics of photolysis is plotted as a function of irradiation period after 
each additional injection.
1
 
 Throughout the entire period of irradiation examined (up to 7 min), the response 
to increasing LMW RSNO (i.e., GSNO and CysNO) concentration was linear (Figure 
4.5). Periods longer than 7 min resulted in slight deviation from linearity, suggesting an 
upper limit where the amount of NO liberated from RSNOs is no longer at a steady rate 
and begins to diminish, as noted for the chemiluminescent data (Figure 4.1). Likewise, 
the amperometric responses to GSNO and CysNO were comparable with GSNO giving a 
slightly higher sensitivity than CysNO (Table 4.1.). This disparity in response was also 
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Figure 4.4 Representative amperometric response to injections of CysNO in 
deoxygenated PBS followed by 7 min periods of irradiation with visible light to calibrate 
response. 
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Figure 4.5 Calibration curves of amperometric response to GSNO (open shapes) and 
CysNO (filled shapes)  at either 1 (square), 4 (circle), or 7 min (triangle) of visible 
irradiation. Data is represented as means ± SD (n ≥3). 
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Table 4.1 Effect of irradiation time on amperometric sensitivity and limit of detection to a 
range of S-nitrosothiol species. 
 Sensitivity (nA μM
-1
) Limit of Detection (μM) 
 Irradiation Time (min) 
RSNO species 1 4 7 1 4 7 
CysNO (PBS) 0.27 0.92 1.31 0.18 0.05 0.04 
GSNO  0.33 1.08 1.56 0.14 0.04 0.03 
AlbSNO  0.02 0.08 0.11 2.66 0.61 0.42 
CysNO (plasma) 0.03 0.05 0.07 0.40 0.24 0.17 
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 reflected in the compounds’ molar absorptivities at 545 nm (ε = 17.2 and 14.9 M-1 cm-1 
for GSNO and CysNO, respectively).
26
 Nevertheless, the similar sensitivities illustrate 
the potential of this methodology to analyze multiple LMW RSNOs. While an irradiation 
period of 7 min facilitated the greatest sensitivity, 1 min of visible light exposure still 
provided linear response with suitable sensitivity (0.33 and 0.27 nA μM-1 for GSNO and 
CysNO, respectively). Of note, the sensitivities achieved with varying irradiation times 
were acquired with the same electrode. The reported electrochemical sensitivities are 
meant to illustrate tunability. The innate sensitivity of the electrode to NO is not changing 
in this method. As shown in Table 4.1, theoretical detection limits (based on S/N =3) may 
be lowered with longer irradiation times, highlighting the interplay between analysis time 
and sensitivity for this methodology. While the responses were linear for 0.16–5.0 μM 
RSNO throughout the irradiation period, improved linearity was noted at higher 
concentrations (0.6–5.0 μM RSNO). For example, the linearity from 0.16–5.0 μM was 
characterized with an R
2
 = 0.9804 at 7 min of irradiation for CysNO, while an R
2
 = 
0.9916 was achieved for 0.6–5.0 μM. The deviation from linearity at lower 
concentrations (i.e., 160 nM) suggests that feasible detection limits may be dependent on 
the light source intensity. Indeed, the total amounts of NO released during irradiation for 
CysNO and GSNO elucidated by chemiluminescence were ~0.07 and 0.11 μmol NO per 
μmol of RSNO, respectively. As each RSNO molecule binds one molar equivalent of NO, 
this amount corresponds to only 7 and 11% RSNO to NO liberation efficiency during the 
7 min of irradiation for CysNO and GSNO, respectively. We predict that greater intensity 
sources would improve RSNO to NO conversion thus enhancing overall sensitivity, 
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lowering detection limits, and extending the linear range. Unfortunately, such sources 
were not available for this study. 
 The superior sensitivity of the NO-permselective electrode warranted the 
investigation of its coupling with reductive-based RSNO cleavage for comparison. The 
influence of copper (II) nitrate, varied reducing agents (e.g., DTT and GSH), and their 
concentrations (1–10 μM) on the measurement of GSNO in PBS was thus evaluated 
employing similar xerogel-modified electrodes. While signal (i.e., current) was observed 
upon injection of copper nitrate with and without DTT into solutions of GSNO, the use of 
GSH as a reducing agent proved most efficient in converting Cu(II) to Cu(I), the required 
active species for RSNO decomposition, and yielded the most rapid response (Figure 4.6). 
The observed signal using Cu(II) (without added reducing agent) may be attributed to 
trace thiol in the RSNO solution generating active Cu(I).
28
  Experiments were performed 
with Cu(II) opposed to directly utilizing Cu(I) as Cu(I) compounds are generally 
insoluble in water.
29
 After systematically examining the concentration dependency of 
these reagents (Figure 4.7), it was found that injecting a freshly mixed solution of 10 μM 
copper nitrate and 10 μM GSH generated the greatest and most rapid GSNO response. As 
might be expected, the copper-mediated reductive cleavage yielded larger currents than 
visible photolysis due to the visible light only weakly cleaving the S–N bond while the 
reductive pathway employed a large concentration to afford the greatest response by near 
complete RSNO to NO conversion.
19
 Nevertheless, the benefit of visible photolysis is the 
avoidance of additional reagents. As such, visible photolysis was the focus of the 
remainder of our studies. 
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Figure 4.6 Representative amperometric response to 2.0 μM GSNO upon injection of 2.5 
μM copper nitrate with 10 μM GSH (solid line), 10 μM DTT (dashed line), or alone (no 
reducing agent, dotted line). 
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Figure 4.7 Amperometric response to 2.0 μM GSNO upon injection into (A) 2.0 μM 
copper nitrate and 1 (dashed line), 4 (dotted line), 6 (thin solid line) or 10 μM (thick solid 
line) GSH and (B) 2.0 μM GSH and 1 (dashed line), 3 (dotted line), 5 (thin solid line) and 
10 μM (thick solid line) copper nitrate. 
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4.3.2.  Analysis of Macromolecular RSNOs 
 Nitrosated proteins, particularly nitrosated serum albumin (AlbSNO), constitute a 
majority of RSNO species in circulation.
30
 Thus, RSNO analysis of physiological fluids 
would benefit from a simple method capable of quantifying nitrosated macromolecules. 
Of note, the utility of previous electrochemical RSNO sensor designs has only been 
demonstrated for nitrosated proteins in the presence of additional cysteine that promotes 
transnitrosation (i.e., direct transfer of the nitroso moiety) between the protein and LMW 
thiol.
20
 The subsequent amperometric response is attributed to CysNO 
formation/detection.  
 Similar to the LMW RSNO species, the amperometric response to AlbSNO 
during irradiation was investigated as a function of the RSNO to NO liberation protocol 
(Figure 4.8.). While detection of AlbSNO was achieved with visible light photolysis, the 
sensitivity was greatly reduced compared to the LMW RSNOs (Table 4.1). In addition, 
the theoretical detection limit was also much greater, partly explaining the large 
variability and limited linearity observed. Chemiluminescent analysis of AlbSNO 
corroborated this hypothesis by indicating only 3% conversion of RSNO to NO during 
the 7 min irradiation period (Figure 4.9). The reduced AlbSNO to NO conversion 
efficiency was noted by others previously.
5
 While AlbSNO exhibits a greater molar 
absorptivity than typical LMW species at 545 nm (3869 vs. 17.2 M
-1
 cm
-1
, 
respectively),
26
 the unusual stability of the protein-based S–N bond relative to LMW 
species has been well characterized and evident by more stable NO storage.
23
 As shown 
in Figure 4.9, irradiation with visible light seemed to sustain the NO generation rather 
than enhance it as was the case for LMW RSNOs, suggesting irradiation periods longer  
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Figure 4.8. Calibration curves of amperometric response to AlbSNO after 1 (square), 4 
(circle), and 7 min (triangle) of visible irradiation. Data is represented as means ± SD (n 
≥3). 
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Figure 4.9 Chemiluminescent measurement of AlbSNO to NO liberation with the 7 min 
period of visible light irradiation noted. AlbSNO concentration was 1.0 μM. 
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than 7 min may not be limiting in achieving increased response to macromolecular 
species. Of note, longer analysis periods proved too great of an analytical burden for the 
incremental increases in current and were thus not evaluated further. Although less 
sensitive to nitrosated proteins, the ability for direct measurement (i.e., without relying on 
transnitrosation to LMW RSNOs) sets this strategy apart from previous electrochemical 
macromolecular RSNO detection schemes. 
 
4.3.3.  Detection in Plasma 
 Investigating the efficacy of RSNO detection in physiological fluids is necessary 
to evaluate the potential of this methodology for biologically-relevant studies (e.g., the 
study of RSNO fluctuations in blood).
3
 Initial efforts to detect RSNOs in 40 mL of whole 
blood proved problematic (i.e., no appreciable signal), ostensibly due to an inability of 
the light to penetrate the sample and scattering/absorbance from red blood cells. Previous 
studies have shown RSNO  photoinstability in blood for samples exposed to ambient 
light in vessels with  large surface area to volume ratios (i.e., surgical butterfly tubing), 
suggesting detection feasibility using photolytic cleavage if adequate light penetration is 
achieved.
31-33
 Nevertheless, the greater translucency of plasma represents a more suitable 
matrix for ex vivo analysis. Similar to PBS, oxygenated plasma showed little response 
during irradiation. In contrast, irradiating a fresh sample of deoxygenated plasma for 7 
min led to a current response of ~0.2 nA that may be ascribed to endogenous RSNO 
species. Subsequent additions of CysNO to calibrate the sensor response in plasma 
resulted in a sensitivity of only 0.07 nA μM-1, illustrating unexpected diminished 
analytical performance in this physiological matrix (Figure 4.10 and Table 4.1). Previous  
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Figure 4.10. Representative amperometric response to injections of CysNO in 
deoxygenated plasma followed by 7 min periods of irradiation with visible light. Of note, 
the small current response illustrates the presence of photoelectric interference that is 
baseline subtracted prior to analysis.  
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work has noted similarly diminished sensitivity in physiological fluids, and have 
attributed such response to rapid scavenging of NO by proteins (e.g., cell-free 
hemoglobin).
5, 10, 34
 In this instance, the slight opacity of plasma (compared to PBS) may 
also diminish sensitivity. Nevertheless, the response for this configuration was linear (R
2
 
= 0.9949) with a limit of detection of 0.17 μM for 7 min of irradiation. Due to disparate 
sensitivity to LMW and protein RSNOs, determination of the endogenous levels of 
RSNOs in plasma using this approach remains convoluted. However, the lessened 
sensitivity to AlbSNO in PBS and further reduced sensitivity in plasma indicates that this 
methodology may prove useful for selective measurement of LMW RSNOs in 
physiological fluids. Indeed, injections of AlbSNO into plasma did not result in any 
appreciable increase in sensor response. Based on this knowledge and the sensitivity in 
plasma, the calculated amount of endogenous LMW RSNO species in the porcine plasma 
sample was determined to be ~2.79 μM. Comparative study of analytical methodologies 
is still necessary to confirm this concentration as it is at the higher end of the previously 
reported range (i.e., 1 nM to 10 μM) of plasma RSNO levels.5 
 
4.4.  Conclusions 
 The analytical methodology developed in this work represents the first coupling 
of photolytic cleavage with electrochemical RSNO detection. The sensitivity to LMW 
RSNOs achieved after 7 min of irradiation surpasses that of recently reported RSNO 
electrochemical sensors,
17, 20
 in part due to the use of an analytically superior NO-
permselective electrode. The studies described in this work were not designed for a 
clinical goal, but rather to demonstrate the utility and response tunability.  Both the light 
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source and corresponding electrode materials may be optimized further to aid in the 
detection of RSNOs when using this method for a specific application. For instance, the 
use of higher intensity sources may increase the observed signals while more narrow 
visible light filters may lead to increased selectivity for specific RSNOs. Miniaturized 
needle type microelectrodes and the use of fiber optics may extend the use of this 
methodology to in vivo analysis. 
 To broaden the analytical utility of this method, future studies aim to increase the 
RSNO to NO conversion efficiency to enhance the signal and shorten associated response 
times. Besides increased light intensity, this may be facilitated using microfluidic device 
technology.
35
 Indeed, thin channels and small sample volumes would enable a larger 
portion of the sample to be irradiated to produce NO. The narrow channels and 
corresponding thin sample cross sections may also decrease sample opacity and red blood 
cell scattering, facilitating RSNO analysis in whole blood.
31-33
 Although early studies 
demonstrated a laser source was insufficient to generate appreciable signal from the bulk 
solution of RSNOs, the smaller sample requirements of microfluidic devices may benefit 
from the use of such highly focused sources. Studies are currently underway in our 
laboratory to integrate NO-permselective electrodes within microfluidic devices and 
evaluate their promise for RSNO detection via photolysis. 
 A thorough comparative investigation must still be undertaken with the use of 
these and previously reported devices
14-21
 to more accurately determine the actual basal 
levels of RSNOs in blood. Careful attention to sample handling and preparation are 
obviously critical to the validity of such measurements.
5, 6, 36
 Once determined, the future 
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application of such devices for point-of-care diagnostics and prognostics may finally be 
achieved and guide clinical intervention and disease outcome.
3
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Chapter 5:  
Summary and Future Directions 
 
 
5.1  Summary  
 S-Nitrosothiols are a unique class of NO transport/delivery vehicle that have both 
found utility as exogenous therapeutics and play pivotal roles endogenously as stable NO 
transporters.
1, 2
 The design and modification of sol-gel derived scaffolds (e.g., silica 
particles and polymeric coatings) with RSNO functionalities stands to benefit the 
biomedical arena by providing materials with enhanced NO storage and varied release 
characteristics. In turn, new antibacterial agents and biocompatible device coatings may 
be envisioned with longer, more stable NO release. Furthermore, the importance of 
RSNOs as physiological transporters of NO bioactivity warrants investigation into 
accurate characterization of their concentration through the development of improved 
analytical methodology. 
 In Chapter 2, the synthesis of RSNO-modified silica particles was described as a 
strategy for storing/releasing larger concentrations of NO. Specifically, sol-gel chemistry 
was used to introduce the thiol precursor modification into a silica network via co-
condensation of mercaptosilane (i.e., MPTMS) and alkoxysilane precursors (i.e., TEOS 
and TMOS). Both the concentrations of reactants (i.e., water, ammonia, and silane) and 
the silane feed rate into the reaction vessel proved important for yielding monodisperse, 
spherical particles with diameters ranging from 241–718 nm. Control over size was most
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 impacted by the concentration of water in the reaction. For example, decreasing the 
water content from 32.5 to 16.2 M, resulted in altering the size from 416 to 718 nm for 
the 75 mol% MPTMS (balance TEOS) composition. Elemental analysis revealed that the 
amount of sulfur in the particles whose sizes were tuned in this manner remained constant. 
Thus, conversion to RSNO (NO donor form) yielded particles of distinct size with 
comparable material composition and NO storage. Indeed, subsequent nitrosation 
resulted in NO storage approaching ~4.40 µmol NO mg
-1
 for the range of particle 
compositions. Behaving similar to low molecular weight S-nitrosothiol NO donors, the 
NO release from the macromolecular silica vehicles was found to be influenced by light, 
temperature, and metal ions. When the NO release was triggered strictly by thermal 
decomposition at physiological temperature, the particles released a total of 1.17 μmol 
NO mg
-1
 over 2 d with a corresponding half life of ~3 h. These NO release characteristics 
illustrate the great therapeutic potential of such materials. 
 In Chapter 3, the synthesis of a tertiary thiol-bearing silane precursor (i.e., 
NAPTMS) was described to enable enhanced NO storage stability at physiological 
temperature. The novel silane was co-condensed with a range of alkoxy- and 
alkylalkoxysilanes (i.e., TMOS, TEOS, MTMOS, and BTMOS) under various synthetic 
parameters to systematically evaluate the formation of stable xerogel films. Resulting 
xerogels were subsequently nitrosated to yield tertiary RSNO-modified coatings. 
Variation in both the concentration of the NAPTMS and xerogel coating thickness 
provided the greatest tunability in the amount of total NO storage for the films (0.87–1.78 
μmol cm-2). While some formulations (i.e., thicker coatings) exhibited minimal 
fragmentation upon soaking in solution at physiological temperature for up to 1 week, 
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others proved very structurally stable. Steric hindrance surrounding the nitroso 
functionality improved the thermal stability of the tertiary RSNO donor compared to 
previous primary RSNO-modified xerogels,
3
 resulting in limited NO release at 
physiological temperature. The stability of the xerogels’ NO reservoirs allowed 
photolysis to be used as a more selective trigger for controlled NO delivery. Over a 1 h 
incubation period at 37 °C, average NO fluxes were an order of magnitude larger under 
irradiation than in the dark for a given composition (e.g., 22.7 ± 3.0 vs. 2.7 ± 0.4 pmol 
cm
-2
 s
-1
 for the 20% NAPTMS balance TEOS, 30 μL cast composition, respectively). The 
utility of such controllable NO-releasing films was demonstrated in their ability to 
significantly reduce bacterial adhesion (by ~90 %) exclusively under irradiation.  
 In Chapter 4, the coupling of visible photolysis (i.e., 500–550 nm) and 
amperometric NO detection was discussed as a simpler, potentially more selective and 
sensitive RSNO detection scheme than currently employed analytical methodology. The 
use of photolysis to cleave the S–N bond and generate detectable NO avoids the necessity 
of adding, immobilizing, or affixing reductive catalysts and reducing agents to the sensor 
surface as necessary for previous RSNO sensor formulations.
4-7
 Furthermore, restriction 
of irradiation to the visible range alleviates concerns of overestimating RSNO levels, a 
criticism of previous methodology employing UV photolysis.
8
 The amount of irradiation 
(i.e., exposure time) enables tunability as well. For example, increasing the irradiation 
time both enhanced sensitivity up to 1.56 nA μM-1 and lowered theoretical detection 
limits (down to 30 nM) for low molecular weight RSNOs (i.e., S-nitrosoglutathione, S-
nitrosocysteine). The similar susceptibility of these species to visible photolysis enabled 
their detection with comparable sensitivity, suggesting this method is appropriate for 
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detection of a range of low molecular weight RSNO species. Detection of nitrosated 
proteins (i.e., S-nitrosoalbumin) was also possible, albeit at a decreased sensitivity (0.11 
nA μM-1). Nevertheless, this represents an advantage over previous RSNO sensors 
incapable of directly detecting nitrosated macromolecules.
4-7
 The detection scheme was 
successfully applied to RSNO detection in biological fluids (i.e., plasma). Although the 
sensitivity was further decreased and detection seemingly restricted to low molecular 
weight RSNOs in this instance, it still illustrates the potential of this method for future  
physiological analysis of RSNOs. 
 
5.2  Future Directions 
 Large NO storage, monodispersity, and tunable size position the RSNO-modified 
particles described in Chapter 2 as both polymer dopants and NO release therapeutics. 
The non-ionic character of the nitroso moiety and the larger size of the particles may 
enable greater retention within polymeric films to improve the design of stable NO-
releasing polymers by preventing leaching. Indeed, work in this area has already been 
initiated by Koh et al. and preliminary results suggests RSNO-modified particles are 
superior NO release polymer dopants than their N-diazeniumdiolate counterparts in terms 
of extending NO release durations from these films.
9
 
 The bactericidal efficacy of these materials against both planktonic bacteria
10
 and 
established biofilms
11
 was previously described for N-diazeniumdiolate silica particles 
indicating great promise for NO release silica compared to their low molecular weight 
analogues. Extending these studies to use RSNO-modified particles may provide insight 
into how extended NO release from a material and NO release via a different NO donor 
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affects the bactericidal efficacy against such systems. Characterizing the efficacy of these 
RSNO particles against bacteria is necessary to evaluate their true promise as a potential 
antimicrobial therapeutic. 
  The ability to tune particle size while maintaining consistent NO storage and 
composition (e.g., sulfur content) of the RSNO-modified particles opens up numerous 
avenues of study. The effects of size and surface charge may be deconvoluted from NO 
release properties to provide insight into new information such as how bacterial efficacy 
and association are affected by size. Current work has been initiated in this area for N-
diazeniumdiolate particle systems by Carpenter et al.
12
 Extending such work to RSNO-
modified particles may provide additional insight. Of note, Carpenter et al. used sol-gel 
chemistry in conjunction with a reverse microemulsion technique to control particle 
size.
12
 The use of such a method in the synthesis of RSNO-modified particles may enable 
diameters <~240 nm to be achieved, further enhancing the number of NO release vehicle 
compositions available for study and application. 
 As described in Chapter 3, tertiary RSNOs are more stable than their primary 
counterparts.
1
 Thus, the tertiary RSNO silane precursor (NAPTMS) reported in Chapter 3 
should be evaluated in the synthesis of silica particles via sol-gel chemistry. Due to the 
thermal stability of such RSNOs, particles derived from these may prove beneficial as 
NO-releasing photoantibacterial therapeutics. Additionally, the enhanced thermal 
stability may still provide significant levels of NO release at a device/tissue interface if 
particles were doped into a polymer layer at an adequate weight percent. Such sustained 
NO release may improve the long-term biocompatibility of medical devices plagued by 
the foreign body response in the chronic phase.
13
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 Previously reported N-diazeniumdiolate xerogels lacked sufficient analyte 
permeability to function as adequate glucose sensor membranes, attributed to exposure to 
high pressures of NO necessary to form the NO donor.
14
  As exposure to such harsh 
conditions is not necessary to form RSNO donors, RSNO-modified xerogels may prove 
more promising as sensor membranes. Although the NO release at physiological 
temperature alone was not sufficient to reduce bacterial adhesion to these xerogels, the 
level of NO required to benefit/influence to wound healing, collagen deposition, and 
angiogenesis may be lower, thus still positioning these xerogels as potential biomaterial 
membranes. For example, the low NO fluxes of the tertiary xerogel system in the dark 
may prove beneficial in mitigating platelet adhesion as Robbins et al. previously reported 
NO fluxes of only 0.4 pmol cm
-2
 s
-1
 capable of reducing platelet adhesion to surfaces.
15
 
The use of these materials as intravascular device/sensor coatings may thus prove more 
beneficial in the absence of direct irradiation. 
 The photoinitiated antimicrobial action reported in Chapter 3 suggests that tertiary 
RSNO xerogels would prove highly beneficial for a range of applications. A thorough 
evaluation of what levels of irradiation elicit what specifics fluxes of NO is necessary to 
truly determine the potential of these materials. For instance, the possibility of steady 
fluxes of NO during exposure to ambient room lighting may enable application to both 
hospital and household disinfectants. Furthermore, light-controlled NO fluxes may open 
new avenues of research and understanding into the concentration-dependent roles of NO. 
on a fundamental level. Tumor development is one example where the concentration of 
NO proves to be either deleterious or beneficial.
16
 Specific fluxes of NO generated via 
light may prove useful in evaluating the threshold of NO required for tumoricidal activity. 
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Stevens et al. previously reported the antitumor efficacy of NO-releasing sol-derived 
materials.
17
  The use of photodynamic therapy is also a well known treatment in 
oncology.
18
 Thus, similar means of treatment may be employed with the use of high 
intensity light to liberate large concentrations of NO from xerogel materials near tumor 
sites. For instance, an optical fiber dipcoated with the tertiary RSNO-modified xerogel 
may provide directed NO release to tumors.  
 The work discussed in Chapter 4 was preliminary but the results indicate clinical 
potential. To further develop this methodology, the intensity of the light source should be 
investigated. Increased RSNO to NO conversion efficiency would undoubtedly improve 
the response time and increase the sensitivity of the method. By varying the wavelength 
of visible irradiation and intensity, the selectivity to specific RSNO species may be 
enhanced depending on their susceptibility to decomposition at a given wavelength. For 
example, SNAP has a maximum absorbance at 591 nm whereas GSNO absorbs at 544 
nm.
1, 2
 Although SNAP is not found endogenously, such selectivity could prove useful for 
analysis in instances when SNAP is administered as a therapeutic. The overall selectivity 
of this technique warrants a systematic study comparing UV and visible irradiation to 
ensure that visible photolysis is more selective over other NOx species such as nitrite. 
 As described in Chapter 4, the possibility of reductive-based cleavage coupled 
with sensitive fluorosilane xerogel-based NO analysis suggests an alternative scheme of 
RSNO detection with higher sensitivity. The ability to measure nitrosated proteins and 
low molecular weight RSNO species other than GSNO should be evaluated next. 
Miniaturization and integration of both photolytic and reductive detection schemes into a 
microfluidic device is a long-term future direction. The minimal sample volume and large 
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surface area to volume associated with microfluidic channels may facilitate enhanced 
RSNO to NO conversion via photolysis. Additionally, the channels could be used to mix 
large concentrations of copper and reducing agent to generate appreciable amounts of 
Cu(I) in situ, possibly enhancing the RSNO to NO decomposition and ensuing sensor 
response. 
 The ease of applying xerogel membranes to varied surfaces and their optical 
transparency suggests that the use of an optically transparent electrode material (i.e., 
indium tin oxide) and a fiber optic system may allow complete integration of the light 
source, NO-permselective membrane, and the electrode into one device. For example, 
Van Dyke and Cheng have reported on a fiber optic-based spectroelectrochemical 
probe.
19
 A similar design could be used for RSNO detection once modified with the NO-
permselective membrane. While photoelectric interference may be a large problem in this 
instance, such an integrated device would potentially enable in vivo determination of 
RSNO levels. Clearly the ultimate goal of developing this methodology is its application 
to the detection of basal RSNO levels in physiology. The most sophisticated sensor 
designs should thus be evaluated against other methods of RSNO detection to definitively 
assess basal levels of RSNOs in physiological fluids. Once complete, such technology 
may prove useful in disease state assessment. 
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